{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "e1476db9",
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "6d3c5fa7",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\IPython\\core\\interactiveshell.py:3444: DtypeWarning: Columns (0,27) have mixed types.Specify dtype option on import or set low_memory=False.\n",
      "  exec(code_obj, self.user_global_ns, self.user_ns)\n"
     ]
    }
   ],
   "source": [
    "cd=pd.read_csv(\"C:\\\\Users\\\\rabhi\\\\OneDrive\\\\Documents\\\\All.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "874248f8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>...</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>URL</th>\n",
       "      <th>Unnamed: 27</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1.0</td>\n",
       "      <td>NCT05876325</td>\n",
       "      <td>Financial and Insurance Assistance- Oncology F...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Financial Stress|Pediatric Cancer</td>\n",
       "      <td>Other: FINassist</td>\n",
       "      <td>FINassist Feasibility|FINassist Adherence|FINa...</td>\n",
       "      <td>Jean Edward|Robert Wood Johnson Foundation|Uni...</td>\n",
       "      <td>...</td>\n",
       "      <td>April 1, 2021</td>\n",
       "      <td>September 1, 2022</td>\n",
       "      <td>December 31, 2022</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>University of Kentucky DanceBlue Pediatric Hem...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05876325</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2.0</td>\n",
       "      <td>NCT05875532</td>\n",
       "      <td>Study of Progression to Progressive Fibrosing ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Lung Diseases, Interstitial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Incidence probability of progression to PF-ILD...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>...</td>\n",
       "      <td>April 20, 2023</td>\n",
       "      <td>May 1, 2023</td>\n",
       "      <td>May 1, 2023</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>Boehringer Ingelheim Pharmaceuticals, Inc., Ri...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05875532</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3.0</td>\n",
       "      <td>NCT05874817</td>\n",
       "      <td>Retrospective Assessment of AE-Related Healthc...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Percentage of patients with adverse events (AE...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>...</td>\n",
       "      <td>May 1, 2021</td>\n",
       "      <td>May 20, 2022</td>\n",
       "      <td>May 20, 2022</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>Novartis, East Hanover, New Jersey, United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05874817</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4.0</td>\n",
       "      <td>NCT05874232</td>\n",
       "      <td>The Impact of Heartfulness Self-Care Program o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Anxiety|Satisfaction With Life|Loneliness</td>\n",
       "      <td>Behavioral: Self-Care Program through Heartful...</td>\n",
       "      <td>Assess the current level of Anxiety|Changes le...</td>\n",
       "      <td>Heartfulness Institute</td>\n",
       "      <td>...</td>\n",
       "      <td>February 3, 2022</td>\n",
       "      <td>June 3, 2022</td>\n",
       "      <td>July 3, 2022</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>Ranjani B Iyer, Novi, Michigan, United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05874232</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5.0</td>\n",
       "      <td>NCT05873907</td>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Chronic Graft-versus-host Disease (cGVHD)</td>\n",
       "      <td>Drug: AMG 592|Other: Placebo</td>\n",
       "      <td>Number of Participants with Treatment-emergent...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>...</td>\n",
       "      <td>October 19, 2015</td>\n",
       "      <td>June 16, 2017</td>\n",
       "      <td>July 28, 2017</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>Research Site, Aventura, Florida, United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05873907</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70220</th>\n",
       "      <td>9996.0</td>\n",
       "      <td>NCT01964430</td>\n",
       "      <td>Nab-paclitaxel and Gemcitabine vs Gemcitabine ...</td>\n",
       "      <td>apact</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Pancreatic Neoplasms|Digestive System Neoplasm...</td>\n",
       "      <td>Drug: nab-Paclitaxel|Drug: Gemcitabine</td>\n",
       "      <td>Kaplan Meier Estimate for Disease Free Surviva...</td>\n",
       "      <td>Celgene</td>\n",
       "      <td>...</td>\n",
       "      <td>March 28, 2014</td>\n",
       "      <td>June 30, 2022</td>\n",
       "      <td>June 30, 2022</td>\n",
       "      <td>October 17, 2013</td>\n",
       "      <td>January 6, 2020</td>\n",
       "      <td>December 9, 2022</td>\n",
       "      <td>Local Institution - 043, Scottsdale, Arizona, ...</td>\n",
       "      <td>\"Study Protocol\", https://ClinicalTrials.gov/P...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01964430</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70221</th>\n",
       "      <td>9997.0</td>\n",
       "      <td>NCT01732796</td>\n",
       "      <td>IFN-free Combination Therapy in HCV-infected P...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Hepatitis C, Chronic</td>\n",
       "      <td>Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...</td>\n",
       "      <td>SVR12 Rates With Historical Control|Comparison...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>...</td>\n",
       "      <td>Dec-12</td>\n",
       "      <td>Jan-15</td>\n",
       "      <td>Jan-15</td>\n",
       "      <td>November 26, 2012</td>\n",
       "      <td>April 18, 2016</td>\n",
       "      <td>April 18, 2016</td>\n",
       "      <td>1241.20.00026 Boehringer Ingelheim Investigati...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01732796</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70222</th>\n",
       "      <td>9998.0</td>\n",
       "      <td>NCT01959516</td>\n",
       "      <td>Effect of Glycopyrronium on Morning Symptoms a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COPD</td>\n",
       "      <td>Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...</td>\n",
       "      <td>Forced Expiratory Volume in 1 Second (FEV1) AU...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>...</td>\n",
       "      <td>Feb-14</td>\n",
       "      <td>Oct-14</td>\n",
       "      <td>Oct-14</td>\n",
       "      <td>October 10, 2013</td>\n",
       "      <td>April 15, 2016</td>\n",
       "      <td>April 15, 2016</td>\n",
       "      <td>Novartis Investigative Site, Geesthacht, Schle...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01959516</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70223</th>\n",
       "      <td>9999.0</td>\n",
       "      <td>NCT01584648</td>\n",
       "      <td>A Study Comparing Trametinib and Dabrafenib Co...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...</td>\n",
       "      <td>Progression-Free Survival (PFS) as Assessed by...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>...</td>\n",
       "      <td>May 4, 2012</td>\n",
       "      <td>August 26, 2013</td>\n",
       "      <td>February 28, 2019</td>\n",
       "      <td>April 25, 2012</td>\n",
       "      <td>August 15, 2014</td>\n",
       "      <td>February 17, 2021</td>\n",
       "      <td>Novartis Investigative Site, Scottsdale, Arizo...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01584648</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70224</th>\n",
       "      <td>10000.0</td>\n",
       "      <td>NCT01578707</td>\n",
       "      <td>A Phase 3 Study of Ibrutinib (PCI-32765) Versu...</td>\n",
       "      <td>RESONATE™</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Relapsed or Refractory Chronic Lymphocytic Leu...</td>\n",
       "      <td>Drug: ofatumumab|Drug: ibrutinib</td>\n",
       "      <td>PFS (Progression Free Survival) by Independent...</td>\n",
       "      <td>Pharmacyclics LLC.|Janssen Research &amp; Developm...</td>\n",
       "      <td>...</td>\n",
       "      <td>Jun-12</td>\n",
       "      <td>Nov-13</td>\n",
       "      <td>October 25, 2018</td>\n",
       "      <td>April 17, 2012</td>\n",
       "      <td>October 12, 2015</td>\n",
       "      <td>December 18, 2019</td>\n",
       "      <td>Site #408, La Jolla, California, United States...</td>\n",
       "      <td>\"Study Protocol\", https://ClinicalTrials.gov/P...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01578707</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>70225 rows × 28 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          Rank   NCT Number  \\\n",
       "0          1.0  NCT05876325   \n",
       "1          2.0  NCT05875532   \n",
       "2          3.0  NCT05874817   \n",
       "3          4.0  NCT05874232   \n",
       "4          5.0  NCT05873907   \n",
       "...        ...          ...   \n",
       "70220   9996.0  NCT01964430   \n",
       "70221   9997.0  NCT01732796   \n",
       "70222   9998.0  NCT01959516   \n",
       "70223   9999.0  NCT01584648   \n",
       "70224  10000.0  NCT01578707   \n",
       "\n",
       "                                                   Title    Acronym  \\\n",
       "0      Financial and Insurance Assistance- Oncology F...        NaN   \n",
       "1      Study of Progression to Progressive Fibrosing ...        NaN   \n",
       "2      Retrospective Assessment of AE-Related Healthc...        NaN   \n",
       "3      The Impact of Heartfulness Self-Care Program o...        NaN   \n",
       "4      A Study to Evaluate the Safety, Tolerability, ...        NaN   \n",
       "...                                                  ...        ...   \n",
       "70220  Nab-paclitaxel and Gemcitabine vs Gemcitabine ...      apact   \n",
       "70221  IFN-free Combination Therapy in HCV-infected P...        NaN   \n",
       "70222  Effect of Glycopyrronium on Morning Symptoms a...        NaN   \n",
       "70223  A Study Comparing Trametinib and Dabrafenib Co...        NaN   \n",
       "70224  A Phase 3 Study of Ibrutinib (PCI-32765) Versu...  RESONATE™   \n",
       "\n",
       "          Status         Study Results  \\\n",
       "0      Completed  No Results Available   \n",
       "1      Completed  No Results Available   \n",
       "2      Completed  No Results Available   \n",
       "3      Completed  No Results Available   \n",
       "4      Completed  No Results Available   \n",
       "...          ...                   ...   \n",
       "70220  Completed           Has Results   \n",
       "70221  Completed           Has Results   \n",
       "70222  Completed           Has Results   \n",
       "70223  Completed           Has Results   \n",
       "70224  Completed           Has Results   \n",
       "\n",
       "                                              Conditions  \\\n",
       "0                      Financial Stress|Pediatric Cancer   \n",
       "1                            Lung Diseases, Interstitial   \n",
       "2                                               Melanoma   \n",
       "3              Anxiety|Satisfaction With Life|Loneliness   \n",
       "4              Chronic Graft-versus-host Disease (cGVHD)   \n",
       "...                                                  ...   \n",
       "70220  Pancreatic Neoplasms|Digestive System Neoplasm...   \n",
       "70221                               Hepatitis C, Chronic   \n",
       "70222                                               COPD   \n",
       "70223                                           Melanoma   \n",
       "70224  Relapsed or Refractory Chronic Lymphocytic Leu...   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                                       Other: FINassist   \n",
       "1                                                    NaN   \n",
       "2                                                    NaN   \n",
       "3      Behavioral: Self-Care Program through Heartful...   \n",
       "4                           Drug: AMG 592|Other: Placebo   \n",
       "...                                                  ...   \n",
       "70220             Drug: nab-Paclitaxel|Drug: Gemcitabine   \n",
       "70221  Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...   \n",
       "70222  Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...   \n",
       "70223  Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...   \n",
       "70224                   Drug: ofatumumab|Drug: ibrutinib   \n",
       "\n",
       "                                        Outcome Measures  \\\n",
       "0      FINassist Feasibility|FINassist Adherence|FINa...   \n",
       "1      Incidence probability of progression to PF-ILD...   \n",
       "2      Percentage of patients with adverse events (AE...   \n",
       "3      Assess the current level of Anxiety|Changes le...   \n",
       "4      Number of Participants with Treatment-emergent...   \n",
       "...                                                  ...   \n",
       "70220  Kaplan Meier Estimate for Disease Free Surviva...   \n",
       "70221  SVR12 Rates With Historical Control|Comparison...   \n",
       "70222  Forced Expiratory Volume in 1 Second (FEV1) AU...   \n",
       "70223  Progression-Free Survival (PFS) as Assessed by...   \n",
       "70224  PFS (Progression Free Survival) by Independent...   \n",
       "\n",
       "                                   Sponsor/Collaborators  ...  \\\n",
       "0      Jean Edward|Robert Wood Johnson Foundation|Uni...  ...   \n",
       "1                                   Boehringer Ingelheim  ...   \n",
       "2                      Novartis Pharmaceuticals|Novartis  ...   \n",
       "3                                 Heartfulness Institute  ...   \n",
       "4                                                  Amgen  ...   \n",
       "...                                                  ...  ...   \n",
       "70220                                            Celgene  ...   \n",
       "70221                               Boehringer Ingelheim  ...   \n",
       "70222                  Novartis Pharmaceuticals|Novartis  ...   \n",
       "70223                  Novartis Pharmaceuticals|Novartis  ...   \n",
       "70224  Pharmacyclics LLC.|Janssen Research & Developm...  ...   \n",
       "\n",
       "             Start Date Primary Completion Date    Completion Date  \\\n",
       "0         April 1, 2021       September 1, 2022  December 31, 2022   \n",
       "1        April 20, 2023             May 1, 2023        May 1, 2023   \n",
       "2           May 1, 2021            May 20, 2022       May 20, 2022   \n",
       "3      February 3, 2022            June 3, 2022       July 3, 2022   \n",
       "4      October 19, 2015           June 16, 2017      July 28, 2017   \n",
       "...                 ...                     ...                ...   \n",
       "70220    March 28, 2014           June 30, 2022      June 30, 2022   \n",
       "70221            Dec-12                  Jan-15             Jan-15   \n",
       "70222            Feb-14                  Oct-14             Oct-14   \n",
       "70223       May 4, 2012         August 26, 2013  February 28, 2019   \n",
       "70224            Jun-12                  Nov-13   October 25, 2018   \n",
       "\n",
       "            First Posted Results First Posted Last Update Posted  \\\n",
       "0           May 25, 2023                  NaN       May 25, 2023   \n",
       "1           May 25, 2023                  NaN       May 25, 2023   \n",
       "2           May 25, 2023                  NaN       May 25, 2023   \n",
       "3           May 24, 2023                  NaN       May 24, 2023   \n",
       "4           May 24, 2023                  NaN       May 24, 2023   \n",
       "...                  ...                  ...                ...   \n",
       "70220   October 17, 2013      January 6, 2020   December 9, 2022   \n",
       "70221  November 26, 2012       April 18, 2016     April 18, 2016   \n",
       "70222   October 10, 2013       April 15, 2016     April 15, 2016   \n",
       "70223     April 25, 2012      August 15, 2014  February 17, 2021   \n",
       "70224     April 17, 2012     October 12, 2015  December 18, 2019   \n",
       "\n",
       "                                               Locations  \\\n",
       "0      University of Kentucky DanceBlue Pediatric Hem...   \n",
       "1      Boehringer Ingelheim Pharmaceuticals, Inc., Ri...   \n",
       "2      Novartis, East Hanover, New Jersey, United States   \n",
       "3          Ranjani B Iyer, Novi, Michigan, United States   \n",
       "4        Research Site, Aventura, Florida, United States   \n",
       "...                                                  ...   \n",
       "70220  Local Institution - 043, Scottsdale, Arizona, ...   \n",
       "70221  1241.20.00026 Boehringer Ingelheim Investigati...   \n",
       "70222  Novartis Investigative Site, Geesthacht, Schle...   \n",
       "70223  Novartis Investigative Site, Scottsdale, Arizo...   \n",
       "70224  Site #408, La Jolla, California, United States...   \n",
       "\n",
       "                                         Study Documents  \\\n",
       "0                                                    NaN   \n",
       "1                                                    NaN   \n",
       "2                                                    NaN   \n",
       "3                                                    NaN   \n",
       "4                                                    NaN   \n",
       "...                                                  ...   \n",
       "70220  \"Study Protocol\", https://ClinicalTrials.gov/P...   \n",
       "70221                                                NaN   \n",
       "70222                                                NaN   \n",
       "70223                                                NaN   \n",
       "70224  \"Study Protocol\", https://ClinicalTrials.gov/P...   \n",
       "\n",
       "                                               URL Unnamed: 27  \n",
       "0      https://ClinicalTrials.gov/show/NCT05876325         NaN  \n",
       "1      https://ClinicalTrials.gov/show/NCT05875532         NaN  \n",
       "2      https://ClinicalTrials.gov/show/NCT05874817         NaN  \n",
       "3      https://ClinicalTrials.gov/show/NCT05874232         NaN  \n",
       "4      https://ClinicalTrials.gov/show/NCT05873907         NaN  \n",
       "...                                            ...         ...  \n",
       "70220  https://ClinicalTrials.gov/show/NCT01964430         NaN  \n",
       "70221  https://ClinicalTrials.gov/show/NCT01732796         NaN  \n",
       "70222  https://ClinicalTrials.gov/show/NCT01959516         NaN  \n",
       "70223  https://ClinicalTrials.gov/show/NCT01584648         NaN  \n",
       "70224  https://ClinicalTrials.gov/show/NCT01578707         NaN  \n",
       "\n",
       "[70225 rows x 28 columns]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "e61445f3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 70225 entries, 0 to 70224\n",
      "Data columns (total 28 columns):\n",
      " #   Column                   Non-Null Count  Dtype  \n",
      "---  ------                   --------------  -----  \n",
      " 0   Rank                     69944 non-null  object \n",
      " 1   NCT Number               69944 non-null  object \n",
      " 2   Title                    69944 non-null  object \n",
      " 3   Acronym                  25509 non-null  object \n",
      " 4   Status                   69944 non-null  object \n",
      " 5   Study Results            69944 non-null  object \n",
      " 6   Conditions               69944 non-null  object \n",
      " 7   Interventions            64223 non-null  object \n",
      " 8   Outcome Measures         68633 non-null  object \n",
      " 9   Sponsor/Collaborators    69944 non-null  object \n",
      " 10  Gender                   69873 non-null  object \n",
      " 11  Age                      69944 non-null  object \n",
      " 12  Phases                   56080 non-null  object \n",
      " 13  Enrollment               69506 non-null  float64\n",
      " 14  Funded Bys               69944 non-null  object \n",
      " 15  Study Type               69944 non-null  object \n",
      " 16  Study Designs            69721 non-null  object \n",
      " 17  Other IDs                69929 non-null  object \n",
      " 18  Start Date               69731 non-null  object \n",
      " 19  Primary Completion Date  67626 non-null  object \n",
      " 20  Completion Date          68333 non-null  object \n",
      " 21  First Posted             69944 non-null  object \n",
      " 22  Results First Posted     14732 non-null  object \n",
      " 23  Last Update Posted       69944 non-null  object \n",
      " 24  Locations                69944 non-null  object \n",
      " 25  Study Documents          7860 non-null   object \n",
      " 26  URL                      69664 non-null  object \n",
      " 27  Unnamed: 27              1 non-null      object \n",
      "dtypes: float64(1), object(27)\n",
      "memory usage: 15.0+ MB\n"
     ]
    }
   ],
   "source": [
    "cd.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "06c6dfb0",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd=cd.drop(['Unnamed: 27'],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "5565e4ee",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Acronym</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>...</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Results First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Study Documents</th>\n",
       "      <th>URL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1.0</td>\n",
       "      <td>NCT05876325</td>\n",
       "      <td>Financial and Insurance Assistance- Oncology F...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Financial Stress|Pediatric Cancer</td>\n",
       "      <td>Other: FINassist</td>\n",
       "      <td>FINassist Feasibility|FINassist Adherence|FINa...</td>\n",
       "      <td>Jean Edward|Robert Wood Johnson Foundation|Uni...</td>\n",
       "      <td>...</td>\n",
       "      <td>57238</td>\n",
       "      <td>April 1, 2021</td>\n",
       "      <td>September 1, 2022</td>\n",
       "      <td>December 31, 2022</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>University of Kentucky DanceBlue Pediatric Hem...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05876325</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2.0</td>\n",
       "      <td>NCT05875532</td>\n",
       "      <td>Study of Progression to Progressive Fibrosing ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Lung Diseases, Interstitial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Incidence probability of progression to PF-ILD...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>...</td>\n",
       "      <td>1199-0523</td>\n",
       "      <td>April 20, 2023</td>\n",
       "      <td>May 1, 2023</td>\n",
       "      <td>May 1, 2023</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>Boehringer Ingelheim Pharmaceuticals, Inc., Ri...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05875532</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3.0</td>\n",
       "      <td>NCT05874817</td>\n",
       "      <td>Retrospective Assessment of AE-Related Healthc...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Percentage of patients with adverse events (AE...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>...</td>\n",
       "      <td>CTMT212AUS62</td>\n",
       "      <td>May 1, 2021</td>\n",
       "      <td>May 20, 2022</td>\n",
       "      <td>May 20, 2022</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>Novartis, East Hanover, New Jersey, United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05874817</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4.0</td>\n",
       "      <td>NCT05874232</td>\n",
       "      <td>The Impact of Heartfulness Self-Care Program o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Anxiety|Satisfaction With Life|Loneliness</td>\n",
       "      <td>Behavioral: Self-Care Program through Heartful...</td>\n",
       "      <td>Assess the current level of Anxiety|Changes le...</td>\n",
       "      <td>Heartfulness Institute</td>\n",
       "      <td>...</td>\n",
       "      <td>02-01-2022</td>\n",
       "      <td>February 3, 2022</td>\n",
       "      <td>June 3, 2022</td>\n",
       "      <td>July 3, 2022</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>Ranjani B Iyer, Novi, Michigan, United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05874232</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5.0</td>\n",
       "      <td>NCT05873907</td>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Chronic Graft-versus-host Disease (cGVHD)</td>\n",
       "      <td>Drug: AMG 592|Other: Placebo</td>\n",
       "      <td>Number of Participants with Treatment-emergent...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>...</td>\n",
       "      <td>20140324</td>\n",
       "      <td>October 19, 2015</td>\n",
       "      <td>June 16, 2017</td>\n",
       "      <td>July 28, 2017</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>NaN</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>Research Site, Aventura, Florida, United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05873907</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70220</th>\n",
       "      <td>9996.0</td>\n",
       "      <td>NCT01964430</td>\n",
       "      <td>Nab-paclitaxel and Gemcitabine vs Gemcitabine ...</td>\n",
       "      <td>apact</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Pancreatic Neoplasms|Digestive System Neoplasm...</td>\n",
       "      <td>Drug: nab-Paclitaxel|Drug: Gemcitabine</td>\n",
       "      <td>Kaplan Meier Estimate for Disease Free Surviva...</td>\n",
       "      <td>Celgene</td>\n",
       "      <td>...</td>\n",
       "      <td>ABI-007-PANC-003|2013-003398-91</td>\n",
       "      <td>March 28, 2014</td>\n",
       "      <td>June 30, 2022</td>\n",
       "      <td>June 30, 2022</td>\n",
       "      <td>October 17, 2013</td>\n",
       "      <td>January 6, 2020</td>\n",
       "      <td>December 9, 2022</td>\n",
       "      <td>Local Institution - 043, Scottsdale, Arizona, ...</td>\n",
       "      <td>\"Study Protocol\", https://ClinicalTrials.gov/P...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01964430</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70221</th>\n",
       "      <td>9997.0</td>\n",
       "      <td>NCT01732796</td>\n",
       "      <td>IFN-free Combination Therapy in HCV-infected P...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Hepatitis C, Chronic</td>\n",
       "      <td>Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...</td>\n",
       "      <td>SVR12 Rates With Historical Control|Comparison...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>...</td>\n",
       "      <td>1241.20|2012-003533-41</td>\n",
       "      <td>Dec-12</td>\n",
       "      <td>Jan-15</td>\n",
       "      <td>Jan-15</td>\n",
       "      <td>November 26, 2012</td>\n",
       "      <td>April 18, 2016</td>\n",
       "      <td>April 18, 2016</td>\n",
       "      <td>1241.20.00026 Boehringer Ingelheim Investigati...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01732796</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70222</th>\n",
       "      <td>9998.0</td>\n",
       "      <td>NCT01959516</td>\n",
       "      <td>Effect of Glycopyrronium on Morning Symptoms a...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COPD</td>\n",
       "      <td>Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...</td>\n",
       "      <td>Forced Expiratory Volume in 1 Second (FEV1) AU...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>...</td>\n",
       "      <td>CNVA237A3401</td>\n",
       "      <td>Feb-14</td>\n",
       "      <td>Oct-14</td>\n",
       "      <td>Oct-14</td>\n",
       "      <td>October 10, 2013</td>\n",
       "      <td>April 15, 2016</td>\n",
       "      <td>April 15, 2016</td>\n",
       "      <td>Novartis Investigative Site, Geesthacht, Schle...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01959516</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70223</th>\n",
       "      <td>9999.0</td>\n",
       "      <td>NCT01584648</td>\n",
       "      <td>A Study Comparing Trametinib and Dabrafenib Co...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...</td>\n",
       "      <td>Progression-Free Survival (PFS) as Assessed by...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>...</td>\n",
       "      <td>115306|2011-006087-49|CDRB436B2301</td>\n",
       "      <td>May 4, 2012</td>\n",
       "      <td>August 26, 2013</td>\n",
       "      <td>February 28, 2019</td>\n",
       "      <td>April 25, 2012</td>\n",
       "      <td>August 15, 2014</td>\n",
       "      <td>February 17, 2021</td>\n",
       "      <td>Novartis Investigative Site, Scottsdale, Arizo...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01584648</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70224</th>\n",
       "      <td>10000.0</td>\n",
       "      <td>NCT01578707</td>\n",
       "      <td>A Phase 3 Study of Ibrutinib (PCI-32765) Versu...</td>\n",
       "      <td>RESONATE™</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Relapsed or Refractory Chronic Lymphocytic Leu...</td>\n",
       "      <td>Drug: ofatumumab|Drug: ibrutinib</td>\n",
       "      <td>PFS (Progression Free Survival) by Independent...</td>\n",
       "      <td>Pharmacyclics LLC.|Janssen Research &amp; Developm...</td>\n",
       "      <td>...</td>\n",
       "      <td>PCYC-1112-CA|2012-000694-23</td>\n",
       "      <td>Jun-12</td>\n",
       "      <td>Nov-13</td>\n",
       "      <td>October 25, 2018</td>\n",
       "      <td>April 17, 2012</td>\n",
       "      <td>October 12, 2015</td>\n",
       "      <td>December 18, 2019</td>\n",
       "      <td>Site #408, La Jolla, California, United States...</td>\n",
       "      <td>\"Study Protocol\", https://ClinicalTrials.gov/P...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01578707</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>70225 rows × 27 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          Rank   NCT Number  \\\n",
       "0          1.0  NCT05876325   \n",
       "1          2.0  NCT05875532   \n",
       "2          3.0  NCT05874817   \n",
       "3          4.0  NCT05874232   \n",
       "4          5.0  NCT05873907   \n",
       "...        ...          ...   \n",
       "70220   9996.0  NCT01964430   \n",
       "70221   9997.0  NCT01732796   \n",
       "70222   9998.0  NCT01959516   \n",
       "70223   9999.0  NCT01584648   \n",
       "70224  10000.0  NCT01578707   \n",
       "\n",
       "                                                   Title    Acronym  \\\n",
       "0      Financial and Insurance Assistance- Oncology F...        NaN   \n",
       "1      Study of Progression to Progressive Fibrosing ...        NaN   \n",
       "2      Retrospective Assessment of AE-Related Healthc...        NaN   \n",
       "3      The Impact of Heartfulness Self-Care Program o...        NaN   \n",
       "4      A Study to Evaluate the Safety, Tolerability, ...        NaN   \n",
       "...                                                  ...        ...   \n",
       "70220  Nab-paclitaxel and Gemcitabine vs Gemcitabine ...      apact   \n",
       "70221  IFN-free Combination Therapy in HCV-infected P...        NaN   \n",
       "70222  Effect of Glycopyrronium on Morning Symptoms a...        NaN   \n",
       "70223  A Study Comparing Trametinib and Dabrafenib Co...        NaN   \n",
       "70224  A Phase 3 Study of Ibrutinib (PCI-32765) Versu...  RESONATE™   \n",
       "\n",
       "          Status         Study Results  \\\n",
       "0      Completed  No Results Available   \n",
       "1      Completed  No Results Available   \n",
       "2      Completed  No Results Available   \n",
       "3      Completed  No Results Available   \n",
       "4      Completed  No Results Available   \n",
       "...          ...                   ...   \n",
       "70220  Completed           Has Results   \n",
       "70221  Completed           Has Results   \n",
       "70222  Completed           Has Results   \n",
       "70223  Completed           Has Results   \n",
       "70224  Completed           Has Results   \n",
       "\n",
       "                                              Conditions  \\\n",
       "0                      Financial Stress|Pediatric Cancer   \n",
       "1                            Lung Diseases, Interstitial   \n",
       "2                                               Melanoma   \n",
       "3              Anxiety|Satisfaction With Life|Loneliness   \n",
       "4              Chronic Graft-versus-host Disease (cGVHD)   \n",
       "...                                                  ...   \n",
       "70220  Pancreatic Neoplasms|Digestive System Neoplasm...   \n",
       "70221                               Hepatitis C, Chronic   \n",
       "70222                                               COPD   \n",
       "70223                                           Melanoma   \n",
       "70224  Relapsed or Refractory Chronic Lymphocytic Leu...   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                                       Other: FINassist   \n",
       "1                                                    NaN   \n",
       "2                                                    NaN   \n",
       "3      Behavioral: Self-Care Program through Heartful...   \n",
       "4                           Drug: AMG 592|Other: Placebo   \n",
       "...                                                  ...   \n",
       "70220             Drug: nab-Paclitaxel|Drug: Gemcitabine   \n",
       "70221  Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...   \n",
       "70222  Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...   \n",
       "70223  Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...   \n",
       "70224                   Drug: ofatumumab|Drug: ibrutinib   \n",
       "\n",
       "                                        Outcome Measures  \\\n",
       "0      FINassist Feasibility|FINassist Adherence|FINa...   \n",
       "1      Incidence probability of progression to PF-ILD...   \n",
       "2      Percentage of patients with adverse events (AE...   \n",
       "3      Assess the current level of Anxiety|Changes le...   \n",
       "4      Number of Participants with Treatment-emergent...   \n",
       "...                                                  ...   \n",
       "70220  Kaplan Meier Estimate for Disease Free Surviva...   \n",
       "70221  SVR12 Rates With Historical Control|Comparison...   \n",
       "70222  Forced Expiratory Volume in 1 Second (FEV1) AU...   \n",
       "70223  Progression-Free Survival (PFS) as Assessed by...   \n",
       "70224  PFS (Progression Free Survival) by Independent...   \n",
       "\n",
       "                                   Sponsor/Collaborators  ...  \\\n",
       "0      Jean Edward|Robert Wood Johnson Foundation|Uni...  ...   \n",
       "1                                   Boehringer Ingelheim  ...   \n",
       "2                      Novartis Pharmaceuticals|Novartis  ...   \n",
       "3                                 Heartfulness Institute  ...   \n",
       "4                                                  Amgen  ...   \n",
       "...                                                  ...  ...   \n",
       "70220                                            Celgene  ...   \n",
       "70221                               Boehringer Ingelheim  ...   \n",
       "70222                  Novartis Pharmaceuticals|Novartis  ...   \n",
       "70223                  Novartis Pharmaceuticals|Novartis  ...   \n",
       "70224  Pharmacyclics LLC.|Janssen Research & Developm...  ...   \n",
       "\n",
       "                                Other IDs        Start Date  \\\n",
       "0                                   57238     April 1, 2021   \n",
       "1                               1199-0523    April 20, 2023   \n",
       "2                            CTMT212AUS62       May 1, 2021   \n",
       "3                              02-01-2022  February 3, 2022   \n",
       "4                                20140324  October 19, 2015   \n",
       "...                                   ...               ...   \n",
       "70220     ABI-007-PANC-003|2013-003398-91    March 28, 2014   \n",
       "70221              1241.20|2012-003533-41            Dec-12   \n",
       "70222                        CNVA237A3401            Feb-14   \n",
       "70223  115306|2011-006087-49|CDRB436B2301       May 4, 2012   \n",
       "70224         PCYC-1112-CA|2012-000694-23            Jun-12   \n",
       "\n",
       "      Primary Completion Date    Completion Date       First Posted  \\\n",
       "0           September 1, 2022  December 31, 2022       May 25, 2023   \n",
       "1                 May 1, 2023        May 1, 2023       May 25, 2023   \n",
       "2                May 20, 2022       May 20, 2022       May 25, 2023   \n",
       "3                June 3, 2022       July 3, 2022       May 24, 2023   \n",
       "4               June 16, 2017      July 28, 2017       May 24, 2023   \n",
       "...                       ...                ...                ...   \n",
       "70220           June 30, 2022      June 30, 2022   October 17, 2013   \n",
       "70221                  Jan-15             Jan-15  November 26, 2012   \n",
       "70222                  Oct-14             Oct-14   October 10, 2013   \n",
       "70223         August 26, 2013  February 28, 2019     April 25, 2012   \n",
       "70224                  Nov-13   October 25, 2018     April 17, 2012   \n",
       "\n",
       "      Results First Posted Last Update Posted  \\\n",
       "0                      NaN       May 25, 2023   \n",
       "1                      NaN       May 25, 2023   \n",
       "2                      NaN       May 25, 2023   \n",
       "3                      NaN       May 24, 2023   \n",
       "4                      NaN       May 24, 2023   \n",
       "...                    ...                ...   \n",
       "70220      January 6, 2020   December 9, 2022   \n",
       "70221       April 18, 2016     April 18, 2016   \n",
       "70222       April 15, 2016     April 15, 2016   \n",
       "70223      August 15, 2014  February 17, 2021   \n",
       "70224     October 12, 2015  December 18, 2019   \n",
       "\n",
       "                                               Locations  \\\n",
       "0      University of Kentucky DanceBlue Pediatric Hem...   \n",
       "1      Boehringer Ingelheim Pharmaceuticals, Inc., Ri...   \n",
       "2      Novartis, East Hanover, New Jersey, United States   \n",
       "3          Ranjani B Iyer, Novi, Michigan, United States   \n",
       "4        Research Site, Aventura, Florida, United States   \n",
       "...                                                  ...   \n",
       "70220  Local Institution - 043, Scottsdale, Arizona, ...   \n",
       "70221  1241.20.00026 Boehringer Ingelheim Investigati...   \n",
       "70222  Novartis Investigative Site, Geesthacht, Schle...   \n",
       "70223  Novartis Investigative Site, Scottsdale, Arizo...   \n",
       "70224  Site #408, La Jolla, California, United States...   \n",
       "\n",
       "                                         Study Documents  \\\n",
       "0                                                    NaN   \n",
       "1                                                    NaN   \n",
       "2                                                    NaN   \n",
       "3                                                    NaN   \n",
       "4                                                    NaN   \n",
       "...                                                  ...   \n",
       "70220  \"Study Protocol\", https://ClinicalTrials.gov/P...   \n",
       "70221                                                NaN   \n",
       "70222                                                NaN   \n",
       "70223                                                NaN   \n",
       "70224  \"Study Protocol\", https://ClinicalTrials.gov/P...   \n",
       "\n",
       "                                               URL  \n",
       "0      https://ClinicalTrials.gov/show/NCT05876325  \n",
       "1      https://ClinicalTrials.gov/show/NCT05875532  \n",
       "2      https://ClinicalTrials.gov/show/NCT05874817  \n",
       "3      https://ClinicalTrials.gov/show/NCT05874232  \n",
       "4      https://ClinicalTrials.gov/show/NCT05873907  \n",
       "...                                            ...  \n",
       "70220  https://ClinicalTrials.gov/show/NCT01964430  \n",
       "70221  https://ClinicalTrials.gov/show/NCT01732796  \n",
       "70222  https://ClinicalTrials.gov/show/NCT01959516  \n",
       "70223  https://ClinicalTrials.gov/show/NCT01584648  \n",
       "70224  https://ClinicalTrials.gov/show/NCT01578707  \n",
       "\n",
       "[70225 rows x 27 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "563637b2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Rank                         281\n",
       "NCT Number                   281\n",
       "Title                        281\n",
       "Acronym                    44716\n",
       "Status                       281\n",
       "Study Results                281\n",
       "Conditions                   281\n",
       "Interventions               6002\n",
       "Outcome Measures            1592\n",
       "Sponsor/Collaborators        281\n",
       "Gender                       352\n",
       "Age                          281\n",
       "Phases                     14145\n",
       "Enrollment                   719\n",
       "Funded Bys                   281\n",
       "Study Type                   281\n",
       "Study Designs                504\n",
       "Other IDs                    296\n",
       "Start Date                   494\n",
       "Primary Completion Date     2599\n",
       "Completion Date             1892\n",
       "First Posted                 281\n",
       "Results First Posted       55493\n",
       "Last Update Posted           281\n",
       "Locations                    281\n",
       "Study Documents            62365\n",
       "URL                          561\n",
       "dtype: int64"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "9fe5a35e",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd=cd.drop(['Acronym','Study Documents','Results First Posted'],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "bdb00bfc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Rank</th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Primary Completion Date</th>\n",
       "      <th>Completion Date</th>\n",
       "      <th>First Posted</th>\n",
       "      <th>Last Update Posted</th>\n",
       "      <th>Locations</th>\n",
       "      <th>URL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1.0</td>\n",
       "      <td>NCT05876325</td>\n",
       "      <td>Financial and Insurance Assistance- Oncology F...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Financial Stress|Pediatric Cancer</td>\n",
       "      <td>Other: FINassist</td>\n",
       "      <td>FINassist Feasibility|FINassist Adherence|FINa...</td>\n",
       "      <td>Jean Edward|Robert Wood Johnson Foundation|Uni...</td>\n",
       "      <td>All</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>57238</td>\n",
       "      <td>April 1, 2021</td>\n",
       "      <td>September 1, 2022</td>\n",
       "      <td>December 31, 2022</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>University of Kentucky DanceBlue Pediatric Hem...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05876325</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>2.0</td>\n",
       "      <td>NCT05875532</td>\n",
       "      <td>Study of Progression to Progressive Fibrosing ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Lung Diseases, Interstitial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Incidence probability of progression to PF-ILD...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>1199-0523</td>\n",
       "      <td>April 20, 2023</td>\n",
       "      <td>May 1, 2023</td>\n",
       "      <td>May 1, 2023</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>Boehringer Ingelheim Pharmaceuticals, Inc., Ri...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05875532</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>3.0</td>\n",
       "      <td>NCT05874817</td>\n",
       "      <td>Retrospective Assessment of AE-Related Healthc...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Percentage of patients with adverse events (AE...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>CTMT212AUS62</td>\n",
       "      <td>May 1, 2021</td>\n",
       "      <td>May 20, 2022</td>\n",
       "      <td>May 20, 2022</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>May 25, 2023</td>\n",
       "      <td>Novartis, East Hanover, New Jersey, United States</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05874817</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>4.0</td>\n",
       "      <td>NCT05874232</td>\n",
       "      <td>The Impact of Heartfulness Self-Care Program o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Anxiety|Satisfaction With Life|Loneliness</td>\n",
       "      <td>Behavioral: Self-Care Program through Heartful...</td>\n",
       "      <td>Assess the current level of Anxiety|Changes le...</td>\n",
       "      <td>Heartfulness Institute</td>\n",
       "      <td>All</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>02-01-2022</td>\n",
       "      <td>February 3, 2022</td>\n",
       "      <td>June 3, 2022</td>\n",
       "      <td>July 3, 2022</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>Ranjani B Iyer, Novi, Michigan, United States</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05874232</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5.0</td>\n",
       "      <td>NCT05873907</td>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Chronic Graft-versus-host Disease (cGVHD)</td>\n",
       "      <td>Drug: AMG 592|Other: Placebo</td>\n",
       "      <td>Number of Participants with Treatment-emergent...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>All</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>20140324</td>\n",
       "      <td>October 19, 2015</td>\n",
       "      <td>June 16, 2017</td>\n",
       "      <td>July 28, 2017</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>May 24, 2023</td>\n",
       "      <td>Research Site, Aventura, Florida, United States</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05873907</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70220</th>\n",
       "      <td>9996.0</td>\n",
       "      <td>NCT01964430</td>\n",
       "      <td>Nab-paclitaxel and Gemcitabine vs Gemcitabine ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Pancreatic Neoplasms|Digestive System Neoplasm...</td>\n",
       "      <td>Drug: nab-Paclitaxel|Drug: Gemcitabine</td>\n",
       "      <td>Kaplan Meier Estimate for Disease Free Surviva...</td>\n",
       "      <td>Celgene</td>\n",
       "      <td>All</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>ABI-007-PANC-003|2013-003398-91</td>\n",
       "      <td>March 28, 2014</td>\n",
       "      <td>June 30, 2022</td>\n",
       "      <td>June 30, 2022</td>\n",
       "      <td>October 17, 2013</td>\n",
       "      <td>December 9, 2022</td>\n",
       "      <td>Local Institution - 043, Scottsdale, Arizona, ...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01964430</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70221</th>\n",
       "      <td>9997.0</td>\n",
       "      <td>NCT01732796</td>\n",
       "      <td>IFN-free Combination Therapy in HCV-infected P...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Hepatitis C, Chronic</td>\n",
       "      <td>Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...</td>\n",
       "      <td>SVR12 Rates With Historical Control|Comparison...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>1241.20|2012-003533-41</td>\n",
       "      <td>Dec-12</td>\n",
       "      <td>Jan-15</td>\n",
       "      <td>Jan-15</td>\n",
       "      <td>November 26, 2012</td>\n",
       "      <td>April 18, 2016</td>\n",
       "      <td>1241.20.00026 Boehringer Ingelheim Investigati...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01732796</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70222</th>\n",
       "      <td>9998.0</td>\n",
       "      <td>NCT01959516</td>\n",
       "      <td>Effect of Glycopyrronium on Morning Symptoms a...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COPD</td>\n",
       "      <td>Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...</td>\n",
       "      <td>Forced Expiratory Volume in 1 Second (FEV1) AU...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Cro...</td>\n",
       "      <td>CNVA237A3401</td>\n",
       "      <td>Feb-14</td>\n",
       "      <td>Oct-14</td>\n",
       "      <td>Oct-14</td>\n",
       "      <td>October 10, 2013</td>\n",
       "      <td>April 15, 2016</td>\n",
       "      <td>Novartis Investigative Site, Geesthacht, Schle...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01959516</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70223</th>\n",
       "      <td>9999.0</td>\n",
       "      <td>NCT01584648</td>\n",
       "      <td>A Study Comparing Trametinib and Dabrafenib Co...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...</td>\n",
       "      <td>Progression-Free Survival (PFS) as Assessed by...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>115306|2011-006087-49|CDRB436B2301</td>\n",
       "      <td>May 4, 2012</td>\n",
       "      <td>August 26, 2013</td>\n",
       "      <td>February 28, 2019</td>\n",
       "      <td>April 25, 2012</td>\n",
       "      <td>February 17, 2021</td>\n",
       "      <td>Novartis Investigative Site, Scottsdale, Arizo...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01584648</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70224</th>\n",
       "      <td>10000.0</td>\n",
       "      <td>NCT01578707</td>\n",
       "      <td>A Phase 3 Study of Ibrutinib (PCI-32765) Versu...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Relapsed or Refractory Chronic Lymphocytic Leu...</td>\n",
       "      <td>Drug: ofatumumab|Drug: ibrutinib</td>\n",
       "      <td>PFS (Progression Free Survival) by Independent...</td>\n",
       "      <td>Pharmacyclics LLC.|Janssen Research &amp; Developm...</td>\n",
       "      <td>All</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>PCYC-1112-CA|2012-000694-23</td>\n",
       "      <td>Jun-12</td>\n",
       "      <td>Nov-13</td>\n",
       "      <td>October 25, 2018</td>\n",
       "      <td>April 17, 2012</td>\n",
       "      <td>December 18, 2019</td>\n",
       "      <td>Site #408, La Jolla, California, United States...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01578707</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>70225 rows × 24 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          Rank   NCT Number  \\\n",
       "0          1.0  NCT05876325   \n",
       "1          2.0  NCT05875532   \n",
       "2          3.0  NCT05874817   \n",
       "3          4.0  NCT05874232   \n",
       "4          5.0  NCT05873907   \n",
       "...        ...          ...   \n",
       "70220   9996.0  NCT01964430   \n",
       "70221   9997.0  NCT01732796   \n",
       "70222   9998.0  NCT01959516   \n",
       "70223   9999.0  NCT01584648   \n",
       "70224  10000.0  NCT01578707   \n",
       "\n",
       "                                                   Title     Status  \\\n",
       "0      Financial and Insurance Assistance- Oncology F...  Completed   \n",
       "1      Study of Progression to Progressive Fibrosing ...  Completed   \n",
       "2      Retrospective Assessment of AE-Related Healthc...  Completed   \n",
       "3      The Impact of Heartfulness Self-Care Program o...  Completed   \n",
       "4      A Study to Evaluate the Safety, Tolerability, ...  Completed   \n",
       "...                                                  ...        ...   \n",
       "70220  Nab-paclitaxel and Gemcitabine vs Gemcitabine ...  Completed   \n",
       "70221  IFN-free Combination Therapy in HCV-infected P...  Completed   \n",
       "70222  Effect of Glycopyrronium on Morning Symptoms a...  Completed   \n",
       "70223  A Study Comparing Trametinib and Dabrafenib Co...  Completed   \n",
       "70224  A Phase 3 Study of Ibrutinib (PCI-32765) Versu...  Completed   \n",
       "\n",
       "              Study Results  \\\n",
       "0      No Results Available   \n",
       "1      No Results Available   \n",
       "2      No Results Available   \n",
       "3      No Results Available   \n",
       "4      No Results Available   \n",
       "...                     ...   \n",
       "70220           Has Results   \n",
       "70221           Has Results   \n",
       "70222           Has Results   \n",
       "70223           Has Results   \n",
       "70224           Has Results   \n",
       "\n",
       "                                              Conditions  \\\n",
       "0                      Financial Stress|Pediatric Cancer   \n",
       "1                            Lung Diseases, Interstitial   \n",
       "2                                               Melanoma   \n",
       "3              Anxiety|Satisfaction With Life|Loneliness   \n",
       "4              Chronic Graft-versus-host Disease (cGVHD)   \n",
       "...                                                  ...   \n",
       "70220  Pancreatic Neoplasms|Digestive System Neoplasm...   \n",
       "70221                               Hepatitis C, Chronic   \n",
       "70222                                               COPD   \n",
       "70223                                           Melanoma   \n",
       "70224  Relapsed or Refractory Chronic Lymphocytic Leu...   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                                       Other: FINassist   \n",
       "1                                                    NaN   \n",
       "2                                                    NaN   \n",
       "3      Behavioral: Self-Care Program through Heartful...   \n",
       "4                           Drug: AMG 592|Other: Placebo   \n",
       "...                                                  ...   \n",
       "70220             Drug: nab-Paclitaxel|Drug: Gemcitabine   \n",
       "70221  Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...   \n",
       "70222  Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...   \n",
       "70223  Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...   \n",
       "70224                   Drug: ofatumumab|Drug: ibrutinib   \n",
       "\n",
       "                                        Outcome Measures  \\\n",
       "0      FINassist Feasibility|FINassist Adherence|FINa...   \n",
       "1      Incidence probability of progression to PF-ILD...   \n",
       "2      Percentage of patients with adverse events (AE...   \n",
       "3      Assess the current level of Anxiety|Changes le...   \n",
       "4      Number of Participants with Treatment-emergent...   \n",
       "...                                                  ...   \n",
       "70220  Kaplan Meier Estimate for Disease Free Surviva...   \n",
       "70221  SVR12 Rates With Historical Control|Comparison...   \n",
       "70222  Forced Expiratory Volume in 1 Second (FEV1) AU...   \n",
       "70223  Progression-Free Survival (PFS) as Assessed by...   \n",
       "70224  PFS (Progression Free Survival) by Independent...   \n",
       "\n",
       "                                   Sponsor/Collaborators Gender  ...  \\\n",
       "0      Jean Edward|Robert Wood Johnson Foundation|Uni...    All  ...   \n",
       "1                                   Boehringer Ingelheim    All  ...   \n",
       "2                      Novartis Pharmaceuticals|Novartis    All  ...   \n",
       "3                                 Heartfulness Institute    All  ...   \n",
       "4                                                  Amgen    All  ...   \n",
       "...                                                  ...    ...  ...   \n",
       "70220                                            Celgene    All  ...   \n",
       "70221                               Boehringer Ingelheim    All  ...   \n",
       "70222                  Novartis Pharmaceuticals|Novartis    All  ...   \n",
       "70223                  Novartis Pharmaceuticals|Novartis    All  ...   \n",
       "70224  Pharmacyclics LLC.|Janssen Research & Developm...    All  ...   \n",
       "\n",
       "           Study Type                                      Study Designs  \\\n",
       "0      Interventional  Allocation: Non-Randomized|Intervention Model:...   \n",
       "1       Observational  Observational Model: Cohort|Time Perspective: ...   \n",
       "2       Observational  Observational Model: Cohort|Time Perspective: ...   \n",
       "3      Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "4      Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "...               ...                                                ...   \n",
       "70220  Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "70221  Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "70222  Interventional  Allocation: Randomized|Intervention Model: Cro...   \n",
       "70223  Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "70224  Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "\n",
       "                                Other IDs        Start Date  \\\n",
       "0                                   57238     April 1, 2021   \n",
       "1                               1199-0523    April 20, 2023   \n",
       "2                            CTMT212AUS62       May 1, 2021   \n",
       "3                              02-01-2022  February 3, 2022   \n",
       "4                                20140324  October 19, 2015   \n",
       "...                                   ...               ...   \n",
       "70220     ABI-007-PANC-003|2013-003398-91    March 28, 2014   \n",
       "70221              1241.20|2012-003533-41            Dec-12   \n",
       "70222                        CNVA237A3401            Feb-14   \n",
       "70223  115306|2011-006087-49|CDRB436B2301       May 4, 2012   \n",
       "70224         PCYC-1112-CA|2012-000694-23            Jun-12   \n",
       "\n",
       "      Primary Completion Date    Completion Date       First Posted  \\\n",
       "0           September 1, 2022  December 31, 2022       May 25, 2023   \n",
       "1                 May 1, 2023        May 1, 2023       May 25, 2023   \n",
       "2                May 20, 2022       May 20, 2022       May 25, 2023   \n",
       "3                June 3, 2022       July 3, 2022       May 24, 2023   \n",
       "4               June 16, 2017      July 28, 2017       May 24, 2023   \n",
       "...                       ...                ...                ...   \n",
       "70220           June 30, 2022      June 30, 2022   October 17, 2013   \n",
       "70221                  Jan-15             Jan-15  November 26, 2012   \n",
       "70222                  Oct-14             Oct-14   October 10, 2013   \n",
       "70223         August 26, 2013  February 28, 2019     April 25, 2012   \n",
       "70224                  Nov-13   October 25, 2018     April 17, 2012   \n",
       "\n",
       "      Last Update Posted                                          Locations  \\\n",
       "0           May 25, 2023  University of Kentucky DanceBlue Pediatric Hem...   \n",
       "1           May 25, 2023  Boehringer Ingelheim Pharmaceuticals, Inc., Ri...   \n",
       "2           May 25, 2023  Novartis, East Hanover, New Jersey, United States   \n",
       "3           May 24, 2023      Ranjani B Iyer, Novi, Michigan, United States   \n",
       "4           May 24, 2023    Research Site, Aventura, Florida, United States   \n",
       "...                  ...                                                ...   \n",
       "70220   December 9, 2022  Local Institution - 043, Scottsdale, Arizona, ...   \n",
       "70221     April 18, 2016  1241.20.00026 Boehringer Ingelheim Investigati...   \n",
       "70222     April 15, 2016  Novartis Investigative Site, Geesthacht, Schle...   \n",
       "70223  February 17, 2021  Novartis Investigative Site, Scottsdale, Arizo...   \n",
       "70224  December 18, 2019  Site #408, La Jolla, California, United States...   \n",
       "\n",
       "                                               URL  \n",
       "0      https://ClinicalTrials.gov/show/NCT05876325  \n",
       "1      https://ClinicalTrials.gov/show/NCT05875532  \n",
       "2      https://ClinicalTrials.gov/show/NCT05874817  \n",
       "3      https://ClinicalTrials.gov/show/NCT05874232  \n",
       "4      https://ClinicalTrials.gov/show/NCT05873907  \n",
       "...                                            ...  \n",
       "70220  https://ClinicalTrials.gov/show/NCT01964430  \n",
       "70221  https://ClinicalTrials.gov/show/NCT01732796  \n",
       "70222  https://ClinicalTrials.gov/show/NCT01959516  \n",
       "70223  https://ClinicalTrials.gov/show/NCT01584648  \n",
       "70224  https://ClinicalTrials.gov/show/NCT01578707  \n",
       "\n",
       "[70225 rows x 24 columns]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "0edc4229",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd=cd.drop(['Rank','Primary Completion Date','Completion Date','First Posted','Last Update Posted'],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "f5cd57b3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Locations</th>\n",
       "      <th>URL</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT05876325</td>\n",
       "      <td>Financial and Insurance Assistance- Oncology F...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Financial Stress|Pediatric Cancer</td>\n",
       "      <td>Other: FINassist</td>\n",
       "      <td>FINassist Feasibility|FINassist Adherence|FINa...</td>\n",
       "      <td>Jean Edward|Robert Wood Johnson Foundation|Uni...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 65 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>61.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>57238</td>\n",
       "      <td>April 1, 2021</td>\n",
       "      <td>University of Kentucky DanceBlue Pediatric Hem...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05876325</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT05875532</td>\n",
       "      <td>Study of Progression to Progressive Fibrosing ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Lung Diseases, Interstitial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Incidence probability of progression to PF-ILD...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>1199-0523</td>\n",
       "      <td>April 20, 2023</td>\n",
       "      <td>Boehringer Ingelheim Pharmaceuticals, Inc., Ri...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05875532</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT05874817</td>\n",
       "      <td>Retrospective Assessment of AE-Related Healthc...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Percentage of patients with adverse events (AE...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>17517.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>CTMT212AUS62</td>\n",
       "      <td>May 1, 2021</td>\n",
       "      <td>Novartis, East Hanover, New Jersey, United States</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05874817</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT05874232</td>\n",
       "      <td>The Impact of Heartfulness Self-Care Program o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Anxiety|Satisfaction With Life|Loneliness</td>\n",
       "      <td>Behavioral: Self-Care Program through Heartful...</td>\n",
       "      <td>Assess the current level of Anxiety|Changes le...</td>\n",
       "      <td>Heartfulness Institute</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 80 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>203.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>02-01-2022</td>\n",
       "      <td>February 3, 2022</td>\n",
       "      <td>Ranjani B Iyer, Novi, Michigan, United States</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05874232</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05873907</td>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Chronic Graft-versus-host Disease (cGVHD)</td>\n",
       "      <td>Drug: AMG 592|Other: Placebo</td>\n",
       "      <td>Number of Participants with Treatment-emergent...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>64.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>20140324</td>\n",
       "      <td>October 19, 2015</td>\n",
       "      <td>Research Site, Aventura, Florida, United States</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT05873907</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70220</th>\n",
       "      <td>NCT01964430</td>\n",
       "      <td>Nab-paclitaxel and Gemcitabine vs Gemcitabine ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Pancreatic Neoplasms|Digestive System Neoplasm...</td>\n",
       "      <td>Drug: nab-Paclitaxel|Drug: Gemcitabine</td>\n",
       "      <td>Kaplan Meier Estimate for Disease Free Surviva...</td>\n",
       "      <td>Celgene</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>866.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>ABI-007-PANC-003|2013-003398-91</td>\n",
       "      <td>March 28, 2014</td>\n",
       "      <td>Local Institution - 043, Scottsdale, Arizona, ...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01964430</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70221</th>\n",
       "      <td>NCT01732796</td>\n",
       "      <td>IFN-free Combination Therapy in HCV-infected P...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Hepatitis C, Chronic</td>\n",
       "      <td>Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...</td>\n",
       "      <td>SVR12 Rates With Historical Control|Comparison...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 75 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>470.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>1241.20|2012-003533-41</td>\n",
       "      <td>Dec-12</td>\n",
       "      <td>1241.20.00026 Boehringer Ingelheim Investigati...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01732796</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70222</th>\n",
       "      <td>NCT01959516</td>\n",
       "      <td>Effect of Glycopyrronium on Morning Symptoms a...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COPD</td>\n",
       "      <td>Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...</td>\n",
       "      <td>Forced Expiratory Volume in 1 Second (FEV1) AU...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>40 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>124.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Cro...</td>\n",
       "      <td>CNVA237A3401</td>\n",
       "      <td>Feb-14</td>\n",
       "      <td>Novartis Investigative Site, Geesthacht, Schle...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01959516</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70223</th>\n",
       "      <td>NCT01584648</td>\n",
       "      <td>A Study Comparing Trametinib and Dabrafenib Co...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...</td>\n",
       "      <td>Progression-Free Survival (PFS) as Assessed by...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>423.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>115306|2011-006087-49|CDRB436B2301</td>\n",
       "      <td>May 4, 2012</td>\n",
       "      <td>Novartis Investigative Site, Scottsdale, Arizo...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01584648</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70224</th>\n",
       "      <td>NCT01578707</td>\n",
       "      <td>A Phase 3 Study of Ibrutinib (PCI-32765) Versu...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Relapsed or Refractory Chronic Lymphocytic Leu...</td>\n",
       "      <td>Drug: ofatumumab|Drug: ibrutinib</td>\n",
       "      <td>PFS (Progression Free Survival) by Independent...</td>\n",
       "      <td>Pharmacyclics LLC.|Janssen Research &amp; Developm...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>391.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>PCYC-1112-CA|2012-000694-23</td>\n",
       "      <td>Jun-12</td>\n",
       "      <td>Site #408, La Jolla, California, United States...</td>\n",
       "      <td>https://ClinicalTrials.gov/show/NCT01578707</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>70225 rows × 19 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        NCT Number                                              Title  \\\n",
       "0      NCT05876325  Financial and Insurance Assistance- Oncology F...   \n",
       "1      NCT05875532  Study of Progression to Progressive Fibrosing ...   \n",
       "2      NCT05874817  Retrospective Assessment of AE-Related Healthc...   \n",
       "3      NCT05874232  The Impact of Heartfulness Self-Care Program o...   \n",
       "4      NCT05873907  A Study to Evaluate the Safety, Tolerability, ...   \n",
       "...            ...                                                ...   \n",
       "70220  NCT01964430  Nab-paclitaxel and Gemcitabine vs Gemcitabine ...   \n",
       "70221  NCT01732796  IFN-free Combination Therapy in HCV-infected P...   \n",
       "70222  NCT01959516  Effect of Glycopyrronium on Morning Symptoms a...   \n",
       "70223  NCT01584648  A Study Comparing Trametinib and Dabrafenib Co...   \n",
       "70224  NCT01578707  A Phase 3 Study of Ibrutinib (PCI-32765) Versu...   \n",
       "\n",
       "          Status         Study Results  \\\n",
       "0      Completed  No Results Available   \n",
       "1      Completed  No Results Available   \n",
       "2      Completed  No Results Available   \n",
       "3      Completed  No Results Available   \n",
       "4      Completed  No Results Available   \n",
       "...          ...                   ...   \n",
       "70220  Completed           Has Results   \n",
       "70221  Completed           Has Results   \n",
       "70222  Completed           Has Results   \n",
       "70223  Completed           Has Results   \n",
       "70224  Completed           Has Results   \n",
       "\n",
       "                                              Conditions  \\\n",
       "0                      Financial Stress|Pediatric Cancer   \n",
       "1                            Lung Diseases, Interstitial   \n",
       "2                                               Melanoma   \n",
       "3              Anxiety|Satisfaction With Life|Loneliness   \n",
       "4              Chronic Graft-versus-host Disease (cGVHD)   \n",
       "...                                                  ...   \n",
       "70220  Pancreatic Neoplasms|Digestive System Neoplasm...   \n",
       "70221                               Hepatitis C, Chronic   \n",
       "70222                                               COPD   \n",
       "70223                                           Melanoma   \n",
       "70224  Relapsed or Refractory Chronic Lymphocytic Leu...   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                                       Other: FINassist   \n",
       "1                                                    NaN   \n",
       "2                                                    NaN   \n",
       "3      Behavioral: Self-Care Program through Heartful...   \n",
       "4                           Drug: AMG 592|Other: Placebo   \n",
       "...                                                  ...   \n",
       "70220             Drug: nab-Paclitaxel|Drug: Gemcitabine   \n",
       "70221  Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...   \n",
       "70222  Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...   \n",
       "70223  Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...   \n",
       "70224                   Drug: ofatumumab|Drug: ibrutinib   \n",
       "\n",
       "                                        Outcome Measures  \\\n",
       "0      FINassist Feasibility|FINassist Adherence|FINa...   \n",
       "1      Incidence probability of progression to PF-ILD...   \n",
       "2      Percentage of patients with adverse events (AE...   \n",
       "3      Assess the current level of Anxiety|Changes le...   \n",
       "4      Number of Participants with Treatment-emergent...   \n",
       "...                                                  ...   \n",
       "70220  Kaplan Meier Estimate for Disease Free Surviva...   \n",
       "70221  SVR12 Rates With Historical Control|Comparison...   \n",
       "70222  Forced Expiratory Volume in 1 Second (FEV1) AU...   \n",
       "70223  Progression-Free Survival (PFS) as Assessed by...   \n",
       "70224  PFS (Progression Free Survival) by Independent...   \n",
       "\n",
       "                                   Sponsor/Collaborators Gender  \\\n",
       "0      Jean Edward|Robert Wood Johnson Foundation|Uni...    All   \n",
       "1                                   Boehringer Ingelheim    All   \n",
       "2                      Novartis Pharmaceuticals|Novartis    All   \n",
       "3                                 Heartfulness Institute    All   \n",
       "4                                                  Amgen    All   \n",
       "...                                                  ...    ...   \n",
       "70220                                            Celgene    All   \n",
       "70221                               Boehringer Ingelheim    All   \n",
       "70222                  Novartis Pharmaceuticals|Novartis    All   \n",
       "70223                  Novartis Pharmaceuticals|Novartis    All   \n",
       "70224  Pharmacyclics LLC.|Janssen Research & Developm...    All   \n",
       "\n",
       "                                                     Age          Phases  \\\n",
       "0            18 Years to 65 Years   (Adult, Older Adult)  Not Applicable   \n",
       "1              18 Years and older   (Adult, Older Adult)             NaN   \n",
       "2              18 Years and older   (Adult, Older Adult)             NaN   \n",
       "3      14 Years to 80 Years   (Child, Adult, Older Ad...  Not Applicable   \n",
       "4                         18 Years to 55 Years   (Adult)         Phase 1   \n",
       "...                                                  ...             ...   \n",
       "70220          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "70221        18 Years to 75 Years   (Adult, Older Adult)         Phase 3   \n",
       "70222          40 Years and older   (Adult, Older Adult)         Phase 4   \n",
       "70223          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "70224          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "\n",
       "       Enrollment Funded Bys      Study Type  \\\n",
       "0            61.0      Other  Interventional   \n",
       "1        200000.0   Industry   Observational   \n",
       "2         17517.0   Industry   Observational   \n",
       "3           203.0      Other  Interventional   \n",
       "4            64.0   Industry  Interventional   \n",
       "...           ...        ...             ...   \n",
       "70220       866.0   Industry  Interventional   \n",
       "70221       470.0   Industry  Interventional   \n",
       "70222       124.0   Industry  Interventional   \n",
       "70223       423.0   Industry  Interventional   \n",
       "70224       391.0   Industry  Interventional   \n",
       "\n",
       "                                           Study Designs  \\\n",
       "0      Allocation: Non-Randomized|Intervention Model:...   \n",
       "1      Observational Model: Cohort|Time Perspective: ...   \n",
       "2      Observational Model: Cohort|Time Perspective: ...   \n",
       "3      Allocation: Randomized|Intervention Model: Par...   \n",
       "4      Allocation: Randomized|Intervention Model: Par...   \n",
       "...                                                  ...   \n",
       "70220  Allocation: Randomized|Intervention Model: Par...   \n",
       "70221  Allocation: Randomized|Intervention Model: Par...   \n",
       "70222  Allocation: Randomized|Intervention Model: Cro...   \n",
       "70223  Allocation: Randomized|Intervention Model: Par...   \n",
       "70224  Allocation: Randomized|Intervention Model: Par...   \n",
       "\n",
       "                                Other IDs        Start Date  \\\n",
       "0                                   57238     April 1, 2021   \n",
       "1                               1199-0523    April 20, 2023   \n",
       "2                            CTMT212AUS62       May 1, 2021   \n",
       "3                              02-01-2022  February 3, 2022   \n",
       "4                                20140324  October 19, 2015   \n",
       "...                                   ...               ...   \n",
       "70220     ABI-007-PANC-003|2013-003398-91    March 28, 2014   \n",
       "70221              1241.20|2012-003533-41            Dec-12   \n",
       "70222                        CNVA237A3401            Feb-14   \n",
       "70223  115306|2011-006087-49|CDRB436B2301       May 4, 2012   \n",
       "70224         PCYC-1112-CA|2012-000694-23            Jun-12   \n",
       "\n",
       "                                               Locations  \\\n",
       "0      University of Kentucky DanceBlue Pediatric Hem...   \n",
       "1      Boehringer Ingelheim Pharmaceuticals, Inc., Ri...   \n",
       "2      Novartis, East Hanover, New Jersey, United States   \n",
       "3          Ranjani B Iyer, Novi, Michigan, United States   \n",
       "4        Research Site, Aventura, Florida, United States   \n",
       "...                                                  ...   \n",
       "70220  Local Institution - 043, Scottsdale, Arizona, ...   \n",
       "70221  1241.20.00026 Boehringer Ingelheim Investigati...   \n",
       "70222  Novartis Investigative Site, Geesthacht, Schle...   \n",
       "70223  Novartis Investigative Site, Scottsdale, Arizo...   \n",
       "70224  Site #408, La Jolla, California, United States...   \n",
       "\n",
       "                                               URL  \n",
       "0      https://ClinicalTrials.gov/show/NCT05876325  \n",
       "1      https://ClinicalTrials.gov/show/NCT05875532  \n",
       "2      https://ClinicalTrials.gov/show/NCT05874817  \n",
       "3      https://ClinicalTrials.gov/show/NCT05874232  \n",
       "4      https://ClinicalTrials.gov/show/NCT05873907  \n",
       "...                                            ...  \n",
       "70220  https://ClinicalTrials.gov/show/NCT01964430  \n",
       "70221  https://ClinicalTrials.gov/show/NCT01732796  \n",
       "70222  https://ClinicalTrials.gov/show/NCT01959516  \n",
       "70223  https://ClinicalTrials.gov/show/NCT01584648  \n",
       "70224  https://ClinicalTrials.gov/show/NCT01578707  \n",
       "\n",
       "[70225 rows x 19 columns]"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "c0a0d881",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd=cd.drop(['URL'],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "1ac434ef",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Start Date</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT05876325</td>\n",
       "      <td>Financial and Insurance Assistance- Oncology F...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Financial Stress|Pediatric Cancer</td>\n",
       "      <td>Other: FINassist</td>\n",
       "      <td>FINassist Feasibility|FINassist Adherence|FINa...</td>\n",
       "      <td>Jean Edward|Robert Wood Johnson Foundation|Uni...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 65 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>61.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>57238</td>\n",
       "      <td>April 1, 2021</td>\n",
       "      <td>University of Kentucky DanceBlue Pediatric Hem...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT05875532</td>\n",
       "      <td>Study of Progression to Progressive Fibrosing ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Lung Diseases, Interstitial</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Incidence probability of progression to PF-ILD...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>1199-0523</td>\n",
       "      <td>April 20, 2023</td>\n",
       "      <td>Boehringer Ingelheim Pharmaceuticals, Inc., Ri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT05874817</td>\n",
       "      <td>Retrospective Assessment of AE-Related Healthc...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Percentage of patients with adverse events (AE...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>NaN</td>\n",
       "      <td>17517.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>CTMT212AUS62</td>\n",
       "      <td>May 1, 2021</td>\n",
       "      <td>Novartis, East Hanover, New Jersey, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT05874232</td>\n",
       "      <td>The Impact of Heartfulness Self-Care Program o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Anxiety|Satisfaction With Life|Loneliness</td>\n",
       "      <td>Behavioral: Self-Care Program through Heartful...</td>\n",
       "      <td>Assess the current level of Anxiety|Changes le...</td>\n",
       "      <td>Heartfulness Institute</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 80 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>203.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>02-01-2022</td>\n",
       "      <td>February 3, 2022</td>\n",
       "      <td>Ranjani B Iyer, Novi, Michigan, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05873907</td>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Chronic Graft-versus-host Disease (cGVHD)</td>\n",
       "      <td>Drug: AMG 592|Other: Placebo</td>\n",
       "      <td>Number of Participants with Treatment-emergent...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>64.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>20140324</td>\n",
       "      <td>October 19, 2015</td>\n",
       "      <td>Research Site, Aventura, Florida, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70220</th>\n",
       "      <td>NCT01964430</td>\n",
       "      <td>Nab-paclitaxel and Gemcitabine vs Gemcitabine ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Pancreatic Neoplasms|Digestive System Neoplasm...</td>\n",
       "      <td>Drug: nab-Paclitaxel|Drug: Gemcitabine</td>\n",
       "      <td>Kaplan Meier Estimate for Disease Free Surviva...</td>\n",
       "      <td>Celgene</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>866.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>ABI-007-PANC-003|2013-003398-91</td>\n",
       "      <td>March 28, 2014</td>\n",
       "      <td>Local Institution - 043, Scottsdale, Arizona, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70221</th>\n",
       "      <td>NCT01732796</td>\n",
       "      <td>IFN-free Combination Therapy in HCV-infected P...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Hepatitis C, Chronic</td>\n",
       "      <td>Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...</td>\n",
       "      <td>SVR12 Rates With Historical Control|Comparison...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 75 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>470.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>1241.20|2012-003533-41</td>\n",
       "      <td>Dec-12</td>\n",
       "      <td>1241.20.00026 Boehringer Ingelheim Investigati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70222</th>\n",
       "      <td>NCT01959516</td>\n",
       "      <td>Effect of Glycopyrronium on Morning Symptoms a...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COPD</td>\n",
       "      <td>Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...</td>\n",
       "      <td>Forced Expiratory Volume in 1 Second (FEV1) AU...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>40 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>124.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Cro...</td>\n",
       "      <td>CNVA237A3401</td>\n",
       "      <td>Feb-14</td>\n",
       "      <td>Novartis Investigative Site, Geesthacht, Schle...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70223</th>\n",
       "      <td>NCT01584648</td>\n",
       "      <td>A Study Comparing Trametinib and Dabrafenib Co...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...</td>\n",
       "      <td>Progression-Free Survival (PFS) as Assessed by...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>423.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>115306|2011-006087-49|CDRB436B2301</td>\n",
       "      <td>May 4, 2012</td>\n",
       "      <td>Novartis Investigative Site, Scottsdale, Arizo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70224</th>\n",
       "      <td>NCT01578707</td>\n",
       "      <td>A Phase 3 Study of Ibrutinib (PCI-32765) Versu...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Relapsed or Refractory Chronic Lymphocytic Leu...</td>\n",
       "      <td>Drug: ofatumumab|Drug: ibrutinib</td>\n",
       "      <td>PFS (Progression Free Survival) by Independent...</td>\n",
       "      <td>Pharmacyclics LLC.|Janssen Research &amp; Developm...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>391.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>PCYC-1112-CA|2012-000694-23</td>\n",
       "      <td>Jun-12</td>\n",
       "      <td>Site #408, La Jolla, California, United States...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>70225 rows × 18 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        NCT Number                                              Title  \\\n",
       "0      NCT05876325  Financial and Insurance Assistance- Oncology F...   \n",
       "1      NCT05875532  Study of Progression to Progressive Fibrosing ...   \n",
       "2      NCT05874817  Retrospective Assessment of AE-Related Healthc...   \n",
       "3      NCT05874232  The Impact of Heartfulness Self-Care Program o...   \n",
       "4      NCT05873907  A Study to Evaluate the Safety, Tolerability, ...   \n",
       "...            ...                                                ...   \n",
       "70220  NCT01964430  Nab-paclitaxel and Gemcitabine vs Gemcitabine ...   \n",
       "70221  NCT01732796  IFN-free Combination Therapy in HCV-infected P...   \n",
       "70222  NCT01959516  Effect of Glycopyrronium on Morning Symptoms a...   \n",
       "70223  NCT01584648  A Study Comparing Trametinib and Dabrafenib Co...   \n",
       "70224  NCT01578707  A Phase 3 Study of Ibrutinib (PCI-32765) Versu...   \n",
       "\n",
       "          Status         Study Results  \\\n",
       "0      Completed  No Results Available   \n",
       "1      Completed  No Results Available   \n",
       "2      Completed  No Results Available   \n",
       "3      Completed  No Results Available   \n",
       "4      Completed  No Results Available   \n",
       "...          ...                   ...   \n",
       "70220  Completed           Has Results   \n",
       "70221  Completed           Has Results   \n",
       "70222  Completed           Has Results   \n",
       "70223  Completed           Has Results   \n",
       "70224  Completed           Has Results   \n",
       "\n",
       "                                              Conditions  \\\n",
       "0                      Financial Stress|Pediatric Cancer   \n",
       "1                            Lung Diseases, Interstitial   \n",
       "2                                               Melanoma   \n",
       "3              Anxiety|Satisfaction With Life|Loneliness   \n",
       "4              Chronic Graft-versus-host Disease (cGVHD)   \n",
       "...                                                  ...   \n",
       "70220  Pancreatic Neoplasms|Digestive System Neoplasm...   \n",
       "70221                               Hepatitis C, Chronic   \n",
       "70222                                               COPD   \n",
       "70223                                           Melanoma   \n",
       "70224  Relapsed or Refractory Chronic Lymphocytic Leu...   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                                       Other: FINassist   \n",
       "1                                                    NaN   \n",
       "2                                                    NaN   \n",
       "3      Behavioral: Self-Care Program through Heartful...   \n",
       "4                           Drug: AMG 592|Other: Placebo   \n",
       "...                                                  ...   \n",
       "70220             Drug: nab-Paclitaxel|Drug: Gemcitabine   \n",
       "70221  Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...   \n",
       "70222  Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...   \n",
       "70223  Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...   \n",
       "70224                   Drug: ofatumumab|Drug: ibrutinib   \n",
       "\n",
       "                                        Outcome Measures  \\\n",
       "0      FINassist Feasibility|FINassist Adherence|FINa...   \n",
       "1      Incidence probability of progression to PF-ILD...   \n",
       "2      Percentage of patients with adverse events (AE...   \n",
       "3      Assess the current level of Anxiety|Changes le...   \n",
       "4      Number of Participants with Treatment-emergent...   \n",
       "...                                                  ...   \n",
       "70220  Kaplan Meier Estimate for Disease Free Surviva...   \n",
       "70221  SVR12 Rates With Historical Control|Comparison...   \n",
       "70222  Forced Expiratory Volume in 1 Second (FEV1) AU...   \n",
       "70223  Progression-Free Survival (PFS) as Assessed by...   \n",
       "70224  PFS (Progression Free Survival) by Independent...   \n",
       "\n",
       "                                   Sponsor/Collaborators Gender  \\\n",
       "0      Jean Edward|Robert Wood Johnson Foundation|Uni...    All   \n",
       "1                                   Boehringer Ingelheim    All   \n",
       "2                      Novartis Pharmaceuticals|Novartis    All   \n",
       "3                                 Heartfulness Institute    All   \n",
       "4                                                  Amgen    All   \n",
       "...                                                  ...    ...   \n",
       "70220                                            Celgene    All   \n",
       "70221                               Boehringer Ingelheim    All   \n",
       "70222                  Novartis Pharmaceuticals|Novartis    All   \n",
       "70223                  Novartis Pharmaceuticals|Novartis    All   \n",
       "70224  Pharmacyclics LLC.|Janssen Research & Developm...    All   \n",
       "\n",
       "                                                     Age          Phases  \\\n",
       "0            18 Years to 65 Years   (Adult, Older Adult)  Not Applicable   \n",
       "1              18 Years and older   (Adult, Older Adult)             NaN   \n",
       "2              18 Years and older   (Adult, Older Adult)             NaN   \n",
       "3      14 Years to 80 Years   (Child, Adult, Older Ad...  Not Applicable   \n",
       "4                         18 Years to 55 Years   (Adult)         Phase 1   \n",
       "...                                                  ...             ...   \n",
       "70220          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "70221        18 Years to 75 Years   (Adult, Older Adult)         Phase 3   \n",
       "70222          40 Years and older   (Adult, Older Adult)         Phase 4   \n",
       "70223          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "70224          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "\n",
       "       Enrollment Funded Bys      Study Type  \\\n",
       "0            61.0      Other  Interventional   \n",
       "1        200000.0   Industry   Observational   \n",
       "2         17517.0   Industry   Observational   \n",
       "3           203.0      Other  Interventional   \n",
       "4            64.0   Industry  Interventional   \n",
       "...           ...        ...             ...   \n",
       "70220       866.0   Industry  Interventional   \n",
       "70221       470.0   Industry  Interventional   \n",
       "70222       124.0   Industry  Interventional   \n",
       "70223       423.0   Industry  Interventional   \n",
       "70224       391.0   Industry  Interventional   \n",
       "\n",
       "                                           Study Designs  \\\n",
       "0      Allocation: Non-Randomized|Intervention Model:...   \n",
       "1      Observational Model: Cohort|Time Perspective: ...   \n",
       "2      Observational Model: Cohort|Time Perspective: ...   \n",
       "3      Allocation: Randomized|Intervention Model: Par...   \n",
       "4      Allocation: Randomized|Intervention Model: Par...   \n",
       "...                                                  ...   \n",
       "70220  Allocation: Randomized|Intervention Model: Par...   \n",
       "70221  Allocation: Randomized|Intervention Model: Par...   \n",
       "70222  Allocation: Randomized|Intervention Model: Cro...   \n",
       "70223  Allocation: Randomized|Intervention Model: Par...   \n",
       "70224  Allocation: Randomized|Intervention Model: Par...   \n",
       "\n",
       "                                Other IDs        Start Date  \\\n",
       "0                                   57238     April 1, 2021   \n",
       "1                               1199-0523    April 20, 2023   \n",
       "2                            CTMT212AUS62       May 1, 2021   \n",
       "3                              02-01-2022  February 3, 2022   \n",
       "4                                20140324  October 19, 2015   \n",
       "...                                   ...               ...   \n",
       "70220     ABI-007-PANC-003|2013-003398-91    March 28, 2014   \n",
       "70221              1241.20|2012-003533-41            Dec-12   \n",
       "70222                        CNVA237A3401            Feb-14   \n",
       "70223  115306|2011-006087-49|CDRB436B2301       May 4, 2012   \n",
       "70224         PCYC-1112-CA|2012-000694-23            Jun-12   \n",
       "\n",
       "                                               Locations  \n",
       "0      University of Kentucky DanceBlue Pediatric Hem...  \n",
       "1      Boehringer Ingelheim Pharmaceuticals, Inc., Ri...  \n",
       "2      Novartis, East Hanover, New Jersey, United States  \n",
       "3          Ranjani B Iyer, Novi, Michigan, United States  \n",
       "4        Research Site, Aventura, Florida, United States  \n",
       "...                                                  ...  \n",
       "70220  Local Institution - 043, Scottsdale, Arizona, ...  \n",
       "70221  1241.20.00026 Boehringer Ingelheim Investigati...  \n",
       "70222  Novartis Investigative Site, Geesthacht, Schle...  \n",
       "70223  Novartis Investigative Site, Scottsdale, Arizo...  \n",
       "70224  Site #408, La Jolla, California, United States...  \n",
       "\n",
       "[70225 rows x 18 columns]"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "12d9776e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number                 281\n",
       "Title                      281\n",
       "Status                     281\n",
       "Study Results              281\n",
       "Conditions                 281\n",
       "Interventions             6002\n",
       "Outcome Measures          1592\n",
       "Sponsor/Collaborators      281\n",
       "Gender                     352\n",
       "Age                        281\n",
       "Phases                   14145\n",
       "Enrollment                 719\n",
       "Funded Bys                 281\n",
       "Study Type                 281\n",
       "Study Designs              504\n",
       "Other IDs                  296\n",
       "Start Date                 494\n",
       "Locations                  281\n",
       "dtype: int64"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "f75b1e18",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count                      64223\n",
       "unique                     52427\n",
       "top       Other: No intervention\n",
       "freq                         143\n",
       "Name: Interventions, dtype: object"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd['Interventions'].describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "3211db04",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd['Interventions']=cd['Interventions'].fillna(value='Other: No intervention')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "6124802b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count              68633\n",
       "unique             62318\n",
       "top       Bioequivalence\n",
       "freq                  36\n",
       "Name: Outcome Measures, dtype: object"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd['Outcome Measures'].describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "068c1ed3",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd['Outcome Measures']=cd['Outcome Measures'].fillna(value='Bioequivalence')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "c88a3731",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count     69873\n",
       "unique        5\n",
       "top         All\n",
       "freq      60969\n",
       "Name: Gender, dtype: object"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd['Gender'].describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "88b7ed39",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd['Gender']=cd['Gender'].fillna(value='All')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "a1af8bc4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count              56080\n",
       "unique                10\n",
       "top       Not Applicable\n",
       "freq               22962\n",
       "Name: Phases, dtype: object"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd['Phases'].describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "5e08178f",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd['Phases']=cd['Phases'].fillna(value='Not Applicable')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "4cade95a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count    6.950600e+04\n",
       "mean     3.614855e+03\n",
       "std      1.775452e+05\n",
       "min      0.000000e+00\n",
       "25%      2.900000e+01\n",
       "50%      7.000000e+01\n",
       "75%      2.340000e+02\n",
       "max      3.200000e+07\n",
       "Name: Enrollment, dtype: float64"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd['Enrollment'].describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "4f8dd59f",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd['Enrollment']=cd['Enrollment'].fillna(value=3.183136e+03)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "id": "b579e146",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "count     69929\n",
       "unique    64092\n",
       "top           1\n",
       "freq         82\n",
       "Name: Other IDs, dtype: object"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd['Other IDs'].describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "id": "20ba078e",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd['Other IDs']=cd['Other IDs'].fillna(value='1')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "id": "ccd650e2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number               281\n",
       "Title                    281\n",
       "Status                   281\n",
       "Study Results            281\n",
       "Conditions               281\n",
       "Interventions              0\n",
       "Outcome Measures           0\n",
       "Sponsor/Collaborators    281\n",
       "Gender                     0\n",
       "Age                      281\n",
       "Phases                     0\n",
       "Enrollment                 0\n",
       "Funded Bys               281\n",
       "Study Type               281\n",
       "Study Designs            504\n",
       "Other IDs                  0\n",
       "Start Date               494\n",
       "Locations                281\n",
       "dtype: int64"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "id": "aa6901a1",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd=cd.drop(['Start Date'],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "id": "6eef1eed",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd=cd.dropna()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "6b96dcde",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "NCT Number               0\n",
       "Title                    0\n",
       "Status                   0\n",
       "Study Results            0\n",
       "Conditions               0\n",
       "Interventions            0\n",
       "Outcome Measures         0\n",
       "Sponsor/Collaborators    0\n",
       "Gender                   0\n",
       "Age                      0\n",
       "Phases                   0\n",
       "Enrollment               0\n",
       "Funded Bys               0\n",
       "Study Type               0\n",
       "Study Designs            0\n",
       "Other IDs                0\n",
       "Locations                0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "id": "6ab96842",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>NCT Number</th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NCT05876325</td>\n",
       "      <td>Financial and Insurance Assistance- Oncology F...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Financial Stress|Pediatric Cancer</td>\n",
       "      <td>Other: FINassist</td>\n",
       "      <td>FINassist Feasibility|FINassist Adherence|FINa...</td>\n",
       "      <td>Jean Edward|Robert Wood Johnson Foundation|Uni...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 65 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>61.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>57238</td>\n",
       "      <td>University of Kentucky DanceBlue Pediatric Hem...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NCT05875532</td>\n",
       "      <td>Study of Progression to Progressive Fibrosing ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Lung Diseases, Interstitial</td>\n",
       "      <td>Other: No intervention</td>\n",
       "      <td>Incidence probability of progression to PF-ILD...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>1199-0523</td>\n",
       "      <td>Boehringer Ingelheim Pharmaceuticals, Inc., Ri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NCT05874817</td>\n",
       "      <td>Retrospective Assessment of AE-Related Healthc...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Other: No intervention</td>\n",
       "      <td>Percentage of patients with adverse events (AE...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>17517.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>CTMT212AUS62</td>\n",
       "      <td>Novartis, East Hanover, New Jersey, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NCT05874232</td>\n",
       "      <td>The Impact of Heartfulness Self-Care Program o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Anxiety|Satisfaction With Life|Loneliness</td>\n",
       "      <td>Behavioral: Self-Care Program through Heartful...</td>\n",
       "      <td>Assess the current level of Anxiety|Changes le...</td>\n",
       "      <td>Heartfulness Institute</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 80 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>203.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>02-01-2022</td>\n",
       "      <td>Ranjani B Iyer, Novi, Michigan, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NCT05873907</td>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Chronic Graft-versus-host Disease (cGVHD)</td>\n",
       "      <td>Drug: AMG 592|Other: Placebo</td>\n",
       "      <td>Number of Participants with Treatment-emergent...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>64.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>20140324</td>\n",
       "      <td>Research Site, Aventura, Florida, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70220</th>\n",
       "      <td>NCT01964430</td>\n",
       "      <td>Nab-paclitaxel and Gemcitabine vs Gemcitabine ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Pancreatic Neoplasms|Digestive System Neoplasm...</td>\n",
       "      <td>Drug: nab-Paclitaxel|Drug: Gemcitabine</td>\n",
       "      <td>Kaplan Meier Estimate for Disease Free Surviva...</td>\n",
       "      <td>Celgene</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>866.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>ABI-007-PANC-003|2013-003398-91</td>\n",
       "      <td>Local Institution - 043, Scottsdale, Arizona, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70221</th>\n",
       "      <td>NCT01732796</td>\n",
       "      <td>IFN-free Combination Therapy in HCV-infected P...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Hepatitis C, Chronic</td>\n",
       "      <td>Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...</td>\n",
       "      <td>SVR12 Rates With Historical Control|Comparison...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 75 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>470.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>1241.20|2012-003533-41</td>\n",
       "      <td>1241.20.00026 Boehringer Ingelheim Investigati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70222</th>\n",
       "      <td>NCT01959516</td>\n",
       "      <td>Effect of Glycopyrronium on Morning Symptoms a...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COPD</td>\n",
       "      <td>Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...</td>\n",
       "      <td>Forced Expiratory Volume in 1 Second (FEV1) AU...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>40 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>124.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Cro...</td>\n",
       "      <td>CNVA237A3401</td>\n",
       "      <td>Novartis Investigative Site, Geesthacht, Schle...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70223</th>\n",
       "      <td>NCT01584648</td>\n",
       "      <td>A Study Comparing Trametinib and Dabrafenib Co...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...</td>\n",
       "      <td>Progression-Free Survival (PFS) as Assessed by...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>423.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>115306|2011-006087-49|CDRB436B2301</td>\n",
       "      <td>Novartis Investigative Site, Scottsdale, Arizo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70224</th>\n",
       "      <td>NCT01578707</td>\n",
       "      <td>A Phase 3 Study of Ibrutinib (PCI-32765) Versu...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Relapsed or Refractory Chronic Lymphocytic Leu...</td>\n",
       "      <td>Drug: ofatumumab|Drug: ibrutinib</td>\n",
       "      <td>PFS (Progression Free Survival) by Independent...</td>\n",
       "      <td>Pharmacyclics LLC.|Janssen Research &amp; Developm...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>391.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>PCYC-1112-CA|2012-000694-23</td>\n",
       "      <td>Site #408, La Jolla, California, United States...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>69721 rows × 17 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "        NCT Number                                              Title  \\\n",
       "0      NCT05876325  Financial and Insurance Assistance- Oncology F...   \n",
       "1      NCT05875532  Study of Progression to Progressive Fibrosing ...   \n",
       "2      NCT05874817  Retrospective Assessment of AE-Related Healthc...   \n",
       "3      NCT05874232  The Impact of Heartfulness Self-Care Program o...   \n",
       "4      NCT05873907  A Study to Evaluate the Safety, Tolerability, ...   \n",
       "...            ...                                                ...   \n",
       "70220  NCT01964430  Nab-paclitaxel and Gemcitabine vs Gemcitabine ...   \n",
       "70221  NCT01732796  IFN-free Combination Therapy in HCV-infected P...   \n",
       "70222  NCT01959516  Effect of Glycopyrronium on Morning Symptoms a...   \n",
       "70223  NCT01584648  A Study Comparing Trametinib and Dabrafenib Co...   \n",
       "70224  NCT01578707  A Phase 3 Study of Ibrutinib (PCI-32765) Versu...   \n",
       "\n",
       "          Status         Study Results  \\\n",
       "0      Completed  No Results Available   \n",
       "1      Completed  No Results Available   \n",
       "2      Completed  No Results Available   \n",
       "3      Completed  No Results Available   \n",
       "4      Completed  No Results Available   \n",
       "...          ...                   ...   \n",
       "70220  Completed           Has Results   \n",
       "70221  Completed           Has Results   \n",
       "70222  Completed           Has Results   \n",
       "70223  Completed           Has Results   \n",
       "70224  Completed           Has Results   \n",
       "\n",
       "                                              Conditions  \\\n",
       "0                      Financial Stress|Pediatric Cancer   \n",
       "1                            Lung Diseases, Interstitial   \n",
       "2                                               Melanoma   \n",
       "3              Anxiety|Satisfaction With Life|Loneliness   \n",
       "4              Chronic Graft-versus-host Disease (cGVHD)   \n",
       "...                                                  ...   \n",
       "70220  Pancreatic Neoplasms|Digestive System Neoplasm...   \n",
       "70221                               Hepatitis C, Chronic   \n",
       "70222                                               COPD   \n",
       "70223                                           Melanoma   \n",
       "70224  Relapsed or Refractory Chronic Lymphocytic Leu...   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                                       Other: FINassist   \n",
       "1                                 Other: No intervention   \n",
       "2                                 Other: No intervention   \n",
       "3      Behavioral: Self-Care Program through Heartful...   \n",
       "4                           Drug: AMG 592|Other: Placebo   \n",
       "...                                                  ...   \n",
       "70220             Drug: nab-Paclitaxel|Drug: Gemcitabine   \n",
       "70221  Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...   \n",
       "70222  Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...   \n",
       "70223  Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...   \n",
       "70224                   Drug: ofatumumab|Drug: ibrutinib   \n",
       "\n",
       "                                        Outcome Measures  \\\n",
       "0      FINassist Feasibility|FINassist Adherence|FINa...   \n",
       "1      Incidence probability of progression to PF-ILD...   \n",
       "2      Percentage of patients with adverse events (AE...   \n",
       "3      Assess the current level of Anxiety|Changes le...   \n",
       "4      Number of Participants with Treatment-emergent...   \n",
       "...                                                  ...   \n",
       "70220  Kaplan Meier Estimate for Disease Free Surviva...   \n",
       "70221  SVR12 Rates With Historical Control|Comparison...   \n",
       "70222  Forced Expiratory Volume in 1 Second (FEV1) AU...   \n",
       "70223  Progression-Free Survival (PFS) as Assessed by...   \n",
       "70224  PFS (Progression Free Survival) by Independent...   \n",
       "\n",
       "                                   Sponsor/Collaborators Gender  \\\n",
       "0      Jean Edward|Robert Wood Johnson Foundation|Uni...    All   \n",
       "1                                   Boehringer Ingelheim    All   \n",
       "2                      Novartis Pharmaceuticals|Novartis    All   \n",
       "3                                 Heartfulness Institute    All   \n",
       "4                                                  Amgen    All   \n",
       "...                                                  ...    ...   \n",
       "70220                                            Celgene    All   \n",
       "70221                               Boehringer Ingelheim    All   \n",
       "70222                  Novartis Pharmaceuticals|Novartis    All   \n",
       "70223                  Novartis Pharmaceuticals|Novartis    All   \n",
       "70224  Pharmacyclics LLC.|Janssen Research & Developm...    All   \n",
       "\n",
       "                                                     Age          Phases  \\\n",
       "0            18 Years to 65 Years   (Adult, Older Adult)  Not Applicable   \n",
       "1              18 Years and older   (Adult, Older Adult)  Not Applicable   \n",
       "2              18 Years and older   (Adult, Older Adult)  Not Applicable   \n",
       "3      14 Years to 80 Years   (Child, Adult, Older Ad...  Not Applicable   \n",
       "4                         18 Years to 55 Years   (Adult)         Phase 1   \n",
       "...                                                  ...             ...   \n",
       "70220          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "70221        18 Years to 75 Years   (Adult, Older Adult)         Phase 3   \n",
       "70222          40 Years and older   (Adult, Older Adult)         Phase 4   \n",
       "70223          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "70224          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "\n",
       "       Enrollment Funded Bys      Study Type  \\\n",
       "0            61.0      Other  Interventional   \n",
       "1        200000.0   Industry   Observational   \n",
       "2         17517.0   Industry   Observational   \n",
       "3           203.0      Other  Interventional   \n",
       "4            64.0   Industry  Interventional   \n",
       "...           ...        ...             ...   \n",
       "70220       866.0   Industry  Interventional   \n",
       "70221       470.0   Industry  Interventional   \n",
       "70222       124.0   Industry  Interventional   \n",
       "70223       423.0   Industry  Interventional   \n",
       "70224       391.0   Industry  Interventional   \n",
       "\n",
       "                                           Study Designs  \\\n",
       "0      Allocation: Non-Randomized|Intervention Model:...   \n",
       "1      Observational Model: Cohort|Time Perspective: ...   \n",
       "2      Observational Model: Cohort|Time Perspective: ...   \n",
       "3      Allocation: Randomized|Intervention Model: Par...   \n",
       "4      Allocation: Randomized|Intervention Model: Par...   \n",
       "...                                                  ...   \n",
       "70220  Allocation: Randomized|Intervention Model: Par...   \n",
       "70221  Allocation: Randomized|Intervention Model: Par...   \n",
       "70222  Allocation: Randomized|Intervention Model: Cro...   \n",
       "70223  Allocation: Randomized|Intervention Model: Par...   \n",
       "70224  Allocation: Randomized|Intervention Model: Par...   \n",
       "\n",
       "                                Other IDs  \\\n",
       "0                                   57238   \n",
       "1                               1199-0523   \n",
       "2                            CTMT212AUS62   \n",
       "3                              02-01-2022   \n",
       "4                                20140324   \n",
       "...                                   ...   \n",
       "70220     ABI-007-PANC-003|2013-003398-91   \n",
       "70221              1241.20|2012-003533-41   \n",
       "70222                        CNVA237A3401   \n",
       "70223  115306|2011-006087-49|CDRB436B2301   \n",
       "70224         PCYC-1112-CA|2012-000694-23   \n",
       "\n",
       "                                               Locations  \n",
       "0      University of Kentucky DanceBlue Pediatric Hem...  \n",
       "1      Boehringer Ingelheim Pharmaceuticals, Inc., Ri...  \n",
       "2      Novartis, East Hanover, New Jersey, United States  \n",
       "3          Ranjani B Iyer, Novi, Michigan, United States  \n",
       "4        Research Site, Aventura, Florida, United States  \n",
       "...                                                  ...  \n",
       "70220  Local Institution - 043, Scottsdale, Arizona, ...  \n",
       "70221  1241.20.00026 Boehringer Ingelheim Investigati...  \n",
       "70222  Novartis Investigative Site, Geesthacht, Schle...  \n",
       "70223  Novartis Investigative Site, Scottsdale, Arizo...  \n",
       "70224  Site #408, La Jolla, California, United States...  \n",
       "\n",
       "[69721 rows x 17 columns]"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "id": "a380ebc0",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd = cd.astype({'Title': 'object', 'Interventions': 'object','Outcome Measures':'object','Sponsor/Collaborators':'object','Age':'object','Funded Bys':'object','Other IDs':'object','Locations':'object','Conditions':'object'})"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "b14a4791",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\seaborn\\_decorators.py:36: FutureWarning: Pass the following variable as a keyword arg: x. From version 0.12, the only valid positional argument will be `data`, and passing other arguments without an explicit keyword will result in an error or misinterpretation.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:xlabel='Status', ylabel='count'>"
      ]
     },
     "execution_count": 33,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.countplot(cd['Status'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "id": "d6f669e8",
   "metadata": {},
   "outputs": [],
   "source": [
    "val=['Completed','Terminated']\n",
    "cd=cd[cd['Status'].isin(val)]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "4f12d09a",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\seaborn\\_decorators.py:36: FutureWarning: Pass the following variable as a keyword arg: x. From version 0.12, the only valid positional argument will be `data`, and passing other arguments without an explicit keyword will result in an error or misinterpretation.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:xlabel='Status', ylabel='count'>"
      ]
     },
     "execution_count": 35,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.countplot(cd['Status'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "d1ff2fa0",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd=cd.drop(['NCT Number'],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "2f7dec01",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Financial and Insurance Assistance- Oncology F...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Financial Stress|Pediatric Cancer</td>\n",
       "      <td>Other: FINassist</td>\n",
       "      <td>FINassist Feasibility|FINassist Adherence|FINa...</td>\n",
       "      <td>Jean Edward|Robert Wood Johnson Foundation|Uni...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 65 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>61.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>57238</td>\n",
       "      <td>University of Kentucky DanceBlue Pediatric Hem...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Study of Progression to Progressive Fibrosing ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Lung Diseases, Interstitial</td>\n",
       "      <td>Other: No intervention</td>\n",
       "      <td>Incidence probability of progression to PF-ILD...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>1199-0523</td>\n",
       "      <td>Boehringer Ingelheim Pharmaceuticals, Inc., Ri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Retrospective Assessment of AE-Related Healthc...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Other: No intervention</td>\n",
       "      <td>Percentage of patients with adverse events (AE...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>17517.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>CTMT212AUS62</td>\n",
       "      <td>Novartis, East Hanover, New Jersey, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>The Impact of Heartfulness Self-Care Program o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Anxiety|Satisfaction With Life|Loneliness</td>\n",
       "      <td>Behavioral: Self-Care Program through Heartful...</td>\n",
       "      <td>Assess the current level of Anxiety|Changes le...</td>\n",
       "      <td>Heartfulness Institute</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 80 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>203.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>02-01-2022</td>\n",
       "      <td>Ranjani B Iyer, Novi, Michigan, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Chronic Graft-versus-host Disease (cGVHD)</td>\n",
       "      <td>Drug: AMG 592|Other: Placebo</td>\n",
       "      <td>Number of Participants with Treatment-emergent...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>64.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>20140324</td>\n",
       "      <td>Research Site, Aventura, Florida, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70220</th>\n",
       "      <td>Nab-paclitaxel and Gemcitabine vs Gemcitabine ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Pancreatic Neoplasms|Digestive System Neoplasm...</td>\n",
       "      <td>Drug: nab-Paclitaxel|Drug: Gemcitabine</td>\n",
       "      <td>Kaplan Meier Estimate for Disease Free Surviva...</td>\n",
       "      <td>Celgene</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>866.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>ABI-007-PANC-003|2013-003398-91</td>\n",
       "      <td>Local Institution - 043, Scottsdale, Arizona, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70221</th>\n",
       "      <td>IFN-free Combination Therapy in HCV-infected P...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Hepatitis C, Chronic</td>\n",
       "      <td>Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...</td>\n",
       "      <td>SVR12 Rates With Historical Control|Comparison...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 75 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>470.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>1241.20|2012-003533-41</td>\n",
       "      <td>1241.20.00026 Boehringer Ingelheim Investigati...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70222</th>\n",
       "      <td>Effect of Glycopyrronium on Morning Symptoms a...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>COPD</td>\n",
       "      <td>Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...</td>\n",
       "      <td>Forced Expiratory Volume in 1 Second (FEV1) AU...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>40 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>124.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Cro...</td>\n",
       "      <td>CNVA237A3401</td>\n",
       "      <td>Novartis Investigative Site, Geesthacht, Schle...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70223</th>\n",
       "      <td>A Study Comparing Trametinib and Dabrafenib Co...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...</td>\n",
       "      <td>Progression-Free Survival (PFS) as Assessed by...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>423.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>115306|2011-006087-49|CDRB436B2301</td>\n",
       "      <td>Novartis Investigative Site, Scottsdale, Arizo...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>70224</th>\n",
       "      <td>A Phase 3 Study of Ibrutinib (PCI-32765) Versu...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Relapsed or Refractory Chronic Lymphocytic Leu...</td>\n",
       "      <td>Drug: ofatumumab|Drug: ibrutinib</td>\n",
       "      <td>PFS (Progression Free Survival) by Independent...</td>\n",
       "      <td>Pharmacyclics LLC.|Janssen Research &amp; Developm...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>391.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>PCYC-1112-CA|2012-000694-23</td>\n",
       "      <td>Site #408, La Jolla, California, United States...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>69719 rows × 16 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                   Title     Status  \\\n",
       "0      Financial and Insurance Assistance- Oncology F...  Completed   \n",
       "1      Study of Progression to Progressive Fibrosing ...  Completed   \n",
       "2      Retrospective Assessment of AE-Related Healthc...  Completed   \n",
       "3      The Impact of Heartfulness Self-Care Program o...  Completed   \n",
       "4      A Study to Evaluate the Safety, Tolerability, ...  Completed   \n",
       "...                                                  ...        ...   \n",
       "70220  Nab-paclitaxel and Gemcitabine vs Gemcitabine ...  Completed   \n",
       "70221  IFN-free Combination Therapy in HCV-infected P...  Completed   \n",
       "70222  Effect of Glycopyrronium on Morning Symptoms a...  Completed   \n",
       "70223  A Study Comparing Trametinib and Dabrafenib Co...  Completed   \n",
       "70224  A Phase 3 Study of Ibrutinib (PCI-32765) Versu...  Completed   \n",
       "\n",
       "              Study Results  \\\n",
       "0      No Results Available   \n",
       "1      No Results Available   \n",
       "2      No Results Available   \n",
       "3      No Results Available   \n",
       "4      No Results Available   \n",
       "...                     ...   \n",
       "70220           Has Results   \n",
       "70221           Has Results   \n",
       "70222           Has Results   \n",
       "70223           Has Results   \n",
       "70224           Has Results   \n",
       "\n",
       "                                              Conditions  \\\n",
       "0                      Financial Stress|Pediatric Cancer   \n",
       "1                            Lung Diseases, Interstitial   \n",
       "2                                               Melanoma   \n",
       "3              Anxiety|Satisfaction With Life|Loneliness   \n",
       "4              Chronic Graft-versus-host Disease (cGVHD)   \n",
       "...                                                  ...   \n",
       "70220  Pancreatic Neoplasms|Digestive System Neoplasm...   \n",
       "70221                               Hepatitis C, Chronic   \n",
       "70222                                               COPD   \n",
       "70223                                           Melanoma   \n",
       "70224  Relapsed or Refractory Chronic Lymphocytic Leu...   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                                       Other: FINassist   \n",
       "1                                 Other: No intervention   \n",
       "2                                 Other: No intervention   \n",
       "3      Behavioral: Self-Care Program through Heartful...   \n",
       "4                           Drug: AMG 592|Other: Placebo   \n",
       "...                                                  ...   \n",
       "70220             Drug: nab-Paclitaxel|Drug: Gemcitabine   \n",
       "70221  Drug: Ribavirin (RBV)|Drug: BI 201335 (Faldapr...   \n",
       "70222  Drug: Glycopyrronium|Drug: Tiotropium|Drug: Pl...   \n",
       "70223  Drug: Dabrafenib|Drug: Trametinib|Drug: Tramet...   \n",
       "70224                   Drug: ofatumumab|Drug: ibrutinib   \n",
       "\n",
       "                                        Outcome Measures  \\\n",
       "0      FINassist Feasibility|FINassist Adherence|FINa...   \n",
       "1      Incidence probability of progression to PF-ILD...   \n",
       "2      Percentage of patients with adverse events (AE...   \n",
       "3      Assess the current level of Anxiety|Changes le...   \n",
       "4      Number of Participants with Treatment-emergent...   \n",
       "...                                                  ...   \n",
       "70220  Kaplan Meier Estimate for Disease Free Surviva...   \n",
       "70221  SVR12 Rates With Historical Control|Comparison...   \n",
       "70222  Forced Expiratory Volume in 1 Second (FEV1) AU...   \n",
       "70223  Progression-Free Survival (PFS) as Assessed by...   \n",
       "70224  PFS (Progression Free Survival) by Independent...   \n",
       "\n",
       "                                   Sponsor/Collaborators Gender  \\\n",
       "0      Jean Edward|Robert Wood Johnson Foundation|Uni...    All   \n",
       "1                                   Boehringer Ingelheim    All   \n",
       "2                      Novartis Pharmaceuticals|Novartis    All   \n",
       "3                                 Heartfulness Institute    All   \n",
       "4                                                  Amgen    All   \n",
       "...                                                  ...    ...   \n",
       "70220                                            Celgene    All   \n",
       "70221                               Boehringer Ingelheim    All   \n",
       "70222                  Novartis Pharmaceuticals|Novartis    All   \n",
       "70223                  Novartis Pharmaceuticals|Novartis    All   \n",
       "70224  Pharmacyclics LLC.|Janssen Research & Developm...    All   \n",
       "\n",
       "                                                     Age          Phases  \\\n",
       "0            18 Years to 65 Years   (Adult, Older Adult)  Not Applicable   \n",
       "1              18 Years and older   (Adult, Older Adult)  Not Applicable   \n",
       "2              18 Years and older   (Adult, Older Adult)  Not Applicable   \n",
       "3      14 Years to 80 Years   (Child, Adult, Older Ad...  Not Applicable   \n",
       "4                         18 Years to 55 Years   (Adult)         Phase 1   \n",
       "...                                                  ...             ...   \n",
       "70220          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "70221        18 Years to 75 Years   (Adult, Older Adult)         Phase 3   \n",
       "70222          40 Years and older   (Adult, Older Adult)         Phase 4   \n",
       "70223          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "70224          18 Years and older   (Adult, Older Adult)         Phase 3   \n",
       "\n",
       "       Enrollment Funded Bys      Study Type  \\\n",
       "0            61.0      Other  Interventional   \n",
       "1        200000.0   Industry   Observational   \n",
       "2         17517.0   Industry   Observational   \n",
       "3           203.0      Other  Interventional   \n",
       "4            64.0   Industry  Interventional   \n",
       "...           ...        ...             ...   \n",
       "70220       866.0   Industry  Interventional   \n",
       "70221       470.0   Industry  Interventional   \n",
       "70222       124.0   Industry  Interventional   \n",
       "70223       423.0   Industry  Interventional   \n",
       "70224       391.0   Industry  Interventional   \n",
       "\n",
       "                                           Study Designs  \\\n",
       "0      Allocation: Non-Randomized|Intervention Model:...   \n",
       "1      Observational Model: Cohort|Time Perspective: ...   \n",
       "2      Observational Model: Cohort|Time Perspective: ...   \n",
       "3      Allocation: Randomized|Intervention Model: Par...   \n",
       "4      Allocation: Randomized|Intervention Model: Par...   \n",
       "...                                                  ...   \n",
       "70220  Allocation: Randomized|Intervention Model: Par...   \n",
       "70221  Allocation: Randomized|Intervention Model: Par...   \n",
       "70222  Allocation: Randomized|Intervention Model: Cro...   \n",
       "70223  Allocation: Randomized|Intervention Model: Par...   \n",
       "70224  Allocation: Randomized|Intervention Model: Par...   \n",
       "\n",
       "                                Other IDs  \\\n",
       "0                                   57238   \n",
       "1                               1199-0523   \n",
       "2                            CTMT212AUS62   \n",
       "3                              02-01-2022   \n",
       "4                                20140324   \n",
       "...                                   ...   \n",
       "70220     ABI-007-PANC-003|2013-003398-91   \n",
       "70221              1241.20|2012-003533-41   \n",
       "70222                        CNVA237A3401   \n",
       "70223  115306|2011-006087-49|CDRB436B2301   \n",
       "70224         PCYC-1112-CA|2012-000694-23   \n",
       "\n",
       "                                               Locations  \n",
       "0      University of Kentucky DanceBlue Pediatric Hem...  \n",
       "1      Boehringer Ingelheim Pharmaceuticals, Inc., Ri...  \n",
       "2      Novartis, East Hanover, New Jersey, United States  \n",
       "3          Ranjani B Iyer, Novi, Michigan, United States  \n",
       "4        Research Site, Aventura, Florida, United States  \n",
       "...                                                  ...  \n",
       "70220  Local Institution - 043, Scottsdale, Arizona, ...  \n",
       "70221  1241.20.00026 Boehringer Ingelheim Investigati...  \n",
       "70222  Novartis Investigative Site, Geesthacht, Schle...  \n",
       "70223  Novartis Investigative Site, Scottsdale, Arizo...  \n",
       "70224  Site #408, La Jolla, California, United States...  \n",
       "\n",
       "[69719 rows x 16 columns]"
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "cd5c831c",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd1=cd.loc[0:10001]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "6784cf49",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Locations</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Financial and Insurance Assistance- Oncology F...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Financial Stress|Pediatric Cancer</td>\n",
       "      <td>Other: FINassist</td>\n",
       "      <td>FINassist Feasibility|FINassist Adherence|FINa...</td>\n",
       "      <td>Jean Edward|Robert Wood Johnson Foundation|Uni...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 65 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>61.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>57238</td>\n",
       "      <td>University of Kentucky DanceBlue Pediatric Hem...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Study of Progression to Progressive Fibrosing ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Lung Diseases, Interstitial</td>\n",
       "      <td>Other: No intervention</td>\n",
       "      <td>Incidence probability of progression to PF-ILD...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>200000.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>1199-0523</td>\n",
       "      <td>Boehringer Ingelheim Pharmaceuticals, Inc., Ri...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Retrospective Assessment of AE-Related Healthc...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Other: No intervention</td>\n",
       "      <td>Percentage of patients with adverse events (AE...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>17517.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>CTMT212AUS62</td>\n",
       "      <td>Novartis, East Hanover, New Jersey, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>The Impact of Heartfulness Self-Care Program o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Anxiety|Satisfaction With Life|Loneliness</td>\n",
       "      <td>Behavioral: Self-Care Program through Heartful...</td>\n",
       "      <td>Assess the current level of Anxiety|Changes le...</td>\n",
       "      <td>Heartfulness Institute</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 80 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>203.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>02-01-2022</td>\n",
       "      <td>Ranjani B Iyer, Novi, Michigan, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Chronic Graft-versus-host Disease (cGVHD)</td>\n",
       "      <td>Drug: AMG 592|Other: Placebo</td>\n",
       "      <td>Number of Participants with Treatment-emergent...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>64.0</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>20140324</td>\n",
       "      <td>Research Site, Aventura, Florida, United States</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9997</th>\n",
       "      <td>Buprenorphine Stabilization and Induction Onto...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>Has Results</td>\n",
       "      <td>Heroin Dependence</td>\n",
       "      <td>Drug: Buprenorphine/naloxone</td>\n",
       "      <td>Proportion of Heroin-dependent Patients Succes...</td>\n",
       "      <td>New York State Psychiatric Institute|Alkermes,...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 60 Years   (Adult)</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>8.0</td>\n",
       "      <td>Other|Industry</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: N/A|Intervention Model: Single Gro...</td>\n",
       "      <td>7699</td>\n",
       "      <td>New York State Psychiatric Institute, New York...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9998</th>\n",
       "      <td>Using Behavioral Science to Reduce Inappropria...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Antimicrobial Stewardship|Acute Bronchitis|Upp...</td>\n",
       "      <td>Behavioral: Antibiotic Stewardship</td>\n",
       "      <td>Antibiotic prescribing|Diagnostic drift</td>\n",
       "      <td>Lundquist Institute for Biomedical Innovation ...</td>\n",
       "      <td>All</td>\n",
       "      <td>21 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>134.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: N/A|Intervention Model: Single Gro...</td>\n",
       "      <td>31429-01|UL1TR001881</td>\n",
       "      <td>Department of Health Services, Los Angeles, Ca...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9999</th>\n",
       "      <td>Procalcitonin at Zero and 24 Hours as a Progno...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Pneumonia</td>\n",
       "      <td>Diagnostic Test: Procalcitonin lab test</td>\n",
       "      <td>Change in Procalcitonin level|qSOFA score|Leng...</td>\n",
       "      <td>Spectrum Health - Lakeland|Michigan State Univ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>185.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>MMMC#1577</td>\n",
       "      <td>Lakeland Regional Healthcare, Saint Joseph, Mi...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10000</th>\n",
       "      <td>Laser Bandage and Surgical Stent as Palatal Do...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Palate; Wound</td>\n",
       "      <td>Device: Laser Bandage|Procedure: Hemostatic ag...</td>\n",
       "      <td>EPITHELIALIZATION</td>\n",
       "      <td>Krishnadevaraya College of Dental Sciences &amp; H...</td>\n",
       "      <td>All</td>\n",
       "      <td>22 Years to 55 Years   (Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>24.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>02_D012_117073</td>\n",
       "      <td>Krishnadevaraya college of dental sciences, Ba...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10001</th>\n",
       "      <td>Granulocyte Colony Stimulating Factor Four Wee...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Alcoholic Hepatitis</td>\n",
       "      <td>Drug: Standard Medical Therapy|Drug: G-CSF|Dru...</td>\n",
       "      <td>Survival at the end of 90 days|Number of CD34+...</td>\n",
       "      <td>Postgraduate Institute of Medical Education an...</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years to 75 Years   (Adult, Older Adult)</td>\n",
       "      <td>Phase 4</td>\n",
       "      <td>66.0</td>\n",
       "      <td>Other</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>GCSF IN SAH</td>\n",
       "      <td>Dept of Hepatology, PGIMER, Chandigarh, India</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>10000 rows × 16 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                   Title      Status  \\\n",
       "0      Financial and Insurance Assistance- Oncology F...   Completed   \n",
       "1      Study of Progression to Progressive Fibrosing ...   Completed   \n",
       "2      Retrospective Assessment of AE-Related Healthc...   Completed   \n",
       "3      The Impact of Heartfulness Self-Care Program o...   Completed   \n",
       "4      A Study to Evaluate the Safety, Tolerability, ...   Completed   \n",
       "...                                                  ...         ...   \n",
       "9997   Buprenorphine Stabilization and Induction Onto...  Terminated   \n",
       "9998   Using Behavioral Science to Reduce Inappropria...   Completed   \n",
       "9999   Procalcitonin at Zero and 24 Hours as a Progno...   Completed   \n",
       "10000  Laser Bandage and Surgical Stent as Palatal Do...   Completed   \n",
       "10001  Granulocyte Colony Stimulating Factor Four Wee...   Completed   \n",
       "\n",
       "              Study Results  \\\n",
       "0      No Results Available   \n",
       "1      No Results Available   \n",
       "2      No Results Available   \n",
       "3      No Results Available   \n",
       "4      No Results Available   \n",
       "...                     ...   \n",
       "9997            Has Results   \n",
       "9998   No Results Available   \n",
       "9999   No Results Available   \n",
       "10000  No Results Available   \n",
       "10001  No Results Available   \n",
       "\n",
       "                                              Conditions  \\\n",
       "0                      Financial Stress|Pediatric Cancer   \n",
       "1                            Lung Diseases, Interstitial   \n",
       "2                                               Melanoma   \n",
       "3              Anxiety|Satisfaction With Life|Loneliness   \n",
       "4              Chronic Graft-versus-host Disease (cGVHD)   \n",
       "...                                                  ...   \n",
       "9997                                   Heroin Dependence   \n",
       "9998   Antimicrobial Stewardship|Acute Bronchitis|Upp...   \n",
       "9999                                           Pneumonia   \n",
       "10000                                      Palate; Wound   \n",
       "10001                                Alcoholic Hepatitis   \n",
       "\n",
       "                                           Interventions  \\\n",
       "0                                       Other: FINassist   \n",
       "1                                 Other: No intervention   \n",
       "2                                 Other: No intervention   \n",
       "3      Behavioral: Self-Care Program through Heartful...   \n",
       "4                           Drug: AMG 592|Other: Placebo   \n",
       "...                                                  ...   \n",
       "9997                        Drug: Buprenorphine/naloxone   \n",
       "9998                  Behavioral: Antibiotic Stewardship   \n",
       "9999             Diagnostic Test: Procalcitonin lab test   \n",
       "10000  Device: Laser Bandage|Procedure: Hemostatic ag...   \n",
       "10001  Drug: Standard Medical Therapy|Drug: G-CSF|Dru...   \n",
       "\n",
       "                                        Outcome Measures  \\\n",
       "0      FINassist Feasibility|FINassist Adherence|FINa...   \n",
       "1      Incidence probability of progression to PF-ILD...   \n",
       "2      Percentage of patients with adverse events (AE...   \n",
       "3      Assess the current level of Anxiety|Changes le...   \n",
       "4      Number of Participants with Treatment-emergent...   \n",
       "...                                                  ...   \n",
       "9997   Proportion of Heroin-dependent Patients Succes...   \n",
       "9998             Antibiotic prescribing|Diagnostic drift   \n",
       "9999   Change in Procalcitonin level|qSOFA score|Leng...   \n",
       "10000                                  EPITHELIALIZATION   \n",
       "10001  Survival at the end of 90 days|Number of CD34+...   \n",
       "\n",
       "                                   Sponsor/Collaborators Gender  \\\n",
       "0      Jean Edward|Robert Wood Johnson Foundation|Uni...    All   \n",
       "1                                   Boehringer Ingelheim    All   \n",
       "2                      Novartis Pharmaceuticals|Novartis    All   \n",
       "3                                 Heartfulness Institute    All   \n",
       "4                                                  Amgen    All   \n",
       "...                                                  ...    ...   \n",
       "9997   New York State Psychiatric Institute|Alkermes,...    All   \n",
       "9998   Lundquist Institute for Biomedical Innovation ...    All   \n",
       "9999   Spectrum Health - Lakeland|Michigan State Univ...    All   \n",
       "10000  Krishnadevaraya College of Dental Sciences & H...    All   \n",
       "10001  Postgraduate Institute of Medical Education an...   Male   \n",
       "\n",
       "                                                     Age          Phases  \\\n",
       "0            18 Years to 65 Years   (Adult, Older Adult)  Not Applicable   \n",
       "1              18 Years and older   (Adult, Older Adult)  Not Applicable   \n",
       "2              18 Years and older   (Adult, Older Adult)  Not Applicable   \n",
       "3      14 Years to 80 Years   (Child, Adult, Older Ad...  Not Applicable   \n",
       "4                         18 Years to 55 Years   (Adult)         Phase 1   \n",
       "...                                                  ...             ...   \n",
       "9997                      18 Years to 60 Years   (Adult)         Phase 3   \n",
       "9998           21 Years and older   (Adult, Older Adult)  Not Applicable   \n",
       "9999           18 Years and older   (Adult, Older Adult)  Not Applicable   \n",
       "10000                     22 Years to 55 Years   (Adult)  Not Applicable   \n",
       "10001        18 Years to 75 Years   (Adult, Older Adult)         Phase 4   \n",
       "\n",
       "       Enrollment      Funded Bys      Study Type  \\\n",
       "0            61.0           Other  Interventional   \n",
       "1        200000.0        Industry   Observational   \n",
       "2         17517.0        Industry   Observational   \n",
       "3           203.0           Other  Interventional   \n",
       "4            64.0        Industry  Interventional   \n",
       "...           ...             ...             ...   \n",
       "9997          8.0  Other|Industry  Interventional   \n",
       "9998        134.0           Other  Interventional   \n",
       "9999        185.0           Other   Observational   \n",
       "10000        24.0           Other  Interventional   \n",
       "10001        66.0           Other  Interventional   \n",
       "\n",
       "                                           Study Designs  \\\n",
       "0      Allocation: Non-Randomized|Intervention Model:...   \n",
       "1      Observational Model: Cohort|Time Perspective: ...   \n",
       "2      Observational Model: Cohort|Time Perspective: ...   \n",
       "3      Allocation: Randomized|Intervention Model: Par...   \n",
       "4      Allocation: Randomized|Intervention Model: Par...   \n",
       "...                                                  ...   \n",
       "9997   Allocation: N/A|Intervention Model: Single Gro...   \n",
       "9998   Allocation: N/A|Intervention Model: Single Gro...   \n",
       "9999   Observational Model: Cohort|Time Perspective: ...   \n",
       "10000  Allocation: Randomized|Intervention Model: Par...   \n",
       "10001  Allocation: Randomized|Intervention Model: Par...   \n",
       "\n",
       "                  Other IDs                                          Locations  \n",
       "0                     57238  University of Kentucky DanceBlue Pediatric Hem...  \n",
       "1                 1199-0523  Boehringer Ingelheim Pharmaceuticals, Inc., Ri...  \n",
       "2              CTMT212AUS62  Novartis, East Hanover, New Jersey, United States  \n",
       "3                02-01-2022      Ranjani B Iyer, Novi, Michigan, United States  \n",
       "4                  20140324    Research Site, Aventura, Florida, United States  \n",
       "...                     ...                                                ...  \n",
       "9997                   7699  New York State Psychiatric Institute, New York...  \n",
       "9998   31429-01|UL1TR001881  Department of Health Services, Los Angeles, Ca...  \n",
       "9999              MMMC#1577  Lakeland Regional Healthcare, Saint Joseph, Mi...  \n",
       "10000        02_D012_117073  Krishnadevaraya college of dental sciences, Ba...  \n",
       "10001           GCSF IN SAH      Dept of Hepatology, PGIMER, Chandigarh, India  \n",
       "\n",
       "[10000 rows x 16 columns]"
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cd1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "ed345e96",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd1.to_csv(r'C:/Users/rabhi/OneDrive/Documents/All1.csv', index = False, header = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "id": "5e38e6be",
   "metadata": {},
   "outputs": [],
   "source": [
    "o1=pd.read_csv(\"C:/Users/rabhi/OneDrive/Documents/O1.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "id": "c21c40f8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>Enrollment</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Locations</th>\n",
       "      <th>OModel</th>\n",
       "      <th>Time Perspective</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Study of Progression to Progressive Fibrosing ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Lung Diseases, Interstitial</td>\n",
       "      <td>Other: No intervention</td>\n",
       "      <td>Incidence probability of progression to PF-ILD...</td>\n",
       "      <td>Boehringer Ingelheim</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>200000</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>1199-0523</td>\n",
       "      <td>Boehringer Ingelheim Pharmaceuticals, Inc., Ri...</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Retrospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Retrospective Assessment of AE-Related Healthc...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Melanoma</td>\n",
       "      <td>Other: No intervention</td>\n",
       "      <td>Percentage of patients with adverse events (AE...</td>\n",
       "      <td>Novartis Pharmaceuticals|Novartis</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>17517</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>CTMT212AUS62</td>\n",
       "      <td>Novartis, East Hanover, New Jersey, United States</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Retrospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>THA With and Without Computer Navigation</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Hip Osteoarthritis|Avascular Necrosis of Hip</td>\n",
       "      <td>Procedure: Intraoperative Fluoroscopic Compute...</td>\n",
       "      <td>Cup inclination|Cup anteversion|Leg length dis...</td>\n",
       "      <td>Southeast Orthopedic Specialists</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 95 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>234</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>DPS-JMP-2019-078</td>\n",
       "      <td>Southeast Orthopedic Specialists, Jacksonville...</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Retrospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>ABO Blood Group Type Association With COVID-19...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>COVID-19|Blood Group Antigen Abnormality|Blood...</td>\n",
       "      <td>Other: No Intervention</td>\n",
       "      <td>Length of hospital stay|Hospital Mortality|Dis...</td>\n",
       "      <td>Arrowhead Regional Medical Center</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 90 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>599</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>22-53</td>\n",
       "      <td>Arrowhead Regional Medical Center, Colton, Cal...</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Retrospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>A Study to Learn About the First and Later Lin...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Metastatic Renal Cell Carcinoma</td>\n",
       "      <td>Other: No intervention</td>\n",
       "      <td>Demographical characteristics|Date of mRCC dia...</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>494</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>A4061100</td>\n",
       "      <td>Pfizer Headquarters, New York, New York, Unite...</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Retrospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1663</th>\n",
       "      <td>Measurement of Beta Cell Death in Individuals ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Cystic Fibrosis-related Diabetes</td>\n",
       "      <td>Diagnostic Test: Measurement of differentially...</td>\n",
       "      <td>Levels of differentially methylated insulin DN...</td>\n",
       "      <td>University of Nebraska|Cystic Fibrosis Foundation</td>\n",
       "      <td>All</td>\n",
       "      <td>up to 21 Years   (Child, Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>40</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>611-18-EP</td>\n",
       "      <td>Children's Hospital and Medical Center, Omaha,...</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Cross-Sectional</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1664</th>\n",
       "      <td>Indications for Osteochondral Allograft Transp...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Post-Traumatic Osteoarthritis of Ankle|Ankle O...</td>\n",
       "      <td>Procedure: Osteochondral allograft ankle</td>\n",
       "      <td>Visual Analog Scale (VAS) score|American Ortho...</td>\n",
       "      <td>University of Missouri-Columbia</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>10</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>2011144</td>\n",
       "      <td>Missouri Orthopaedic Institute, Columbia, Miss...</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1665</th>\n",
       "      <td>iBeat Wristwatch Validation Study</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Arrythmia, Cardiac</td>\n",
       "      <td>Device: iBeat wristwatch device</td>\n",
       "      <td>Detect hemodynamic significant (e.g. Ventricul...</td>\n",
       "      <td>University of California, San Francisco|iBeat ...</td>\n",
       "      <td>All</td>\n",
       "      <td>21 Years to 85 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>55</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Case-Only|Time Perspectiv...</td>\n",
       "      <td>17-23761</td>\n",
       "      <td>University of California, San Francisco, San F...</td>\n",
       "      <td>Observational Model: Case-Only</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1666</th>\n",
       "      <td>Single Center Post Approval Proximal Humerus F...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Proximal Humeral Fracture</td>\n",
       "      <td>Device: Conventus Cage PH device</td>\n",
       "      <td>Primary Performance Patient Assessment</td>\n",
       "      <td>Conventus Orthopaedics, Inc.</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>10</td>\n",
       "      <td>Industry</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Case-Only|Time Perspectiv...</td>\n",
       "      <td>7821</td>\n",
       "      <td>The University of Texas Health Science Center ...</td>\n",
       "      <td>Observational Model: Case-Only</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1667</th>\n",
       "      <td>Procalcitonin at Zero and 24 Hours as a Progno...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Pneumonia</td>\n",
       "      <td>Diagnostic Test: Procalcitonin lab test</td>\n",
       "      <td>Change in Procalcitonin level|qSOFA score|Leng...</td>\n",
       "      <td>Spectrum Health - Lakeland|Michigan State Univ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>185</td>\n",
       "      <td>Other</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>MMMC#1577</td>\n",
       "      <td>Lakeland Regional Healthcare, Saint Joseph, Mi...</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>1668 rows × 18 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  Title      Status  \\\n",
       "0     Study of Progression to Progressive Fibrosing ...   Completed   \n",
       "1     Retrospective Assessment of AE-Related Healthc...   Completed   \n",
       "2              THA With and Without Computer Navigation   Completed   \n",
       "3     ABO Blood Group Type Association With COVID-19...   Completed   \n",
       "4     A Study to Learn About the First and Later Lin...   Completed   \n",
       "...                                                 ...         ...   \n",
       "1663  Measurement of Beta Cell Death in Individuals ...   Completed   \n",
       "1664  Indications for Osteochondral Allograft Transp...   Completed   \n",
       "1665                  iBeat Wristwatch Validation Study   Completed   \n",
       "1666  Single Center Post Approval Proximal Humerus F...  Terminated   \n",
       "1667  Procalcitonin at Zero and 24 Hours as a Progno...   Completed   \n",
       "\n",
       "             Study Results                                         Conditions  \\\n",
       "0     No Results Available                        Lung Diseases, Interstitial   \n",
       "1     No Results Available                                           Melanoma   \n",
       "2     No Results Available       Hip Osteoarthritis|Avascular Necrosis of Hip   \n",
       "3     No Results Available  COVID-19|Blood Group Antigen Abnormality|Blood...   \n",
       "4     No Results Available                    Metastatic Renal Cell Carcinoma   \n",
       "...                    ...                                                ...   \n",
       "1663  No Results Available                   Cystic Fibrosis-related Diabetes   \n",
       "1664  No Results Available  Post-Traumatic Osteoarthritis of Ankle|Ankle O...   \n",
       "1665  No Results Available                                 Arrythmia, Cardiac   \n",
       "1666  No Results Available                          Proximal Humeral Fracture   \n",
       "1667  No Results Available                                          Pneumonia   \n",
       "\n",
       "                                          Interventions  \\\n",
       "0                                Other: No intervention   \n",
       "1                                Other: No intervention   \n",
       "2     Procedure: Intraoperative Fluoroscopic Compute...   \n",
       "3                                Other: No Intervention   \n",
       "4                                Other: No intervention   \n",
       "...                                                 ...   \n",
       "1663  Diagnostic Test: Measurement of differentially...   \n",
       "1664           Procedure: Osteochondral allograft ankle   \n",
       "1665                    Device: iBeat wristwatch device   \n",
       "1666                   Device: Conventus Cage PH device   \n",
       "1667            Diagnostic Test: Procalcitonin lab test   \n",
       "\n",
       "                                       Outcome Measures  \\\n",
       "0     Incidence probability of progression to PF-ILD...   \n",
       "1     Percentage of patients with adverse events (AE...   \n",
       "2     Cup inclination|Cup anteversion|Leg length dis...   \n",
       "3     Length of hospital stay|Hospital Mortality|Dis...   \n",
       "4     Demographical characteristics|Date of mRCC dia...   \n",
       "...                                                 ...   \n",
       "1663  Levels of differentially methylated insulin DN...   \n",
       "1664  Visual Analog Scale (VAS) score|American Ortho...   \n",
       "1665  Detect hemodynamic significant (e.g. Ventricul...   \n",
       "1666             Primary Performance Patient Assessment   \n",
       "1667  Change in Procalcitonin level|qSOFA score|Leng...   \n",
       "\n",
       "                                  Sponsor/Collaborators Gender  \\\n",
       "0                                  Boehringer Ingelheim    All   \n",
       "1                     Novartis Pharmaceuticals|Novartis    All   \n",
       "2                      Southeast Orthopedic Specialists    All   \n",
       "3                     Arrowhead Regional Medical Center    All   \n",
       "4                                                Pfizer    All   \n",
       "...                                                 ...    ...   \n",
       "1663  University of Nebraska|Cystic Fibrosis Foundation    All   \n",
       "1664                    University of Missouri-Columbia    All   \n",
       "1665  University of California, San Francisco|iBeat ...    All   \n",
       "1666                       Conventus Orthopaedics, Inc.    All   \n",
       "1667  Spectrum Health - Lakeland|Michigan State Univ...    All   \n",
       "\n",
       "                                              Age          Phases  Enrollment  \\\n",
       "0       18 Years and older   (Adult, Older Adult)  Not Applicable      200000   \n",
       "1       18 Years and older   (Adult, Older Adult)  Not Applicable       17517   \n",
       "2     18 Years to 95 Years   (Adult, Older Adult)  Not Applicable         234   \n",
       "3     18 Years to 90 Years   (Adult, Older Adult)  Not Applicable         599   \n",
       "4       18 Years and older   (Adult, Older Adult)  Not Applicable         494   \n",
       "...                                           ...             ...         ...   \n",
       "1663              up to 21 Years   (Child, Adult)  Not Applicable          40   \n",
       "1664               18 Years to 55 Years   (Adult)  Not Applicable          10   \n",
       "1665  21 Years to 85 Years   (Adult, Older Adult)  Not Applicable          55   \n",
       "1666    18 Years and older   (Adult, Older Adult)  Not Applicable          10   \n",
       "1667    18 Years and older   (Adult, Older Adult)  Not Applicable         185   \n",
       "\n",
       "     Funded Bys     Study Type  \\\n",
       "0      Industry  Observational   \n",
       "1      Industry  Observational   \n",
       "2         Other  Observational   \n",
       "3         Other  Observational   \n",
       "4      Industry  Observational   \n",
       "...         ...            ...   \n",
       "1663      Other  Observational   \n",
       "1664      Other  Observational   \n",
       "1665      Other  Observational   \n",
       "1666   Industry  Observational   \n",
       "1667      Other  Observational   \n",
       "\n",
       "                                          Study Designs         Other IDs  \\\n",
       "0     Observational Model: Cohort|Time Perspective: ...         1199-0523   \n",
       "1     Observational Model: Cohort|Time Perspective: ...      CTMT212AUS62   \n",
       "2     Observational Model: Cohort|Time Perspective: ...  DPS-JMP-2019-078   \n",
       "3     Observational Model: Cohort|Time Perspective: ...             22-53   \n",
       "4     Observational Model: Cohort|Time Perspective: ...          A4061100   \n",
       "...                                                 ...               ...   \n",
       "1663  Observational Model: Cohort|Time Perspective: ...         611-18-EP   \n",
       "1664  Observational Model: Cohort|Time Perspective: ...           2011144   \n",
       "1665  Observational Model: Case-Only|Time Perspectiv...          17-23761   \n",
       "1666  Observational Model: Case-Only|Time Perspectiv...              7821   \n",
       "1667  Observational Model: Cohort|Time Perspective: ...         MMMC#1577   \n",
       "\n",
       "                                              Locations  \\\n",
       "0     Boehringer Ingelheim Pharmaceuticals, Inc., Ri...   \n",
       "1     Novartis, East Hanover, New Jersey, United States   \n",
       "2     Southeast Orthopedic Specialists, Jacksonville...   \n",
       "3     Arrowhead Regional Medical Center, Colton, Cal...   \n",
       "4     Pfizer Headquarters, New York, New York, Unite...   \n",
       "...                                                 ...   \n",
       "1663  Children's Hospital and Medical Center, Omaha,...   \n",
       "1664  Missouri Orthopaedic Institute, Columbia, Miss...   \n",
       "1665  University of California, San Francisco, San F...   \n",
       "1666  The University of Texas Health Science Center ...   \n",
       "1667  Lakeland Regional Healthcare, Saint Joseph, Mi...   \n",
       "\n",
       "                              OModel                   Time Perspective  \n",
       "0        Observational Model: Cohort    Time Perspective: Retrospective  \n",
       "1        Observational Model: Cohort    Time Perspective: Retrospective  \n",
       "2        Observational Model: Cohort    Time Perspective: Retrospective  \n",
       "3        Observational Model: Cohort    Time Perspective: Retrospective  \n",
       "4        Observational Model: Cohort    Time Perspective: Retrospective  \n",
       "...                              ...                                ...  \n",
       "1663     Observational Model: Cohort  Time Perspective: Cross-Sectional  \n",
       "1664     Observational Model: Cohort      Time Perspective: Prospective  \n",
       "1665  Observational Model: Case-Only      Time Perspective: Prospective  \n",
       "1666  Observational Model: Case-Only      Time Perspective: Prospective  \n",
       "1667     Observational Model: Cohort      Time Perspective: Prospective  \n",
       "\n",
       "[1668 rows x 18 columns]"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "o1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "id": "01f65ee4",
   "metadata": {},
   "outputs": [],
   "source": [
    "o1[['OModel','Time Perspective']] = o1['Study Designs'].str.split('|', expand=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "id": "73460723",
   "metadata": {},
   "outputs": [],
   "source": [
    "o1.to_csv(r'C:/Users/rabhi/OneDrive/Documents/O11.csv', index = False, header = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "a2094e2a",
   "metadata": {},
   "outputs": [],
   "source": [
    "i1=pd.read_csv(\"C:/Users/rabhi/OneDrive/Documents/I1.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "afb6df8c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>IModel</th>\n",
       "      <th>Masking</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>OModel</th>\n",
       "      <th>Time Perspective</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Financial and Insurance Assistance- Oncology F...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Financial Stress|Pediatric Cancer</td>\n",
       "      <td>Other: FINassist</td>\n",
       "      <td>FINassist Feasibility|FINassist Adherence|FINa...</td>\n",
       "      <td>Jean Edward|Robert Wood Johnson Foundation|Uni...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 65 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>57238</td>\n",
       "      <td>University of Kentucky DanceBlue Pediatric Hem...</td>\n",
       "      <td>Allocation: Non-Randomized</td>\n",
       "      <td>Intervention Model: Single Group Assignment</td>\n",
       "      <td>Masking: None (Open Label)</td>\n",
       "      <td>Primary Purpose: Health Services Research</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>The Impact of Heartfulness Self-Care Program o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Anxiety|Satisfaction With Life|Loneliness</td>\n",
       "      <td>Behavioral: Self-Care Program through Heartful...</td>\n",
       "      <td>Assess the current level of Anxiety|Changes le...</td>\n",
       "      <td>Heartfulness Institute</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 80 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>02-01-2022</td>\n",
       "      <td>Ranjani B Iyer, Novi, Michigan, United States</td>\n",
       "      <td>Allocation: Randomized</td>\n",
       "      <td>Intervention Model: Parallel Assignment</td>\n",
       "      <td>Masking: Double (Participant, Investigator)</td>\n",
       "      <td>Primary Purpose: Supportive Care</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Chronic Graft-versus-host Disease (cGVHD)</td>\n",
       "      <td>Drug: AMG 592|Other: Placebo</td>\n",
       "      <td>Number of Participants with Treatment-emergent...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>20140324</td>\n",
       "      <td>Research Site, Aventura, Florida, United States</td>\n",
       "      <td>Allocation: Randomized</td>\n",
       "      <td>Intervention Model: Parallel Assignment</td>\n",
       "      <td>Masking: Double (Participant, Investigator)</td>\n",
       "      <td>Primary Purpose: Basic Science</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>A Study to Learn About Effect of Sisunatovir i...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Respiratory Syncytial Virus Infections</td>\n",
       "      <td>Drug: 200 mg RV521/78 µCi [ 14C]-RV521.</td>\n",
       "      <td>Tmax (Time of maximum observed concentration)|...</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: N/A|Intervention Model: Single Gro...</td>\n",
       "      <td>REVC008|C5241008</td>\n",
       "      <td>Pharmaron Clinical Pharmacology Center, Baltim...</td>\n",
       "      <td>Allocation: N/A</td>\n",
       "      <td>Intervention Model: Single Group Assignment</td>\n",
       "      <td>Masking: None (Open Label)</td>\n",
       "      <td>Primary Purpose: Treatment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Circadian Modulation of Grape Consumption and ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Oxidative Stress</td>\n",
       "      <td>Other: Grape</td>\n",
       "      <td>Urine F2-isoprostane</td>\n",
       "      <td>Idaho State University</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 50 Years   (Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>IRB-FY2021-264</td>\n",
       "      <td>Idaho State University, Pocatello, Idaho, Unit...</td>\n",
       "      <td>Allocation: Randomized</td>\n",
       "      <td>Intervention Model: Parallel Assignment</td>\n",
       "      <td>Masking: Triple (Participant, Care Provider, O...</td>\n",
       "      <td>Primary Purpose: Basic Science</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9995</th>\n",
       "      <td>Measurement of Beta Cell Death in Individuals ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Cystic Fibrosis-related Diabetes</td>\n",
       "      <td>Diagnostic Test: Measurement of differentially...</td>\n",
       "      <td>Levels of differentially methylated insulin DN...</td>\n",
       "      <td>University of Nebraska|Cystic Fibrosis Foundation</td>\n",
       "      <td>All</td>\n",
       "      <td>up to 21 Years   (Child, Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>611-18-EP</td>\n",
       "      <td>Children's Hospital and Medical Center, Omaha,...</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Cross-Sectional</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Cross-Sectional</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9996</th>\n",
       "      <td>Indications for Osteochondral Allograft Transp...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Post-Traumatic Osteoarthritis of Ankle|Ankle O...</td>\n",
       "      <td>Procedure: Osteochondral allograft ankle</td>\n",
       "      <td>Visual Analog Scale (VAS) score|American Ortho...</td>\n",
       "      <td>University of Missouri-Columbia</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>2011144</td>\n",
       "      <td>Missouri Orthopaedic Institute, Columbia, Miss...</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9997</th>\n",
       "      <td>iBeat Wristwatch Validation Study</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Arrythmia, Cardiac</td>\n",
       "      <td>Device: iBeat wristwatch device</td>\n",
       "      <td>Detect hemodynamic significant (e.g. Ventricul...</td>\n",
       "      <td>University of California, San Francisco|iBeat ...</td>\n",
       "      <td>All</td>\n",
       "      <td>21 Years to 85 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Case-Only|Time Perspectiv...</td>\n",
       "      <td>17-23761</td>\n",
       "      <td>University of California, San Francisco, San F...</td>\n",
       "      <td>Observational Model: Case-Only</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Observational Model: Case-Only</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9998</th>\n",
       "      <td>Single Center Post Approval Proximal Humerus F...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Proximal Humeral Fracture</td>\n",
       "      <td>Device: Conventus Cage PH device</td>\n",
       "      <td>Primary Performance Patient Assessment</td>\n",
       "      <td>Conventus Orthopaedics, Inc.</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Case-Only|Time Perspectiv...</td>\n",
       "      <td>7821</td>\n",
       "      <td>The University of Texas Health Science Center ...</td>\n",
       "      <td>Observational Model: Case-Only</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Observational Model: Case-Only</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9999</th>\n",
       "      <td>Procalcitonin at Zero and 24 Hours as a Progno...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Pneumonia</td>\n",
       "      <td>Diagnostic Test: Procalcitonin lab test</td>\n",
       "      <td>Change in Procalcitonin level|qSOFA score|Leng...</td>\n",
       "      <td>Spectrum Health - Lakeland|Michigan State Univ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>MMMC#1577</td>\n",
       "      <td>Lakeland Regional Healthcare, Saint Joseph, Mi...</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>10000 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  Title      Status  \\\n",
       "0     Financial and Insurance Assistance- Oncology F...   Completed   \n",
       "1     The Impact of Heartfulness Self-Care Program o...   Completed   \n",
       "2     A Study to Evaluate the Safety, Tolerability, ...   Completed   \n",
       "3     A Study to Learn About Effect of Sisunatovir i...   Completed   \n",
       "4     Circadian Modulation of Grape Consumption and ...   Completed   \n",
       "...                                                 ...         ...   \n",
       "9995  Measurement of Beta Cell Death in Individuals ...   Completed   \n",
       "9996  Indications for Osteochondral Allograft Transp...   Completed   \n",
       "9997                  iBeat Wristwatch Validation Study   Completed   \n",
       "9998  Single Center Post Approval Proximal Humerus F...  Terminated   \n",
       "9999  Procalcitonin at Zero and 24 Hours as a Progno...   Completed   \n",
       "\n",
       "             Study Results                                         Conditions  \\\n",
       "0     No Results Available                  Financial Stress|Pediatric Cancer   \n",
       "1     No Results Available          Anxiety|Satisfaction With Life|Loneliness   \n",
       "2     No Results Available          Chronic Graft-versus-host Disease (cGVHD)   \n",
       "3     No Results Available             Respiratory Syncytial Virus Infections   \n",
       "4     No Results Available                                   Oxidative Stress   \n",
       "...                    ...                                                ...   \n",
       "9995  No Results Available                   Cystic Fibrosis-related Diabetes   \n",
       "9996  No Results Available  Post-Traumatic Osteoarthritis of Ankle|Ankle O...   \n",
       "9997  No Results Available                                 Arrythmia, Cardiac   \n",
       "9998  No Results Available                          Proximal Humeral Fracture   \n",
       "9999  No Results Available                                          Pneumonia   \n",
       "\n",
       "                                          Interventions  \\\n",
       "0                                      Other: FINassist   \n",
       "1     Behavioral: Self-Care Program through Heartful...   \n",
       "2                          Drug: AMG 592|Other: Placebo   \n",
       "3               Drug: 200 mg RV521/78 µCi [ 14C]-RV521.   \n",
       "4                                          Other: Grape   \n",
       "...                                                 ...   \n",
       "9995  Diagnostic Test: Measurement of differentially...   \n",
       "9996           Procedure: Osteochondral allograft ankle   \n",
       "9997                    Device: iBeat wristwatch device   \n",
       "9998                   Device: Conventus Cage PH device   \n",
       "9999            Diagnostic Test: Procalcitonin lab test   \n",
       "\n",
       "                                       Outcome Measures  \\\n",
       "0     FINassist Feasibility|FINassist Adherence|FINa...   \n",
       "1     Assess the current level of Anxiety|Changes le...   \n",
       "2     Number of Participants with Treatment-emergent...   \n",
       "3     Tmax (Time of maximum observed concentration)|...   \n",
       "4                                  Urine F2-isoprostane   \n",
       "...                                                 ...   \n",
       "9995  Levels of differentially methylated insulin DN...   \n",
       "9996  Visual Analog Scale (VAS) score|American Ortho...   \n",
       "9997  Detect hemodynamic significant (e.g. Ventricul...   \n",
       "9998             Primary Performance Patient Assessment   \n",
       "9999  Change in Procalcitonin level|qSOFA score|Leng...   \n",
       "\n",
       "                                  Sponsor/Collaborators Gender  \\\n",
       "0     Jean Edward|Robert Wood Johnson Foundation|Uni...    All   \n",
       "1                                Heartfulness Institute    All   \n",
       "2                                                 Amgen    All   \n",
       "3                                                Pfizer   Male   \n",
       "4                                Idaho State University    All   \n",
       "...                                                 ...    ...   \n",
       "9995  University of Nebraska|Cystic Fibrosis Foundation    All   \n",
       "9996                    University of Missouri-Columbia    All   \n",
       "9997  University of California, San Francisco|iBeat ...    All   \n",
       "9998                       Conventus Orthopaedics, Inc.    All   \n",
       "9999  Spectrum Health - Lakeland|Michigan State Univ...    All   \n",
       "\n",
       "                                                    Age          Phases  ...  \\\n",
       "0           18 Years to 65 Years   (Adult, Older Adult)  Not Applicable  ...   \n",
       "1     14 Years to 80 Years   (Child, Adult, Older Ad...  Not Applicable  ...   \n",
       "2                        18 Years to 55 Years   (Adult)         Phase 1  ...   \n",
       "3                        18 Years to 55 Years   (Adult)         Phase 1  ...   \n",
       "4                        18 Years to 50 Years   (Adult)  Not Applicable  ...   \n",
       "...                                                 ...             ...  ...   \n",
       "9995                    up to 21 Years   (Child, Adult)  Not Applicable  ...   \n",
       "9996                     18 Years to 55 Years   (Adult)  Not Applicable  ...   \n",
       "9997        21 Years to 85 Years   (Adult, Older Adult)  Not Applicable  ...   \n",
       "9998          18 Years and older   (Adult, Older Adult)  Not Applicable  ...   \n",
       "9999          18 Years and older   (Adult, Older Adult)  Not Applicable  ...   \n",
       "\n",
       "          Study Type                                      Study Designs  \\\n",
       "0     Interventional  Allocation: Non-Randomized|Intervention Model:...   \n",
       "1     Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "2     Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "3     Interventional  Allocation: N/A|Intervention Model: Single Gro...   \n",
       "4     Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "...              ...                                                ...   \n",
       "9995   Observational  Observational Model: Cohort|Time Perspective: ...   \n",
       "9996   Observational  Observational Model: Cohort|Time Perspective: ...   \n",
       "9997   Observational  Observational Model: Case-Only|Time Perspectiv...   \n",
       "9998   Observational  Observational Model: Case-Only|Time Perspectiv...   \n",
       "9999   Observational  Observational Model: Cohort|Time Perspective: ...   \n",
       "\n",
       "             Other IDs                                          Locations  \\\n",
       "0                57238  University of Kentucky DanceBlue Pediatric Hem...   \n",
       "1           02-01-2022      Ranjani B Iyer, Novi, Michigan, United States   \n",
       "2             20140324    Research Site, Aventura, Florida, United States   \n",
       "3     REVC008|C5241008  Pharmaron Clinical Pharmacology Center, Baltim...   \n",
       "4       IRB-FY2021-264  Idaho State University, Pocatello, Idaho, Unit...   \n",
       "...                ...                                                ...   \n",
       "9995         611-18-EP  Children's Hospital and Medical Center, Omaha,...   \n",
       "9996           2011144  Missouri Orthopaedic Institute, Columbia, Miss...   \n",
       "9997          17-23761  University of California, San Francisco, San F...   \n",
       "9998              7821  The University of Texas Health Science Center ...   \n",
       "9999         MMMC#1577  Lakeland Regional Healthcare, Saint Joseph, Mi...   \n",
       "\n",
       "                          Allocation  \\\n",
       "0         Allocation: Non-Randomized   \n",
       "1             Allocation: Randomized   \n",
       "2             Allocation: Randomized   \n",
       "3                    Allocation: N/A   \n",
       "4             Allocation: Randomized   \n",
       "...                              ...   \n",
       "9995     Observational Model: Cohort   \n",
       "9996     Observational Model: Cohort   \n",
       "9997  Observational Model: Case-Only   \n",
       "9998  Observational Model: Case-Only   \n",
       "9999     Observational Model: Cohort   \n",
       "\n",
       "                                           IModel  \\\n",
       "0     Intervention Model: Single Group Assignment   \n",
       "1         Intervention Model: Parallel Assignment   \n",
       "2         Intervention Model: Parallel Assignment   \n",
       "3     Intervention Model: Single Group Assignment   \n",
       "4         Intervention Model: Parallel Assignment   \n",
       "...                                           ...   \n",
       "9995            Time Perspective: Cross-Sectional   \n",
       "9996                Time Perspective: Prospective   \n",
       "9997                Time Perspective: Prospective   \n",
       "9998                Time Perspective: Prospective   \n",
       "9999                Time Perspective: Prospective   \n",
       "\n",
       "                                                Masking  \\\n",
       "0                            Masking: None (Open Label)   \n",
       "1           Masking: Double (Participant, Investigator)   \n",
       "2           Masking: Double (Participant, Investigator)   \n",
       "3                            Masking: None (Open Label)   \n",
       "4     Masking: Triple (Participant, Care Provider, O...   \n",
       "...                                                 ...   \n",
       "9995                                                NaN   \n",
       "9996                                                NaN   \n",
       "9997                                                NaN   \n",
       "9998                                                NaN   \n",
       "9999                                                NaN   \n",
       "\n",
       "                                Primary Purpose  \\\n",
       "0     Primary Purpose: Health Services Research   \n",
       "1              Primary Purpose: Supportive Care   \n",
       "2                Primary Purpose: Basic Science   \n",
       "3                    Primary Purpose: Treatment   \n",
       "4                Primary Purpose: Basic Science   \n",
       "...                                         ...   \n",
       "9995                                        NaN   \n",
       "9996                                        NaN   \n",
       "9997                                        NaN   \n",
       "9998                                        NaN   \n",
       "9999                                        NaN   \n",
       "\n",
       "                              OModel                   Time Perspective  \n",
       "0                                NaN                                NaN  \n",
       "1                                NaN                                NaN  \n",
       "2                                NaN                                NaN  \n",
       "3                                NaN                                NaN  \n",
       "4                                NaN                                NaN  \n",
       "...                              ...                                ...  \n",
       "9995     Observational Model: Cohort  Time Perspective: Cross-Sectional  \n",
       "9996     Observational Model: Cohort      Time Perspective: Prospective  \n",
       "9997  Observational Model: Case-Only      Time Perspective: Prospective  \n",
       "9998  Observational Model: Case-Only      Time Perspective: Prospective  \n",
       "9999     Observational Model: Cohort      Time Perspective: Prospective  \n",
       "\n",
       "[10000 rows x 22 columns]"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "i1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "8a51c94a",
   "metadata": {},
   "outputs": [],
   "source": [
    "i1[['Allocation', 'IModel','Masking','Primary Purpose']] = i1['Study Designs'].str.split('|', expand=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "b7b3a56f",
   "metadata": {},
   "outputs": [],
   "source": [
    "i1.to_csv(r'C:/Users/rabhi/OneDrive/Documents/I11.csv', index = False, header = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "2ccf346e",
   "metadata": {},
   "outputs": [],
   "source": [
    "cds1=pd.read_csv(\"C:/Users/rabhi/OneDrive/Documents/S1.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "e134cf6e",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>IModel</th>\n",
       "      <th>Masking</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>OModel</th>\n",
       "      <th>Time Perspective</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Financial and Insurance Assistance- Oncology F...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Financial Stress|Pediatric Cancer</td>\n",
       "      <td>Other: FINassist</td>\n",
       "      <td>FINassist Feasibility|FINassist Adherence|FINa...</td>\n",
       "      <td>Jean Edward|Robert Wood Johnson Foundation|Uni...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 65 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>57238</td>\n",
       "      <td>University of Kentucky DanceBlue Pediatric Hem...</td>\n",
       "      <td>Allocation: Non-Randomized</td>\n",
       "      <td>Intervention Model: Single Group Assignment</td>\n",
       "      <td>Masking: None (Open Label)</td>\n",
       "      <td>Primary Purpose: Health Services Research</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>The Impact of Heartfulness Self-Care Program o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Anxiety|Satisfaction With Life|Loneliness</td>\n",
       "      <td>Behavioral: Self-Care Program through Heartful...</td>\n",
       "      <td>Assess the current level of Anxiety|Changes le...</td>\n",
       "      <td>Heartfulness Institute</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 80 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>02-01-2022</td>\n",
       "      <td>Ranjani B Iyer, Novi, Michigan, United States</td>\n",
       "      <td>Allocation: Randomized</td>\n",
       "      <td>Intervention Model: Parallel Assignment</td>\n",
       "      <td>Masking: Double (Participant, Investigator)</td>\n",
       "      <td>Primary Purpose: Supportive Care</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Chronic Graft-versus-host Disease (cGVHD)</td>\n",
       "      <td>Drug: AMG 592|Other: Placebo</td>\n",
       "      <td>Number of Participants with Treatment-emergent...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>20140324</td>\n",
       "      <td>Research Site, Aventura, Florida, United States</td>\n",
       "      <td>Allocation: Randomized</td>\n",
       "      <td>Intervention Model: Parallel Assignment</td>\n",
       "      <td>Masking: Double (Participant, Investigator)</td>\n",
       "      <td>Primary Purpose: Basic Science</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>A Study to Learn About Effect of Sisunatovir i...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Respiratory Syncytial Virus Infections</td>\n",
       "      <td>Drug: 200 mg RV521/78 µCi [ 14C]-RV521.</td>\n",
       "      <td>Tmax (Time of maximum observed concentration)|...</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: N/A|Intervention Model: Single Gro...</td>\n",
       "      <td>REVC008|C5241008</td>\n",
       "      <td>Pharmaron Clinical Pharmacology Center, Baltim...</td>\n",
       "      <td>Allocation: N/A</td>\n",
       "      <td>Intervention Model: Single Group Assignment</td>\n",
       "      <td>Masking: None (Open Label)</td>\n",
       "      <td>Primary Purpose: Treatment</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Circadian Modulation of Grape Consumption and ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Oxidative Stress</td>\n",
       "      <td>Other: Grape</td>\n",
       "      <td>Urine F2-isoprostane</td>\n",
       "      <td>Idaho State University</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 50 Years   (Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>IRB-FY2021-264</td>\n",
       "      <td>Idaho State University, Pocatello, Idaho, Unit...</td>\n",
       "      <td>Allocation: Randomized</td>\n",
       "      <td>Intervention Model: Parallel Assignment</td>\n",
       "      <td>Masking: Triple (Participant, Care Provider, O...</td>\n",
       "      <td>Primary Purpose: Basic Science</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9995</th>\n",
       "      <td>Measurement of Beta Cell Death in Individuals ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Cystic Fibrosis-related Diabetes</td>\n",
       "      <td>Diagnostic Test: Measurement of differentially...</td>\n",
       "      <td>Levels of differentially methylated insulin DN...</td>\n",
       "      <td>University of Nebraska|Cystic Fibrosis Foundation</td>\n",
       "      <td>All</td>\n",
       "      <td>up to 21 Years   (Child, Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>611-18-EP</td>\n",
       "      <td>Children's Hospital and Medical Center, Omaha,...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Cross-Sectional</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9996</th>\n",
       "      <td>Indications for Osteochondral Allograft Transp...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Post-Traumatic Osteoarthritis of Ankle|Ankle O...</td>\n",
       "      <td>Procedure: Osteochondral allograft ankle</td>\n",
       "      <td>Visual Analog Scale (VAS) score|American Ortho...</td>\n",
       "      <td>University of Missouri-Columbia</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>2011144</td>\n",
       "      <td>Missouri Orthopaedic Institute, Columbia, Miss...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9997</th>\n",
       "      <td>iBeat Wristwatch Validation Study</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Arrythmia, Cardiac</td>\n",
       "      <td>Device: iBeat wristwatch device</td>\n",
       "      <td>Detect hemodynamic significant (e.g. Ventricul...</td>\n",
       "      <td>University of California, San Francisco|iBeat ...</td>\n",
       "      <td>All</td>\n",
       "      <td>21 Years to 85 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Case-Only|Time Perspectiv...</td>\n",
       "      <td>17-23761</td>\n",
       "      <td>University of California, San Francisco, San F...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Observational Model: Case-Only</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9998</th>\n",
       "      <td>Single Center Post Approval Proximal Humerus F...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Proximal Humeral Fracture</td>\n",
       "      <td>Device: Conventus Cage PH device</td>\n",
       "      <td>Primary Performance Patient Assessment</td>\n",
       "      <td>Conventus Orthopaedics, Inc.</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Case-Only|Time Perspectiv...</td>\n",
       "      <td>7821</td>\n",
       "      <td>The University of Texas Health Science Center ...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Observational Model: Case-Only</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9999</th>\n",
       "      <td>Procalcitonin at Zero and 24 Hours as a Progno...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Pneumonia</td>\n",
       "      <td>Diagnostic Test: Procalcitonin lab test</td>\n",
       "      <td>Change in Procalcitonin level|qSOFA score|Leng...</td>\n",
       "      <td>Spectrum Health - Lakeland|Michigan State Univ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>MMMC#1577</td>\n",
       "      <td>Lakeland Regional Healthcare, Saint Joseph, Mi...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>10000 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  Title      Status  \\\n",
       "0     Financial and Insurance Assistance- Oncology F...   Completed   \n",
       "1     The Impact of Heartfulness Self-Care Program o...   Completed   \n",
       "2     A Study to Evaluate the Safety, Tolerability, ...   Completed   \n",
       "3     A Study to Learn About Effect of Sisunatovir i...   Completed   \n",
       "4     Circadian Modulation of Grape Consumption and ...   Completed   \n",
       "...                                                 ...         ...   \n",
       "9995  Measurement of Beta Cell Death in Individuals ...   Completed   \n",
       "9996  Indications for Osteochondral Allograft Transp...   Completed   \n",
       "9997                  iBeat Wristwatch Validation Study   Completed   \n",
       "9998  Single Center Post Approval Proximal Humerus F...  Terminated   \n",
       "9999  Procalcitonin at Zero and 24 Hours as a Progno...   Completed   \n",
       "\n",
       "             Study Results                                         Conditions  \\\n",
       "0     No Results Available                  Financial Stress|Pediatric Cancer   \n",
       "1     No Results Available          Anxiety|Satisfaction With Life|Loneliness   \n",
       "2     No Results Available          Chronic Graft-versus-host Disease (cGVHD)   \n",
       "3     No Results Available             Respiratory Syncytial Virus Infections   \n",
       "4     No Results Available                                   Oxidative Stress   \n",
       "...                    ...                                                ...   \n",
       "9995  No Results Available                   Cystic Fibrosis-related Diabetes   \n",
       "9996  No Results Available  Post-Traumatic Osteoarthritis of Ankle|Ankle O...   \n",
       "9997  No Results Available                                 Arrythmia, Cardiac   \n",
       "9998  No Results Available                          Proximal Humeral Fracture   \n",
       "9999  No Results Available                                          Pneumonia   \n",
       "\n",
       "                                          Interventions  \\\n",
       "0                                      Other: FINassist   \n",
       "1     Behavioral: Self-Care Program through Heartful...   \n",
       "2                          Drug: AMG 592|Other: Placebo   \n",
       "3               Drug: 200 mg RV521/78 µCi [ 14C]-RV521.   \n",
       "4                                          Other: Grape   \n",
       "...                                                 ...   \n",
       "9995  Diagnostic Test: Measurement of differentially...   \n",
       "9996           Procedure: Osteochondral allograft ankle   \n",
       "9997                    Device: iBeat wristwatch device   \n",
       "9998                   Device: Conventus Cage PH device   \n",
       "9999            Diagnostic Test: Procalcitonin lab test   \n",
       "\n",
       "                                       Outcome Measures  \\\n",
       "0     FINassist Feasibility|FINassist Adherence|FINa...   \n",
       "1     Assess the current level of Anxiety|Changes le...   \n",
       "2     Number of Participants with Treatment-emergent...   \n",
       "3     Tmax (Time of maximum observed concentration)|...   \n",
       "4                                  Urine F2-isoprostane   \n",
       "...                                                 ...   \n",
       "9995  Levels of differentially methylated insulin DN...   \n",
       "9996  Visual Analog Scale (VAS) score|American Ortho...   \n",
       "9997  Detect hemodynamic significant (e.g. Ventricul...   \n",
       "9998             Primary Performance Patient Assessment   \n",
       "9999  Change in Procalcitonin level|qSOFA score|Leng...   \n",
       "\n",
       "                                  Sponsor/Collaborators Gender  \\\n",
       "0     Jean Edward|Robert Wood Johnson Foundation|Uni...    All   \n",
       "1                                Heartfulness Institute    All   \n",
       "2                                                 Amgen    All   \n",
       "3                                                Pfizer   Male   \n",
       "4                                Idaho State University    All   \n",
       "...                                                 ...    ...   \n",
       "9995  University of Nebraska|Cystic Fibrosis Foundation    All   \n",
       "9996                    University of Missouri-Columbia    All   \n",
       "9997  University of California, San Francisco|iBeat ...    All   \n",
       "9998                       Conventus Orthopaedics, Inc.    All   \n",
       "9999  Spectrum Health - Lakeland|Michigan State Univ...    All   \n",
       "\n",
       "                                                    Age          Phases  ...  \\\n",
       "0           18 Years to 65 Years   (Adult, Older Adult)  Not Applicable  ...   \n",
       "1     14 Years to 80 Years   (Child, Adult, Older Ad...  Not Applicable  ...   \n",
       "2                        18 Years to 55 Years   (Adult)         Phase 1  ...   \n",
       "3                        18 Years to 55 Years   (Adult)         Phase 1  ...   \n",
       "4                        18 Years to 50 Years   (Adult)  Not Applicable  ...   \n",
       "...                                                 ...             ...  ...   \n",
       "9995                    up to 21 Years   (Child, Adult)  Not Applicable  ...   \n",
       "9996                     18 Years to 55 Years   (Adult)  Not Applicable  ...   \n",
       "9997        21 Years to 85 Years   (Adult, Older Adult)  Not Applicable  ...   \n",
       "9998          18 Years and older   (Adult, Older Adult)  Not Applicable  ...   \n",
       "9999          18 Years and older   (Adult, Older Adult)  Not Applicable  ...   \n",
       "\n",
       "          Study Type                                      Study Designs  \\\n",
       "0     Interventional  Allocation: Non-Randomized|Intervention Model:...   \n",
       "1     Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "2     Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "3     Interventional  Allocation: N/A|Intervention Model: Single Gro...   \n",
       "4     Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "...              ...                                                ...   \n",
       "9995   Observational  Observational Model: Cohort|Time Perspective: ...   \n",
       "9996   Observational  Observational Model: Cohort|Time Perspective: ...   \n",
       "9997   Observational  Observational Model: Case-Only|Time Perspectiv...   \n",
       "9998   Observational  Observational Model: Case-Only|Time Perspectiv...   \n",
       "9999   Observational  Observational Model: Cohort|Time Perspective: ...   \n",
       "\n",
       "             Other IDs                                          Locations  \\\n",
       "0                57238  University of Kentucky DanceBlue Pediatric Hem...   \n",
       "1           02-01-2022      Ranjani B Iyer, Novi, Michigan, United States   \n",
       "2             20140324    Research Site, Aventura, Florida, United States   \n",
       "3     REVC008|C5241008  Pharmaron Clinical Pharmacology Center, Baltim...   \n",
       "4       IRB-FY2021-264  Idaho State University, Pocatello, Idaho, Unit...   \n",
       "...                ...                                                ...   \n",
       "9995         611-18-EP  Children's Hospital and Medical Center, Omaha,...   \n",
       "9996           2011144  Missouri Orthopaedic Institute, Columbia, Miss...   \n",
       "9997          17-23761  University of California, San Francisco, San F...   \n",
       "9998              7821  The University of Texas Health Science Center ...   \n",
       "9999         MMMC#1577  Lakeland Regional Healthcare, Saint Joseph, Mi...   \n",
       "\n",
       "                      Allocation                                       IModel  \\\n",
       "0     Allocation: Non-Randomized  Intervention Model: Single Group Assignment   \n",
       "1         Allocation: Randomized      Intervention Model: Parallel Assignment   \n",
       "2         Allocation: Randomized      Intervention Model: Parallel Assignment   \n",
       "3                Allocation: N/A  Intervention Model: Single Group Assignment   \n",
       "4         Allocation: Randomized      Intervention Model: Parallel Assignment   \n",
       "...                          ...                                          ...   \n",
       "9995                         NaN                                          NaN   \n",
       "9996                         NaN                                          NaN   \n",
       "9997                         NaN                                          NaN   \n",
       "9998                         NaN                                          NaN   \n",
       "9999                         NaN                                          NaN   \n",
       "\n",
       "                                                Masking  \\\n",
       "0                            Masking: None (Open Label)   \n",
       "1           Masking: Double (Participant, Investigator)   \n",
       "2           Masking: Double (Participant, Investigator)   \n",
       "3                            Masking: None (Open Label)   \n",
       "4     Masking: Triple (Participant, Care Provider, O...   \n",
       "...                                                 ...   \n",
       "9995                                                NaN   \n",
       "9996                                                NaN   \n",
       "9997                                                NaN   \n",
       "9998                                                NaN   \n",
       "9999                                                NaN   \n",
       "\n",
       "                                Primary Purpose  \\\n",
       "0     Primary Purpose: Health Services Research   \n",
       "1              Primary Purpose: Supportive Care   \n",
       "2                Primary Purpose: Basic Science   \n",
       "3                    Primary Purpose: Treatment   \n",
       "4                Primary Purpose: Basic Science   \n",
       "...                                         ...   \n",
       "9995                                        NaN   \n",
       "9996                                        NaN   \n",
       "9997                                        NaN   \n",
       "9998                                        NaN   \n",
       "9999                                        NaN   \n",
       "\n",
       "                              OModel                   Time Perspective  \n",
       "0                                NaN                                NaN  \n",
       "1                                NaN                                NaN  \n",
       "2                                NaN                                NaN  \n",
       "3                                NaN                                NaN  \n",
       "4                                NaN                                NaN  \n",
       "...                              ...                                ...  \n",
       "9995     Observational Model: Cohort  Time Perspective: Cross-Sectional  \n",
       "9996     Observational Model: Cohort      Time Perspective: Prospective  \n",
       "9997  Observational Model: Case-Only      Time Perspective: Prospective  \n",
       "9998  Observational Model: Case-Only      Time Perspective: Prospective  \n",
       "9999     Observational Model: Cohort      Time Perspective: Prospective  \n",
       "\n",
       "[10000 rows x 22 columns]"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cds1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "ed595e04",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Title                       0\n",
       "Status                      0\n",
       "Study Results               0\n",
       "Conditions                  0\n",
       "Interventions               0\n",
       "Outcome Measures            0\n",
       "Sponsor/Collaborators       0\n",
       "Gender                      0\n",
       "Age                         0\n",
       "Phases                      0\n",
       "Enrollment                  0\n",
       "Funded Bys                  0\n",
       "Study Type                  0\n",
       "Study Designs               0\n",
       "Other IDs                   0\n",
       "Locations                   0\n",
       "Allocation               1668\n",
       "IModel                   1669\n",
       "Masking                  1669\n",
       "Primary Purpose          1683\n",
       "OModel                   8332\n",
       "Time Perspective         8332\n",
       "dtype: int64"
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cds1.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "7e430996",
   "metadata": {},
   "outputs": [],
   "source": [
    "cds1=cds1.fillna(value='None')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "8fe0c05a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Title                    0\n",
       "Status                   0\n",
       "Study Results            0\n",
       "Conditions               0\n",
       "Interventions            0\n",
       "Outcome Measures         0\n",
       "Sponsor/Collaborators    0\n",
       "Gender                   0\n",
       "Age                      0\n",
       "Phases                   0\n",
       "Enrollment               0\n",
       "Funded Bys               0\n",
       "Study Type               0\n",
       "Study Designs            0\n",
       "Other IDs                0\n",
       "Locations                0\n",
       "Allocation               0\n",
       "IModel                   0\n",
       "Masking                  0\n",
       "Primary Purpose          0\n",
       "OModel                   0\n",
       "Time Perspective         0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cds1.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "314f21fa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>...</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Study Designs</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>IModel</th>\n",
       "      <th>Masking</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>OModel</th>\n",
       "      <th>Time Perspective</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Financial and Insurance Assistance- Oncology F...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Financial Stress|Pediatric Cancer</td>\n",
       "      <td>Other: FINassist</td>\n",
       "      <td>FINassist Feasibility|FINassist Adherence|FINa...</td>\n",
       "      <td>Jean Edward|Robert Wood Johnson Foundation|Uni...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 65 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Non-Randomized|Intervention Model:...</td>\n",
       "      <td>57238</td>\n",
       "      <td>University of Kentucky DanceBlue Pediatric Hem...</td>\n",
       "      <td>Allocation: Non-Randomized</td>\n",
       "      <td>Intervention Model: Single Group Assignment</td>\n",
       "      <td>Masking: None (Open Label)</td>\n",
       "      <td>Primary Purpose: Health Services Research</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>The Impact of Heartfulness Self-Care Program o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Anxiety|Satisfaction With Life|Loneliness</td>\n",
       "      <td>Behavioral: Self-Care Program through Heartful...</td>\n",
       "      <td>Assess the current level of Anxiety|Changes le...</td>\n",
       "      <td>Heartfulness Institute</td>\n",
       "      <td>All</td>\n",
       "      <td>14 Years to 80 Years   (Child, Adult, Older Ad...</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>02-01-2022</td>\n",
       "      <td>Ranjani B Iyer, Novi, Michigan, United States</td>\n",
       "      <td>Allocation: Randomized</td>\n",
       "      <td>Intervention Model: Parallel Assignment</td>\n",
       "      <td>Masking: Double (Participant, Investigator)</td>\n",
       "      <td>Primary Purpose: Supportive Care</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>A Study to Evaluate the Safety, Tolerability, ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Chronic Graft-versus-host Disease (cGVHD)</td>\n",
       "      <td>Drug: AMG 592|Other: Placebo</td>\n",
       "      <td>Number of Participants with Treatment-emergent...</td>\n",
       "      <td>Amgen</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>20140324</td>\n",
       "      <td>Research Site, Aventura, Florida, United States</td>\n",
       "      <td>Allocation: Randomized</td>\n",
       "      <td>Intervention Model: Parallel Assignment</td>\n",
       "      <td>Masking: Double (Participant, Investigator)</td>\n",
       "      <td>Primary Purpose: Basic Science</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>A Study to Learn About Effect of Sisunatovir i...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Respiratory Syncytial Virus Infections</td>\n",
       "      <td>Drug: 200 mg RV521/78 µCi [ 14C]-RV521.</td>\n",
       "      <td>Tmax (Time of maximum observed concentration)|...</td>\n",
       "      <td>Pfizer</td>\n",
       "      <td>Male</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: N/A|Intervention Model: Single Gro...</td>\n",
       "      <td>REVC008|C5241008</td>\n",
       "      <td>Pharmaron Clinical Pharmacology Center, Baltim...</td>\n",
       "      <td>Allocation: N/A</td>\n",
       "      <td>Intervention Model: Single Group Assignment</td>\n",
       "      <td>Masking: None (Open Label)</td>\n",
       "      <td>Primary Purpose: Treatment</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Circadian Modulation of Grape Consumption and ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Oxidative Stress</td>\n",
       "      <td>Other: Grape</td>\n",
       "      <td>Urine F2-isoprostane</td>\n",
       "      <td>Idaho State University</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 50 Years   (Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>Allocation: Randomized|Intervention Model: Par...</td>\n",
       "      <td>IRB-FY2021-264</td>\n",
       "      <td>Idaho State University, Pocatello, Idaho, Unit...</td>\n",
       "      <td>Allocation: Randomized</td>\n",
       "      <td>Intervention Model: Parallel Assignment</td>\n",
       "      <td>Masking: Triple (Participant, Care Provider, O...</td>\n",
       "      <td>Primary Purpose: Basic Science</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9995</th>\n",
       "      <td>Measurement of Beta Cell Death in Individuals ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Cystic Fibrosis-related Diabetes</td>\n",
       "      <td>Diagnostic Test: Measurement of differentially...</td>\n",
       "      <td>Levels of differentially methylated insulin DN...</td>\n",
       "      <td>University of Nebraska|Cystic Fibrosis Foundation</td>\n",
       "      <td>All</td>\n",
       "      <td>up to 21 Years   (Child, Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>611-18-EP</td>\n",
       "      <td>Children's Hospital and Medical Center, Omaha,...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Cross-Sectional</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9996</th>\n",
       "      <td>Indications for Osteochondral Allograft Transp...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Post-Traumatic Osteoarthritis of Ankle|Ankle O...</td>\n",
       "      <td>Procedure: Osteochondral allograft ankle</td>\n",
       "      <td>Visual Analog Scale (VAS) score|American Ortho...</td>\n",
       "      <td>University of Missouri-Columbia</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years to 55 Years   (Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>2011144</td>\n",
       "      <td>Missouri Orthopaedic Institute, Columbia, Miss...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9997</th>\n",
       "      <td>iBeat Wristwatch Validation Study</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Arrythmia, Cardiac</td>\n",
       "      <td>Device: iBeat wristwatch device</td>\n",
       "      <td>Detect hemodynamic significant (e.g. Ventricul...</td>\n",
       "      <td>University of California, San Francisco|iBeat ...</td>\n",
       "      <td>All</td>\n",
       "      <td>21 Years to 85 Years   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Case-Only|Time Perspectiv...</td>\n",
       "      <td>17-23761</td>\n",
       "      <td>University of California, San Francisco, San F...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Observational Model: Case-Only</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9998</th>\n",
       "      <td>Single Center Post Approval Proximal Humerus F...</td>\n",
       "      <td>Terminated</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Proximal Humeral Fracture</td>\n",
       "      <td>Device: Conventus Cage PH device</td>\n",
       "      <td>Primary Performance Patient Assessment</td>\n",
       "      <td>Conventus Orthopaedics, Inc.</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Case-Only|Time Perspectiv...</td>\n",
       "      <td>7821</td>\n",
       "      <td>The University of Texas Health Science Center ...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Observational Model: Case-Only</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9999</th>\n",
       "      <td>Procalcitonin at Zero and 24 Hours as a Progno...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>No Results Available</td>\n",
       "      <td>Pneumonia</td>\n",
       "      <td>Diagnostic Test: Procalcitonin lab test</td>\n",
       "      <td>Change in Procalcitonin level|qSOFA score|Leng...</td>\n",
       "      <td>Spectrum Health - Lakeland|Michigan State Univ...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years and older   (Adult, Older Adult)</td>\n",
       "      <td>Not Applicable</td>\n",
       "      <td>...</td>\n",
       "      <td>Observational</td>\n",
       "      <td>Observational Model: Cohort|Time Perspective: ...</td>\n",
       "      <td>MMMC#1577</td>\n",
       "      <td>Lakeland Regional Healthcare, Saint Joseph, Mi...</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>Observational Model: Cohort</td>\n",
       "      <td>Time Perspective: Prospective</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>10000 rows × 22 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                  Title      Status  \\\n",
       "0     Financial and Insurance Assistance- Oncology F...   Completed   \n",
       "1     The Impact of Heartfulness Self-Care Program o...   Completed   \n",
       "2     A Study to Evaluate the Safety, Tolerability, ...   Completed   \n",
       "3     A Study to Learn About Effect of Sisunatovir i...   Completed   \n",
       "4     Circadian Modulation of Grape Consumption and ...   Completed   \n",
       "...                                                 ...         ...   \n",
       "9995  Measurement of Beta Cell Death in Individuals ...   Completed   \n",
       "9996  Indications for Osteochondral Allograft Transp...   Completed   \n",
       "9997                  iBeat Wristwatch Validation Study   Completed   \n",
       "9998  Single Center Post Approval Proximal Humerus F...  Terminated   \n",
       "9999  Procalcitonin at Zero and 24 Hours as a Progno...   Completed   \n",
       "\n",
       "             Study Results                                         Conditions  \\\n",
       "0     No Results Available                  Financial Stress|Pediatric Cancer   \n",
       "1     No Results Available          Anxiety|Satisfaction With Life|Loneliness   \n",
       "2     No Results Available          Chronic Graft-versus-host Disease (cGVHD)   \n",
       "3     No Results Available             Respiratory Syncytial Virus Infections   \n",
       "4     No Results Available                                   Oxidative Stress   \n",
       "...                    ...                                                ...   \n",
       "9995  No Results Available                   Cystic Fibrosis-related Diabetes   \n",
       "9996  No Results Available  Post-Traumatic Osteoarthritis of Ankle|Ankle O...   \n",
       "9997  No Results Available                                 Arrythmia, Cardiac   \n",
       "9998  No Results Available                          Proximal Humeral Fracture   \n",
       "9999  No Results Available                                          Pneumonia   \n",
       "\n",
       "                                          Interventions  \\\n",
       "0                                      Other: FINassist   \n",
       "1     Behavioral: Self-Care Program through Heartful...   \n",
       "2                          Drug: AMG 592|Other: Placebo   \n",
       "3               Drug: 200 mg RV521/78 µCi [ 14C]-RV521.   \n",
       "4                                          Other: Grape   \n",
       "...                                                 ...   \n",
       "9995  Diagnostic Test: Measurement of differentially...   \n",
       "9996           Procedure: Osteochondral allograft ankle   \n",
       "9997                    Device: iBeat wristwatch device   \n",
       "9998                   Device: Conventus Cage PH device   \n",
       "9999            Diagnostic Test: Procalcitonin lab test   \n",
       "\n",
       "                                       Outcome Measures  \\\n",
       "0     FINassist Feasibility|FINassist Adherence|FINa...   \n",
       "1     Assess the current level of Anxiety|Changes le...   \n",
       "2     Number of Participants with Treatment-emergent...   \n",
       "3     Tmax (Time of maximum observed concentration)|...   \n",
       "4                                  Urine F2-isoprostane   \n",
       "...                                                 ...   \n",
       "9995  Levels of differentially methylated insulin DN...   \n",
       "9996  Visual Analog Scale (VAS) score|American Ortho...   \n",
       "9997  Detect hemodynamic significant (e.g. Ventricul...   \n",
       "9998             Primary Performance Patient Assessment   \n",
       "9999  Change in Procalcitonin level|qSOFA score|Leng...   \n",
       "\n",
       "                                  Sponsor/Collaborators Gender  \\\n",
       "0     Jean Edward|Robert Wood Johnson Foundation|Uni...    All   \n",
       "1                                Heartfulness Institute    All   \n",
       "2                                                 Amgen    All   \n",
       "3                                                Pfizer   Male   \n",
       "4                                Idaho State University    All   \n",
       "...                                                 ...    ...   \n",
       "9995  University of Nebraska|Cystic Fibrosis Foundation    All   \n",
       "9996                    University of Missouri-Columbia    All   \n",
       "9997  University of California, San Francisco|iBeat ...    All   \n",
       "9998                       Conventus Orthopaedics, Inc.    All   \n",
       "9999  Spectrum Health - Lakeland|Michigan State Univ...    All   \n",
       "\n",
       "                                                    Age          Phases  ...  \\\n",
       "0           18 Years to 65 Years   (Adult, Older Adult)  Not Applicable  ...   \n",
       "1     14 Years to 80 Years   (Child, Adult, Older Ad...  Not Applicable  ...   \n",
       "2                        18 Years to 55 Years   (Adult)         Phase 1  ...   \n",
       "3                        18 Years to 55 Years   (Adult)         Phase 1  ...   \n",
       "4                        18 Years to 50 Years   (Adult)  Not Applicable  ...   \n",
       "...                                                 ...             ...  ...   \n",
       "9995                    up to 21 Years   (Child, Adult)  Not Applicable  ...   \n",
       "9996                     18 Years to 55 Years   (Adult)  Not Applicable  ...   \n",
       "9997        21 Years to 85 Years   (Adult, Older Adult)  Not Applicable  ...   \n",
       "9998          18 Years and older   (Adult, Older Adult)  Not Applicable  ...   \n",
       "9999          18 Years and older   (Adult, Older Adult)  Not Applicable  ...   \n",
       "\n",
       "          Study Type                                      Study Designs  \\\n",
       "0     Interventional  Allocation: Non-Randomized|Intervention Model:...   \n",
       "1     Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "2     Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "3     Interventional  Allocation: N/A|Intervention Model: Single Gro...   \n",
       "4     Interventional  Allocation: Randomized|Intervention Model: Par...   \n",
       "...              ...                                                ...   \n",
       "9995   Observational  Observational Model: Cohort|Time Perspective: ...   \n",
       "9996   Observational  Observational Model: Cohort|Time Perspective: ...   \n",
       "9997   Observational  Observational Model: Case-Only|Time Perspectiv...   \n",
       "9998   Observational  Observational Model: Case-Only|Time Perspectiv...   \n",
       "9999   Observational  Observational Model: Cohort|Time Perspective: ...   \n",
       "\n",
       "             Other IDs                                          Locations  \\\n",
       "0                57238  University of Kentucky DanceBlue Pediatric Hem...   \n",
       "1           02-01-2022      Ranjani B Iyer, Novi, Michigan, United States   \n",
       "2             20140324    Research Site, Aventura, Florida, United States   \n",
       "3     REVC008|C5241008  Pharmaron Clinical Pharmacology Center, Baltim...   \n",
       "4       IRB-FY2021-264  Idaho State University, Pocatello, Idaho, Unit...   \n",
       "...                ...                                                ...   \n",
       "9995         611-18-EP  Children's Hospital and Medical Center, Omaha,...   \n",
       "9996           2011144  Missouri Orthopaedic Institute, Columbia, Miss...   \n",
       "9997          17-23761  University of California, San Francisco, San F...   \n",
       "9998              7821  The University of Texas Health Science Center ...   \n",
       "9999         MMMC#1577  Lakeland Regional Healthcare, Saint Joseph, Mi...   \n",
       "\n",
       "                      Allocation                                       IModel  \\\n",
       "0     Allocation: Non-Randomized  Intervention Model: Single Group Assignment   \n",
       "1         Allocation: Randomized      Intervention Model: Parallel Assignment   \n",
       "2         Allocation: Randomized      Intervention Model: Parallel Assignment   \n",
       "3                Allocation: N/A  Intervention Model: Single Group Assignment   \n",
       "4         Allocation: Randomized      Intervention Model: Parallel Assignment   \n",
       "...                          ...                                          ...   \n",
       "9995                        None                                         None   \n",
       "9996                        None                                         None   \n",
       "9997                        None                                         None   \n",
       "9998                        None                                         None   \n",
       "9999                        None                                         None   \n",
       "\n",
       "                                                Masking  \\\n",
       "0                            Masking: None (Open Label)   \n",
       "1           Masking: Double (Participant, Investigator)   \n",
       "2           Masking: Double (Participant, Investigator)   \n",
       "3                            Masking: None (Open Label)   \n",
       "4     Masking: Triple (Participant, Care Provider, O...   \n",
       "...                                                 ...   \n",
       "9995                                               None   \n",
       "9996                                               None   \n",
       "9997                                               None   \n",
       "9998                                               None   \n",
       "9999                                               None   \n",
       "\n",
       "                                Primary Purpose  \\\n",
       "0     Primary Purpose: Health Services Research   \n",
       "1              Primary Purpose: Supportive Care   \n",
       "2                Primary Purpose: Basic Science   \n",
       "3                    Primary Purpose: Treatment   \n",
       "4                Primary Purpose: Basic Science   \n",
       "...                                         ...   \n",
       "9995                                       None   \n",
       "9996                                       None   \n",
       "9997                                       None   \n",
       "9998                                       None   \n",
       "9999                                       None   \n",
       "\n",
       "                              OModel                   Time Perspective  \n",
       "0                               None                               None  \n",
       "1                               None                               None  \n",
       "2                               None                               None  \n",
       "3                               None                               None  \n",
       "4                               None                               None  \n",
       "...                              ...                                ...  \n",
       "9995     Observational Model: Cohort  Time Perspective: Cross-Sectional  \n",
       "9996     Observational Model: Cohort      Time Perspective: Prospective  \n",
       "9997  Observational Model: Case-Only      Time Perspective: Prospective  \n",
       "9998  Observational Model: Case-Only      Time Perspective: Prospective  \n",
       "9999     Observational Model: Cohort      Time Perspective: Prospective  \n",
       "\n",
       "[10000 rows x 22 columns]"
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cds1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "92d59cea",
   "metadata": {},
   "outputs": [],
   "source": [
    "cds1=cds1.drop(['Study Designs'],axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "fd424fff",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "\n",
    "# Create a TfidfVectorizer object\n",
    "vectorizer = TfidfVectorizer(stop_words='english')\n",
    "\n",
    "l=['Title','Conditions','Interventions','Outcome Measures','Sponsor/Collaborators','Age','Other IDs','Locations']\n",
    "\n",
    "for i in l:\n",
    "    vectorizer.fit(cds1[i]) # Fit the vectorizer to the text data\n",
    "    tfidf_representation = vectorizer.transform(cds1[i]) # Transform the text data into a TF-IDF representation\n",
    "    cds1[i]=tfidf_representation.toarray()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "3f463d0b",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "RangeIndex: 10000 entries, 0 to 9999\n",
      "Data columns (total 21 columns):\n",
      " #   Column                 Non-Null Count  Dtype  \n",
      "---  ------                 --------------  -----  \n",
      " 0   Title                  10000 non-null  float64\n",
      " 1   Status                 10000 non-null  int32  \n",
      " 2   Study Results          10000 non-null  int32  \n",
      " 3   Conditions             10000 non-null  float64\n",
      " 4   Interventions          10000 non-null  float64\n",
      " 5   Outcome Measures       10000 non-null  float64\n",
      " 6   Sponsor/Collaborators  10000 non-null  float64\n",
      " 7   Gender                 10000 non-null  int32  \n",
      " 8   Age                    10000 non-null  float64\n",
      " 9   Phases                 10000 non-null  int32  \n",
      " 10  Enrollment             10000 non-null  float64\n",
      " 11  Funded Bys             10000 non-null  int32  \n",
      " 12  Study Type             10000 non-null  int32  \n",
      " 13  Other IDs              10000 non-null  float64\n",
      " 14  Locations              10000 non-null  float64\n",
      " 15  Allocation             10000 non-null  int32  \n",
      " 16  IModel                 10000 non-null  int32  \n",
      " 17  Masking                10000 non-null  int32  \n",
      " 18  Primary Purpose        10000 non-null  int32  \n",
      " 19  OModel                 10000 non-null  int32  \n",
      " 20  Time Perspective       10000 non-null  int32  \n",
      "dtypes: float64(9), int32(12)\n",
      "memory usage: 1.1 MB\n",
      "None\n"
     ]
    }
   ],
   "source": [
    "l1=['Status','Study Results','Gender','Phases','Study Type','Allocation','IModel','Masking','Primary Purpose','OModel','Time Perspective','Funded Bys']\n",
    "from sklearn.preprocessing import LabelEncoder\n",
    "le = LabelEncoder()\n",
    "\n",
    "for feat in l1:\n",
    "    cds1[feat] = le.fit_transform(cds1[feat].astype(str))\n",
    "\n",
    "print (cds1.info())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "58800295",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Title</th>\n",
       "      <th>Status</th>\n",
       "      <th>Study Results</th>\n",
       "      <th>Conditions</th>\n",
       "      <th>Interventions</th>\n",
       "      <th>Outcome Measures</th>\n",
       "      <th>Sponsor/Collaborators</th>\n",
       "      <th>Gender</th>\n",
       "      <th>Age</th>\n",
       "      <th>Phases</th>\n",
       "      <th>...</th>\n",
       "      <th>Funded Bys</th>\n",
       "      <th>Study Type</th>\n",
       "      <th>Other IDs</th>\n",
       "      <th>Locations</th>\n",
       "      <th>Allocation</th>\n",
       "      <th>IModel</th>\n",
       "      <th>Masking</th>\n",
       "      <th>Primary Purpose</th>\n",
       "      <th>OModel</th>\n",
       "      <th>Time Perspective</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1</td>\n",
       "      <td>4</td>\n",
       "      <td>7</td>\n",
       "      <td>4</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>5</td>\n",
       "      <td>8</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>5</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>7</td>\n",
       "      <td>9</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>11</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>2</td>\n",
       "      <td>2</td>\n",
       "      <td>15</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9995</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>11</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5</td>\n",
       "      <td>6</td>\n",
       "      <td>17</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9996</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>11</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5</td>\n",
       "      <td>6</td>\n",
       "      <td>17</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9997</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>11</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5</td>\n",
       "      <td>6</td>\n",
       "      <td>17</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9998</th>\n",
       "      <td>0.0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5</td>\n",
       "      <td>6</td>\n",
       "      <td>17</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9999</th>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>1</td>\n",
       "      <td>...</td>\n",
       "      <td>11</td>\n",
       "      <td>1</td>\n",
       "      <td>0.0</td>\n",
       "      <td>0.0</td>\n",
       "      <td>5</td>\n",
       "      <td>6</td>\n",
       "      <td>17</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>3</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>10000 rows × 21 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "      Title  Status  Study Results  Conditions  Interventions  \\\n",
       "0       0.0       0              1         0.0            0.0   \n",
       "1       0.0       0              1         0.0            0.0   \n",
       "2       0.0       0              1         0.0            0.0   \n",
       "3       0.0       0              1         0.0            0.0   \n",
       "4       0.0       0              1         0.0            0.0   \n",
       "...     ...     ...            ...         ...            ...   \n",
       "9995    0.0       0              1         0.0            0.0   \n",
       "9996    0.0       0              1         0.0            0.0   \n",
       "9997    0.0       0              1         0.0            0.0   \n",
       "9998    0.0       1              1         0.0            0.0   \n",
       "9999    0.0       0              1         0.0            0.0   \n",
       "\n",
       "      Outcome Measures  Sponsor/Collaborators  Gender  Age  Phases  ...  \\\n",
       "0                  0.0                    0.0       0  0.0       1  ...   \n",
       "1                  0.0                    0.0       0  0.0       1  ...   \n",
       "2                  0.0                    0.0       0  0.0       2  ...   \n",
       "3                  0.0                    0.0       2  0.0       2  ...   \n",
       "4                  0.0                    0.0       0  0.0       1  ...   \n",
       "...                ...                    ...     ...  ...     ...  ...   \n",
       "9995               0.0                    0.0       0  0.0       1  ...   \n",
       "9996               0.0                    0.0       0  0.0       1  ...   \n",
       "9997               0.0                    0.0       0  0.0       1  ...   \n",
       "9998               0.0                    0.0       0  0.0       1  ...   \n",
       "9999               0.0                    0.0       0  0.0       1  ...   \n",
       "\n",
       "      Funded Bys  Study Type  Other IDs  Locations  Allocation  IModel  \\\n",
       "0             11           0        0.0        0.0           1       4   \n",
       "1             11           0        0.0        0.0           2       2   \n",
       "2              0           0        0.0        0.0           2       2   \n",
       "3              0           0        0.0        0.0           0       4   \n",
       "4             11           0        0.0        0.0           2       2   \n",
       "...          ...         ...        ...        ...         ...     ...   \n",
       "9995          11           1        0.0        0.0           5       6   \n",
       "9996          11           1        0.0        0.0           5       6   \n",
       "9997          11           1        0.0        0.0           5       6   \n",
       "9998           0           1        0.0        0.0           5       6   \n",
       "9999          11           1        0.0        0.0           5       6   \n",
       "\n",
       "      Masking  Primary Purpose  OModel  Time Perspective  \n",
       "0           7                4       0                 0  \n",
       "1           5                8       0                 0  \n",
       "2           5                1       0                 0  \n",
       "3           7                9       0                 0  \n",
       "4          15                1       0                 0  \n",
       "...       ...              ...     ...               ...  \n",
       "9995       17                0       4                 1  \n",
       "9996       17                0       4                 3  \n",
       "9997       17                0       3                 3  \n",
       "9998       17                0       3                 3  \n",
       "9999       17                0       4                 3  \n",
       "\n",
       "[10000 rows x 21 columns]"
      ]
     },
     "execution_count": 58,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "cds1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "3018250f",
   "metadata": {},
   "outputs": [],
   "source": [
    "x=cds1.drop(['Status'],axis=1)\n",
    "y=cds1['Status']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "dcef01c9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1296x1152 with 2 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.figure(figsize=(18,16))\n",
    "cor=x.corr()\n",
    "sns.heatmap(cor,annot=True,cmap=plt.cm.CMRmap_r)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "596789e4",
   "metadata": {},
   "outputs": [],
   "source": [
    "def correlation(dataset, threshold):\n",
    "    col_corr = set()  # Set of all the names of correlated columns\n",
    "    corr_matrix = dataset.corr()\n",
    "    for i in range(len(corr_matrix.columns)):\n",
    "        for j in range(i):\n",
    "            if (abs(corr_matrix.iloc[i, j])) > threshold: # we are interested in absolute coeff value\n",
    "                colname = corr_matrix.columns[i]  # getting the name of column\n",
    "                col_corr.add(colname)\n",
    "    return col_corr\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "28adf5e5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "4"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "corr_features = correlation(x, 0.80)\n",
    "len(set(corr_features))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "0465a3be",
   "metadata": {},
   "outputs": [],
   "source": [
    "x=x.drop(corr_features,axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "65711ca3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'Allocation', 'Masking', 'OModel', 'Time Perspective'}"
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "corr_features"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "2e67a62f",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.model_selection import train_test_split"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "7be65f16",
   "metadata": {},
   "outputs": [],
   "source": [
    "x_train,x_test,y_train,y_test=train_test_split(x,y,test_size=0.3,random_state=100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "81a2d16e",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.linear_model import LogisticRegression"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "7e451ef0",
   "metadata": {},
   "outputs": [],
   "source": [
    "lr=LogisticRegression(class_weight='balanced')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "id": "7611eb39",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\sklearn\\linear_model\\_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\n",
      "STOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n",
      "\n",
      "Increase the number of iterations (max_iter) or scale the data as shown in:\n",
      "    https://scikit-learn.org/stable/modules/preprocessing.html\n",
      "Please also refer to the documentation for alternative solver options:\n",
      "    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n",
      "  n_iter_i = _check_optimize_result(\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<style>#sk-container-id-6 {color: black;background-color: white;}#sk-container-id-6 pre{padding: 0;}#sk-container-id-6 div.sk-toggleable {background-color: white;}#sk-container-id-6 label.sk-toggleable__label {cursor: pointer;display: block;width: 100%;margin-bottom: 0;padding: 0.3em;box-sizing: border-box;text-align: center;}#sk-container-id-6 label.sk-toggleable__label-arrow:before {content: \"▸\";float: left;margin-right: 0.25em;color: #696969;}#sk-container-id-6 label.sk-toggleable__label-arrow:hover:before {color: black;}#sk-container-id-6 div.sk-estimator:hover label.sk-toggleable__label-arrow:before {color: black;}#sk-container-id-6 div.sk-toggleable__content {max-height: 0;max-width: 0;overflow: hidden;text-align: left;background-color: #f0f8ff;}#sk-container-id-6 div.sk-toggleable__content pre {margin: 0.2em;color: black;border-radius: 0.25em;background-color: #f0f8ff;}#sk-container-id-6 input.sk-toggleable__control:checked~div.sk-toggleable__content {max-height: 200px;max-width: 100%;overflow: auto;}#sk-container-id-6 input.sk-toggleable__control:checked~label.sk-toggleable__label-arrow:before {content: \"▾\";}#sk-container-id-6 div.sk-estimator input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-6 div.sk-label input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-6 input.sk-hidden--visually {border: 0;clip: rect(1px 1px 1px 1px);clip: rect(1px, 1px, 1px, 1px);height: 1px;margin: -1px;overflow: hidden;padding: 0;position: absolute;width: 1px;}#sk-container-id-6 div.sk-estimator {font-family: monospace;background-color: #f0f8ff;border: 1px dotted black;border-radius: 0.25em;box-sizing: border-box;margin-bottom: 0.5em;}#sk-container-id-6 div.sk-estimator:hover {background-color: #d4ebff;}#sk-container-id-6 div.sk-parallel-item::after {content: \"\";width: 100%;border-bottom: 1px solid gray;flex-grow: 1;}#sk-container-id-6 div.sk-label:hover label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-6 div.sk-serial::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: 0;}#sk-container-id-6 div.sk-serial {display: flex;flex-direction: column;align-items: center;background-color: white;padding-right: 0.2em;padding-left: 0.2em;position: relative;}#sk-container-id-6 div.sk-item {position: relative;z-index: 1;}#sk-container-id-6 div.sk-parallel {display: flex;align-items: stretch;justify-content: center;background-color: white;position: relative;}#sk-container-id-6 div.sk-item::before, #sk-container-id-6 div.sk-parallel-item::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: -1;}#sk-container-id-6 div.sk-parallel-item {display: flex;flex-direction: column;z-index: 1;position: relative;background-color: white;}#sk-container-id-6 div.sk-parallel-item:first-child::after {align-self: flex-end;width: 50%;}#sk-container-id-6 div.sk-parallel-item:last-child::after {align-self: flex-start;width: 50%;}#sk-container-id-6 div.sk-parallel-item:only-child::after {width: 0;}#sk-container-id-6 div.sk-dashed-wrapped {border: 1px dashed gray;margin: 0 0.4em 0.5em 0.4em;box-sizing: border-box;padding-bottom: 0.4em;background-color: white;}#sk-container-id-6 div.sk-label label {font-family: monospace;font-weight: bold;display: inline-block;line-height: 1.2em;}#sk-container-id-6 div.sk-label-container {text-align: center;}#sk-container-id-6 div.sk-container {/* jupyter's `normalize.less` sets `[hidden] { display: none; }` but bootstrap.min.css set `[hidden] { display: none !important; }` so we also need the `!important` here to be able to override the default hidden behavior on the sphinx rendered scikit-learn.org. See: https://github.com/scikit-learn/scikit-learn/issues/21755 */display: inline-block !important;position: relative;}#sk-container-id-6 div.sk-text-repr-fallback {display: none;}</style><div id=\"sk-container-id-6\" class=\"sk-top-container\"><div class=\"sk-text-repr-fallback\"><pre>LogisticRegression(class_weight=&#x27;balanced&#x27;)</pre><b>In a Jupyter environment, please rerun this cell to show the HTML representation or trust the notebook. <br />On GitHub, the HTML representation is unable to render, please try loading this page with nbviewer.org.</b></div><div class=\"sk-container\" hidden><div class=\"sk-item\"><div class=\"sk-estimator sk-toggleable\"><input class=\"sk-toggleable__control sk-hidden--visually\" id=\"sk-estimator-id-6\" type=\"checkbox\" checked><label for=\"sk-estimator-id-6\" class=\"sk-toggleable__label sk-toggleable__label-arrow\">LogisticRegression</label><div class=\"sk-toggleable__content\"><pre>LogisticRegression(class_weight=&#x27;balanced&#x27;)</pre></div></div></div></div></div>"
      ],
      "text/plain": [
       "LogisticRegression(class_weight='balanced')"
      ]
     },
     "execution_count": 121,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "lr.fit(x_train,y_train)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "id": "46418ab2",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Predicted Class: [0 0 1 ... 0 0 1]\n"
     ]
    }
   ],
   "source": [
    "y_pred_lr=lr.predict(x_test)\n",
    "print(\"Predicted Class: {}\".format(y_pred_lr))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 71,
   "id": "60f6fb15",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.metrics import classification_report,precision_score,recall_score,f1_score"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "id": "35d4e426",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.6603333333333332"
      ]
     },
     "execution_count": 72,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "recall_score(y_test,y_pred_lr,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "id": "5908ec5c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.8307727129628381"
      ]
     },
     "execution_count": 73,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "precision_score(y_test,y_pred_lr,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 74,
   "id": "d287270d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.716881987740594"
      ]
     },
     "execution_count": 74,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "f1_score(y_test,y_pred_lr,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 75,
   "id": "4c47b987",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.6279416091921026"
      ]
     },
     "execution_count": 75,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from sklearn.metrics import balanced_accuracy_score\n",
    "\n",
    "balanced_acc = balanced_accuracy_score(y_test, y_pred_lr)\n",
    "balanced_acc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 76,
   "id": "79c0b5eb",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYoAAAEWCAYAAAB42tAoAAAAOXRFWHRTb2Z0d2FyZQBNYXRwbG90bGliIHZlcnNpb24zLjQuMywgaHR0cHM6Ly9tYXRwbG90bGliLm9yZy/MnkTPAAAACXBIWXMAAAsTAAALEwEAmpwYAABEkElEQVR4nO3dd3hU1dbA4d8ioRN6E0Kk9yoJiIjSQQURRSkqgnoRBXsviF7UT6+IDRS5XAGRgIoFsCI2sKUAkd6khFBDCymEtPX9cSYQIWWATGaSrPd55nHOzJlzVo5hVvbeZ68tqooxxhiTkxLeDsAYY4xvs0RhjDEmV5YojDHG5MoShTHGmFxZojDGGJMrSxTGGGNyZYnCGGNMrixRmCJFRHaKyAkRSRCR/SIyW0QqnLHPZSLyo4jEi0iciCwRkZZn7FNRRN4QkWjXsba5tqvncF4RkftEZJ2IJIpIjIh8IiJtPPnzGlMQLFGYomigqlYA2gMdgCcz3xCRLsBSYBFQB2gA/AX8JiINXfuUAn4AWgH9gYrAZcBhoFMO53wTuB+4D6gKNAW+AK451+BFxP9cP2OMJ4nNzDZFiYjsBO5U1WWu7f8ArVT1Gtf2CmCtqt5zxue+AWJVdaSI3Am8CDRS1QQ3ztkE2AR0UdXwHPb5GfhQVWe6tke54rzcta3AeOABwB/4DkhQ1UeyHGMR8IuqThGROsDbwBVAAvC6qr6V9xUy5txZi8IUWSISCFwFbHNtl8NpGXySze4fA31cz3sD37qTJFx6ATE5JYlzcB3QGWgJhAJDRUQARKQK0BdYICIlgCU4LaG6rvM/ICL9LvD8xmTLEoUpir4QkXhgN3AQmOh6vSrO7/y+bD6zD8gcf6iWwz45Odf9c/J/qnpEVU8AKwAFurneGwL8oap7gRCghqr+W1VTVHU78F9gWD7EYMxZLFGYoug6VQ0AugPNOZ0AjgIZwEXZfOYi4JDr+eEc9snJue6fk92ZT9TpE14ADHe9NAKY53p+MVBHRI5lPoCngFr5EIMxZ7FEYYosVf0FmA1Mdm0nAn8AN2az+004A9gAy4B+IlLezVP9AASKSHAu+yQC5bJs184u5DO25wNDRORinC6pT12v7wZ2qGrlLI8AVb3azXiNOSeWKExR9wbQR0Tau7afAG5z3coaICJVROQFoAvwvGufuThfxp+KSHMRKSEi1UTkKRE568tYVbcC7wDzRaS7iJQSkTIiMkxEnnDtFgVcLyLlRKQxcEdegavqaiAWmAl8p6rHXG+FA8dF5HERKSsifiLSWkRCzvXiGOMOSxSmSFPVWOADYIJr+1egH3A9zrjCLpxbaC93feGjqidxBrQ3Ad8Dx3G+nKsDYTmc6j5gKjANOAb8DQzGGXQGeB1IAQ4AczjdjZSX+a5YQrP8TOnAQJzbf3fgdJnNBCq5eUxjzondHmuMMSZX1qIwxhiTK48lChF5X0QOisi6HN4XEXnLVRphjYhc4qlYjDHGnD9Ptihm45Q/yMlVQBPXYwzwrgdjMcYYc548lihUdTlwJJddBgEfqONPoLKI5Me96MYYY/KRN4uP1SXLBCMgxvXaWTNcRWQMTquD8uXLd2zevHmBBGiMMYVVWoZyLCkF9u2navxhVqseUtUa53MsbyYKyea1bG/BUtUZwAyA4OBgjYyM9GRcxhhTKKkq4TuOEBoezTdr9kGGclfcOm46vJHGn8zZdb7H9WaiiAHqZdkOBPZ6KRZjjCm0jiWlsHBlDPPDo4ndfYDnfnmfa1s1I3DyizSr7ap0L3PO+/jeTBSLgfEisgCnPEGcquZHYTVjjCnyVJXIXUcJDYvmq7X7SEnLYOyRv7j/szcoc+wIMqgL1A7Il3N5LFGIyHycomzVRSQGp4JnSQBVnQ58DVyNUwI6CRjtqViMMaaoiEtK5bPVMYSGRbP1YAIBpf25vXFZ7v70TSp9+QW0bw9Lv4VL8m/GgccShaoOz+N9BcZ56vzGGFNUqCqroo8SGrabL9fs5WRaBu0CK/HKDW0Y2K4O5dZEwbil8OKL8OijULJkvp7fllw0xhgfFXcilS9W72F+eDSb9sdTvpQfQzoGMrxTEK3TjsGSxRAyHoKDIToaqlXzSByWKIwxxoeoKqt3H2N+WDRL1uwlOTWDNnUr8X/Xt+HadnUoX7IEvPsuPOEqTHzDDXDRRR5LEmCJwhhjfMLx5FQWrd7DvDCn9VCulB+DOwQyolMQbQJdhYE3b4Y774Rff4V+/eC995wk4WGWKIwxxktUlTUxcYSGRbP4r72cSE2nVZ2KvDi4NYPa16VC6Sxf0UlJcPnlkJ4Os2fDyJEg2U1Hy3+WKIwxpoAlnExjUdQeQsOiWb/3OGVL+nFtuzqM6BxE28BKSNYEsGULNGkC5crB3LnOXU21s1sg0XMsURhjTAFZGxNHaPguFkXtJSklnea1A5g0qBWDOtSlYpkz7lRKToZJk+CVV5wWxC23QP/c6qx6jiUKY4zxoMSTaSz+ay+hYdGs3RNHmZIlGNjWaT20r1f5n62HTL/9Bnfc4YxJjB4N11xT8IFnYYnCGGM8YN2eOOaHR7Moai8JJ9NoViuA569txXUd6lKpbC7zHCZNgokTISgIvvsO+vYtuKBzYInCGGPySVJKGktcrYe/YuIo7V+CAa7WwyVBObQeMqk6g9Pt28O99zqT5ypUKLDYc2OJwhhjLtDGfccJDYvmi9V7iD+ZRpOaFZg4sCXXdwikUrk8ZkkfOQIPPgiNG8OECTBwoPPwIZYojDHmPJxISWfJmr3MD49mdfQxSvmX4Jo2FzGicxDBF1fJvfWQaeFCGDfOSRYTJng+6PNkicIYY87B5v3xhIbt4rPVe4hPTqNRjfJMGNCS6zvUpUr5Uu4dZN8+GD8ePvsMOnaEpUuhXTvPBn4BLFEYY0weklPT+WrNPkLDo1m56yil/EpwVZvajOgURKcGVd1rPWS1d68zUP3KK/DQQ+Dv21/Fvh2dMcZ40dYD8cwLi+azVTEcT06jYfXyPH11C27oGEhVd1sPmXbuhCVLnIHqjh1h926oUsUjcec3SxTGGJNFcmo636zbR2hYNBE7j1LST+jf+iJGdAri0obn0XpIT4dp0+Cpp6BECbjxRmdmdSFJEmCJwhhjANh2MIH54dF8uiqGY0mp1K9Wjievas6QjoFUq1D6/A66caNTxO/3351Z1e+9V+DlN/KDJQpjTLF1Mi2db9ftZ15YNOE7juBfQujXqjYjOgfRpWE1SpS4gKJ7SUlwxRWQkQEffOCU4CigIn75zRKFMabY2R7rtB4WrozhaFIqQVXL8Xh/p/VQI+A8Ww+ZNm2CZs2cIn7z5jl3M9WqlT+Be4klCmNMsZCSlsF36/cTGhbNH9sP419C6NOyFiM6B9G1UfULaz0AnDgBzz0HkyfDnDlOC8IHym/kB0sUxpgibeehxFOth8OJKQRWKcuj/ZpxY3AgNQPK5M9Jli93xiK2bnX+O2BA/hzXR1iiMMYUOSlpGXy/4QCh4bv4bdth/EoIvVvUZETni+nWOB9aD1k9/7zTkmjQAJYtg1698u/YPsIShTGmyIg+nERoeDQLV+7mUEIKdSuX5eE+TbkppB61KuZT6yFTZhG/4GCnVtOkSVC+fP6ew0dYojDGFGqp6Rks23CA0PBoVmw9RAmBXi2csYcrmtTALz9bDwCHDjmJoUkTePZZZ60IL68X4WmWKIwxhdLuI0ksiIjm48gYYuNPUqdSGR7s3ZShIfWoXSmfWw/gtCA++cSp0XT0qLNmRDFhicIYU2ikpWewbONB5odHs3xrLAL0aFaTEZ2D6N6sZv63HjLt3Qv33AOLFjldTcuWQdu2njmXD7JEYYzxeTFHk/goYjcfRezmYPxJalcsw709mzAspB51Kpf1fAD798OPP8Krr8IDD/h8Eb/8Vrx+WmNMoZGWnsFPm2MJDdvFz1tiAejetAYvdr6YHs1q4O9XwrMBbN8Oixc7ieGSSyA6GipX9uw5fZQlCmOMT9l77AQLInbzccRu9h9PpmZAacb3aMzQkHoEVinn+QDS0+Gtt+Dpp6FkSRg2zKnPVEyTBFiiMMb4gPQM5efNBwkNi+anzQdR4IomNXh+UCt6Na/p+dZDpvXr4Y47ICzMuZNp+vRCWcQvv1miMMZ4zf64ZNfYQzR745KpEVCau7s3YlhIEPWqFkDrIaukJLjySmduRGio05IopEX88pslCmNMgUrPUJZviWVeWDQ/bjpAhkK3JtWZMKAlvVvWomRBtR4ybdgALVo4RfwWLHCK+NWoUbAx+DhLFMaYAnHgeDIfR+xmQcRu9hw7QfUKpbjrykYMDwkiqFoBtx7AaUFMnAhTpsDs2XDrrdC7d8HHUQhYojDGeExGhrJi2yFCw3axbONB0jOUro2r8dTVLejTshal/Au49ZDp55/hX/+Cbdvgrrvg2mu9E0chYYnCGJPvDsYn80lkDPPDo4k5eoJq5UtxZ7cGDAsJokF1L9dDmjgR/v1vaNTImRvRo4d34ykELFEYY/JFRoby29+HCA2L5vsNB0jLULo0rMbj/ZvTt1UtSvv7eTfAzCJ+nTrBww87yaKcF7q8CiGPJgoR6Q+8CfgBM1X15TPerwR8CAS5YpmsqrM8GZMxJn/Fxp9k4Uqn9RB9JIkq5Uoyumt9hncKomGNCt4OD2Jj4f77nVXnJk4sFkX88pvHEoWI+AHTgD5ADBAhIotVdUOW3cYBG1R1oIjUADaLyDxVTfFUXMaYC5eRofyx/TChYdEs3bCf1HSlc4OqPNy3Kf1a1aZMSS+3HsBpQcyfD/fdB8ePO+tGmPPiyRZFJ2Cbqm4HEJEFwCAga6JQIEBEBKgAHAHSPBiTMeYCHE443XrYeTiJyuVKMrKL03poXNMHWg+ZYmLg7rvhyy+hc2f43/+gVStvR1VoeTJR1AV2Z9mOATqfsc9UYDGwFwgAhqpqxpkHEpExwBiAoKAgjwRrjMmeqvLn9iOEhkfz3br9pKRnEFK/Cvf3bsJVrS/yjdbDmWJjneVJp0xxWhR+PhhjIeLJRJHdlEY9Y7sfEAX0BBoB34vIClU9/o8Pqc4AZgAEBwefeQxjjAccSUzhU1frYfuhRCqW8efmS4MY3imIprUCvB3e2bZtgyVLnEWFOnSA3buhYkVvR1UkeDJRxAD1smwH4rQcshoNvKyqCmwTkR1AcyDcg3EZY3KgqoTvcFoP36x1Wg8dL67Caz0ac01bH209pKXBG2/AhAlQujSMGAG1almSyEeeTBQRQBMRaQDsAYYBI87YJxroBawQkVpAM2C7B2MyxmTjWFLKqbGHv2MTCSjjz/BO9RjR+WKa1fbB1kOmtWudIn4REc6kuXfecZKEyVceSxSqmiYi44HvcG6PfV9V14vIWNf704FJwGwRWYvTVfW4qh7yVEzGmNNUlchdRwkNi+artftIScugQ1BlXh3SlgFt61C2lA+2HrJKSnImy5Uo4dRouukmK+LnIeL0+hQewcHBGhkZ6e0wjCm04pJS+Wx1DKFh0Ww9mEBAaX+u61CX4Z2CaFmnEHTXrFvn3MEkAj/84BTxq17d21H5PBFZqarB5/NZm5ltTDGgqqyKPkpo2G6+XLOXk2kZtAusxCs3tGFguzqUK1UIvgoSE51xiDfegDlznCJ+vXp5O6pioRD8dhhjzlfciVS+WL2H+eHRbNofT4XS/gzpGMjwTkG0rlvJ2+G574cfnCJ+O3bAPffAoEHejqhYsURhTBGjqkTtPkZoWDRL1uwlOTWDNnUr8X/Xt+HadnUoX7qQ/bOfMAFeeAGaNIFffoErrvB2RMVOIfuNMcbk5HhyKotW72FemNN6KFfKj8EdAhnRKYg2gYWo9ZApI8MZqL7sMnjsMXjuOShb1ttRFUuWKIwpxFSVNTFxhIZFs/ivvZxITadVnYq8OLg1g9rXpUJhaz0AHDzozKZu1sypz3TVVc7DeE0h/C0yxiScTGNR1B5Cw6JZv/c4ZUv6cW27OozoHETbwEpIYbxNVBXmzXMqvSYkOGXAjU+wRGFMIbI2Jo7Q8F0sitpLUko6zWsHMGlQKwZ1qEvFMiW9Hd75270bxo6Fr7+GLl1g5kxo2dLbURkXSxTG+LjEk2ks/msvoWHRrN0TR5mSJRjY1mk9tK9XuXC2Hs50+DD89hu8+SaMG2dF/HyMJQpjfNS6PXHMD49mUdReEk6m0axWAM9f24rrOtSlUtlC3HrItGULLF4MjzwC7ds7rYoAHy4XUoxZojDGhySlpLHE1Xr4KyaO0v4lGOBqPVwSVERaD2lp8NprzmpzZcs6E+dq1bIk4cMsURjjAzbuO05oWDRfrN5D/Mk0mtSswMSBLbm+QyCVyhWB1kOmv/6C22+HVatg8GCYNs2K+BUCliiM8ZITKeksWbOX+eHRrI4+Rin/ElzT5iJGdA4i+OIqRaP1kFVSklNyw98fFi6EG27wdkTGTZYojClgm/fHExq2i89W7yE+OY1GNcozYUBLru9QlyrlS3k7vPy3Zg20aQPlysEnnzhF/KpW9XZU5hxYojCmACSnpvPVmn2EhkezctdRSvmV4Ko2tRnRKYhODaoWvdYDOHMhnn4a3n4bZs+GkSOdsuCm0LFEYYwHbT0QT2h4NJ+t2kPciVQaVi/P01e34IaOgVQtiq2HTN9/D2PGwM6dMH68Mx5hCi1LFMbks+TUdL5Zt4/QsGgidh6lpJ/Qv/VFjOgUxKUNi2jrIaunn4aXXnJKcKxYAZdf7u2IzAVyO1GISHlVTfRkMMYUZtsOJjA/PJpPV8VwLCmV+tXK8eRVzRnSMZBqFUp7OzzPyyzid/nl8OST8OyzUKaMt6My+SDPRCEilwEzgQpAkIi0A+5S1Xs8HZwxvu5kWjrfrtvPvLBownccwb+E0K9VbUZ0DqJLw2qUKFHEWw8A+/c73UstWzr1mayIX5HjTovidaAfsBhAVf8SESsIb4q17bFO62HhyhiOJqUSVLUcj/d3Wg81AopB6wGcIn5z5sBDDzm3vl56qbcjMh7iVteTqu4+o1813TPhGOO7UtIy+G79fkLDovlj+2H8Swh9WtZiROcgujaqXjxaD5l27XIGq5cudbqaZs50xiRMkeROotjt6n5SESkF3Ads9GxYxviOnYcST7UeDiemEFilLI/2a8aNwYHUDCimffDHjkFEBEydCnff7YxNmCLLnUQxFngTqAvEAEsBG58wRVpKWgbfbzhAaPguftt2GL8SQu8WNRnR+WK6NS5mrYdMmzc7RfwefdSZNBcdDRUqeDsqUwDcSRTNVPXmrC+ISFfgN8+EZIz3RB9OIjQ8moUrd3MoIYW6lcvycJ+m3BRSj1oVi2nrITUVJk92VpsrXx5uuw1q1rQkUYy4kyjeBi5x4zVjCqXU9AyWbThAaHg0K7YeooRArxbO2MMVTWrgVxxbD5lWr4Y77nD+O2SI09VUs6a3ozIFLMdEISJdgMuAGiLyUJa3KgK2qogp9HYfSWJBRDQfR8YQG3+SOpXK8GDvpgwNqUftSsW09ZBVUhL06QMlS8Knn8L113s7IuMlubUoSuHMnfAHshaKPw4M8WRQxnhKWnoGyzYeZH54NMu3xiJAj2Y1GdE5iO7Nahbv1kOm1audhYTKlXOqvLZrB1WqeDsq40U5JgpV/QX4RURmq+quAozJmHwXczSJjyJ281HEbg7Gn6R2xTLc27MJw0LqUadyWW+H5xvi450Z1dOmOfMjRo6E7t29HZXxAe6MUSSJyKtAK+BUe1xVe3osKmPyQVp6Bj9tjiU0bBc/b4kFoHvTGrzY+WJ6NKuBv5/d0nnKt9/CXXc5y5Hef791M5l/cCdRzAM+Agbg3Cp7GxDryaCMuRB7j5041XrYfzyZmgGlGd+jMUND6hFYpZy3w/M9Tz4JL78MLVrAb79Bly7ejsj4GHcSRTVV/Z+I3J+lO+oXTwdmzLlIz1B+3nyQ0LBoftp8EAWuaFKD5we1olfzmtZ6yE56Ovj5Od1L/v7wzDNQupiUHzHnxJ1Eker67z4RuQbYCwR6LiRj3Lc/LtnVeohmb1wyNQJKc3f3RgwLCaJeVWs9ZGvfPhg3Dlq1gkmToF8/52FMDtxJFC+ISCXgYZz5ExWBBzwZlDG5Sc9Qlm+JZV5YND9uOkCGQrcm1ZkwoCW9W9aipLUesqfqrDT30EOQnGzrRBi35ZkoVPVL19M4oAecmpltTIE6cDyZjyN2syBiN3uOnaB6hVLcdWUjhocEEVTNWg+52rkT/vUvWLYMunVzivg1bertqEwhkduEOz/gJpwaT9+q6joRGQA8BZQFOhRMiKY4y8hQVmw7RGjYLpZtPEh6htK1cTWeuroFfVrWopS/tR7cEhcHq1bBO+84dzdZET9zDnJrUfwPqAeEA2+JyC6gC/CEqn7hzsFFpD9OQUE/YKaqvpzNPt2BN4CSwCFVvdL98E1RdTA+mU8iY5gfHk3M0RNUK1+KO7s1YHhIEPWrl/d2eIXDhg1OEb8nnjhdxK+8XTtz7nJLFMFAW1XNEJEywCGgsarud+fArhbJNKAPTtXZCBFZrKobsuxTGXgH6K+q0SJiRWSKsYwM5be/DxEaFs33Gw6QlqF0aViNx/s3p2+rWpT2t8oxbklJgf/8xxmoDgiA22936jNZkjDnKbdEkaKqGQCqmiwiW9xNEi6dgG2quh1ARBYAg4ANWfYZAXymqtGu8xw8p+hNkRAbf5KFK53WQ/SRJKqUK8norvUZ3imIhjWsQuk5iYx0ivitWQPDhsGbb1oRP3PBcksUzUVkjeu5AI1c2wKoqrbN49h1gd1ZtmOAzmfs0xQoKSI/49STelNVPzjzQCIyBhgDEBQUlMdpTWGQkaH8sf0woWHRLN2wn9R0pXODqjzctyn9WtWmTElrPZyzxETnNtcyZWDRIrj2Wm9HZIqI3BJFiws8dnbV1TSb83cEeuEMkP8hIn+q6pZ/fEh1BjADIDg4+MxjmELkcMLp1sPOw0lULleSkV2c1kPjmtZ6OC+rVjlF/MqXh88/h7ZtoXJlb0dlipDcigJeaCHAGJzB8EyBOJP1ztznkKomAokishxoB2zBFBmqyp/bjxAaHs136/aTkp5Bp/pVub93E65qfZG1Hs7X8ePOQPW7754u4nfFFd6OyhRB7ky4O18RQBMRaQDsAYbhjElktQiYKiL+OGXNOwOvezAm4wWvfLuZ6b/8TcUy/tx8aRAjOgXRpFZA3h80Ofv6a+c21717nQl0N9zg7YhMEeaxRKGqaSIyHvgO5/bY91V1vYiMdb0/XVU3isi3wBogA+cW2nWeiskUvHlhu5j+y98M7xTExIEtrfWQHx5/3LmrqWVLZ72IzmcO/RmTv9xKFCJSFghS1c3ncnBV/Rr4+ozXpp+x/Srw6rkc1xQOP20+yLOL1tOjWQ0mDWplhfkuhCpkZDhF/Hr1cgasn3rKiviZApHnv1wRGQhEAd+6ttuLyGIPx2UKufV74xg/bxXNawcwdcQlliQuxJ49cN11MHGis923Lzz/vCUJU2Dc+df7HM6ciGMAqhoF1PdUQKbw2xd3gttnR1CxbEneHxVC+dKeHAorwlThv/91upiWLoXq1b0dkSmm3PkXnKaqcSK2lrDJW3xyKqNnRZB4Mp2Fd3ehVsUyeX/InG3HDmfi3E8/OetF/Pe/0Lixt6MyxZQ7iWKdiIwA/ESkCXAf8LtnwzKFUWp6BuNCV7P1YAKzRoXQvHZFb4dUeCUkOLOr33sP7rzTivgZr3Lnt+9enPWyTwKhOOXGH/BgTKYQUlWeXbSO5VtiefG61lzRtIa3Qyp81q2Dl15ynrdp4xTxGzPGkoTxOnd+A5up6tOqGuJ6PKOqyR6PzBQq03/Zzvzw3Yzr0YhhnazMyjlJSXEGpy+5BF5/HQ66Sp6VszU2jG9wJ1FMEZFNIjJJRFp5PCJT6Hy5Zi+vfLuJge3q8HCfZt4Op3CJiICOHeG55+DGG53S4FbEz/gYd1a46yEitXEWMZohIhWBj1T1BY9HZ3xe5M4jPPTxX4TUr8KrQ9pSooTd9OC2xETo3x/KlnXWjRg40NsRGZMttzo/VXW/qr4FjMWZU/GsJ4MyhcOOQ4n864NI6lYuy4xbg23WtbsiI53Jc+XLO1Ve16+3JGF8mjsT7lqIyHMisg6YinPHU6DHIzM+7UhiCqNnhSMizBoVQpXypbwdku+Li3PqM4WEwIcfOq9dfjlUquTduIzJgzu3x84C5gN9VfXM6q+mGEpOTWfMB5HsjUtm/r8629Kk7liyBMaOhf374ZFHYMgQb0dkjNvcGaO4tCACMYVDRobyyCd/EbnrKNNGXELHi6t6OyTf9+ijMHmyc8vrF184LQpjCpEcE4WIfKyqN4nIWv654JC7K9yZIujVpZv5cs0+nryqOde0vcjb4fguVUhPB39/pzZTxYpO1ddS1kVnCp/cWhT3u/47oCACMb5vfng07/78Nzd3DmLMFQ29HY7viomBu+92Vpp78UXo08d5GFNI5TiYrar7XE/vUdVdWR/APQUTnvEVv2yJ5Zkv1tG9WQ2ev7YVVvsrGxkZTsmNli3hxx+hdm1vR2RMvnDn9tjs/hS6Kr8DMb5rw97jjJu3iqa1rGR4jrZvh549nQHrTp1g7Vq4915vR2VMvshtjOJunJZDQxFZk+WtAOA3TwdmfMP+uGRunx1BhdL+zBoVQgUrGZ69xERnVvXMmXD77WAtLlOE5PavPhT4Bvg/4Iksr8er6hGPRmV8QsLJNEbPjiDhZBqfjO1C7UpWMvwf1q51Jsw984xzR9OuXc4sa2OKmNz6EFRVdwLjgPgsD0TE7oks4tLSMxgfuootB+KZdvMltLjISoafcvIkPPusU8TvrbdOF/GzJGGKqLxaFAOAlTi3x2ZtSytgt70UUarKxMXr+XlzLC8NbsOVVjL8tD//dBYU2rABbr3VqfZarZq3ozLGo3JMFKo6wPXfBgUXjvEFM5ZvZ15YNHd3b8SIzlYy/JTERLjmGqdG09dfw1V2T4cpHtyp9dRVRMq7nt8iIlNExL49iqiv1uzj/77ZxIC2F/FoXysZDkBY2OkifkuWOEX8LEmYYsSd+xzfBZJEpB3wGLALmOvRqIxXrNx1hAc/jqLjxVWYfGM7Kxl+7JizDOmll54u4nfZZRAQ4NWwjClo7iSKNFVVYBDwpqq+iXOLrClCdh5K5F8frKROpTL8d6SVDOeLL5yJc7NnO6U3brzR2xEZ4zXu3BQfLyJPArcC3UTEDyjp2bBMQTqamMLo2RGoKrNGd6JqcS8Z/tBDziB1u3ZOV1PHjt6OyBivcidRDAVGALer6n7X+MSrng3LFJTk1HTGzI1kz7EThN7ZmQbFtWR41iJ+V1/t3Mn02GNQ0v4mMibPridV3Q/MAyqJyAAgWVU/8HhkxuMyMpRHF64hYudRXruxHcH1i+n0mOho526miROd7d694emnLUkY4+LOXU83AeHAjTjrZoeJiK26UgS89v1mlvy1l8f7N2dguzreDqfgZWTAO+9Aq1bwyy9QpxheA2Pc4E7X09NAiKoeBBCRGsAyYKEnAzOetSA8mmk//c3wTkGMvbIYzp3cts2pybRihVMCfMYMqF/f21EZ45PcSRQlMpOEy2Hcu1vK+KjlW2J5+ot1XNG0BpMGFdOS4cnJsGULzJoFt91mRfyMyYU7ieJbEfkOZ91scAa3v/ZcSMaTNu0/zj3zVtGkZgWmjehQvEqGR0U5RfwmToTWrWHnTihjhQ6NyYs7g9mPAu8BbYF2wAxVfdzTgZn8d+B4MqNnRVC+tB+zRocQUKaYDNYmJzuD08HB8O67p4v4WZIwxi25rUfRBJgMNALWAo+o6p6CCszkr8STadw+O4LjJ1L5eGwXLqpUTCqd/v67U8Rv0yani2nKFKhaTO/uMuY85daieB/4ErgBp4Ls2wUSkcl3aekZ3Dt/NZv2xzP15ktoVaeSt0MqGImJMHAgJCXBt986s6wtSRhzznIbowhQ1f+6nm8WkVUFEZDJX6rKc0vW8+Omg7w4uDU9mtX0dkie98cf0LmzU8Tvyy+d8Qirz2TMecutRVFGRDqIyCUicglQ9oztPIlIfxHZLCLbROSJXPYLEZF0m5+R/2au2MGHf0Zz15UNubnzxd4Ox7OOHnVueb3sMpjrqlvZpYslCWMuUG4tin3AlCzb+7NsK9AztwO7akJNA/oAMUCEiCxW1Q3Z7PcK8N25hW7y8s3afbz0zUauaXMRj/dr7u1wPOuzz2DcOIiNhSefhKFDvR2RMUVGbgsX9bjAY3cCtqnqdgARWYBTgXbDGfvdC3wKhFzg+UwWq6KP8sBHUXSoV5nXbiriJcMffBDeeAPat3cWFOrQwdsRGVOkuDOP4nzVBXZn2Y4BOmfdQUTqAoNxWic5JgoRGQOMAQgKsjWT8rLrcCL/mhNJ7aJcMjxrEb8BA6BmTXjkEavPZIwHeHK2VXZ/wuoZ228Aj6tqem4HUtUZqhqsqsE1atj6zbk5luSUDE9XZdaoEKpVKO3tkPLfzp3Qvz9MmOBs9+rldDdZkjDGIzyZKGKAelm2A4G9Z+wTDCwQkZ3AEOAdEbnOgzEVaSfT0hkzdyUxR07w35HBNKxRwdsh5a+MDHj7becupt9/h4uL+OC8MT4iz64ncQoB3Qw0VNV/u9ajqK2q4Xl8NAJoIiINgD3AMJx1LU5R1QZZzjMb+FJVvzinn8AAzm2wjy1cQ/iOI7w5rD0hRa1k+NatMHo0/Pab05qYPt0ShTEFxJ0WxTtAF2C4azse526mXKlqGjAe526mjcDHqrpeRMaKyNjzjNfkYMr3W1gUtZdH+zVjUPu63g4n/6WkwN9/wwcfOAPWliSMKTDuDGZ3VtVLRGQ1gKoeFRG31spU1a85o4Cgqk7PYd9R7hzTnO3jyN28/eM2hgbX457ujbwdTv5Zvdop4vfcc86aETt3QukiOOZijI9zp0WR6prroHBqPYoMj0Zl3Pbr1kM89dlaujWpzguDWxeNkuHJyc7gdEgIvPeeMzcCLEkY4yXuJIq3gM+BmiLyIvAr8JJHozJu2bw/nrs/XEnjmhWYdvMllCwKJcN//RXatYOXX4aRI2HDBrA73Yzxqjy7nlR1noisBHrh3PJ6napu9HhkJlcHjyczelY4ZUv58f6oECoWhZLhCQkwaBBUrAhLlzorzxljvM6du56CgCRgSdbXVDXak4GZnCWeTOP2OREcO5HKx3d1oU7lQl4y/NdfnfpMFSrAV185t79WKGK39hpTiLnTV/EVTrnxr4AfgO3AN54MyuQsPUO5b/5qNuw9ztQRHWhdtxCXDD982Ole6tbtdBG/Sy+1JGGMj3Gn66lN1m1X5di7PBaRyZGq8vyS9fyw6SCTBrWiZ/Na3g7p/KjCwoUwfjwcOeLMsB42zNtRGWNycM61nlR1lYhYAT8v+N+vO/jgj12MuaIht3ap7+1wzt+DD8Kbb0LHjs5YRLt23o7IGJMLd8YoHsqyWQK4BIj1WEQmW9+u28+LX2/kqta1eaJ/ISwZrgppaU49pmuvhTp14KGHnKJ+xhif5s4YRUCWR2mcsYpBngzK/NPq6KM88NFq2terzOtD2xe+kuE7dkDfvqeL+PXsCY89ZknCmEIi13+prol2FVT10QKKx5wh+nASd86JpGZAISwZnp4OU6fCU0+Bnx/ceKO3IzLGnIccE4WI+KtqmrvLnpr8F5eUyujZ4aRlKLNGh1C9MJUM37IFRo1y1q++6ipnhnW9enl+zBjje3JrUYTjjEdEichi4BMgMfNNVf3Mw7EVayfT0rnrw0h2HznB3Ds60aiwlQxPS4Ndu+DDD2HECCgKpUWMKabc6SSuChzGWYVOcWZnK2CJwkNUlSc+Xcuf252S4Z0bVvN2SO6JjHSK+E2aBC1bwvbtVp/JmCIgt0RR03XH0zpOJ4hMZ65UZ/LR68u28vnqPTzSt2nhKBl+4gRMnAivvQa1a8N99zn1mSxJGFMk5HbXkx9QwfUIyPI882E8YOHKGN76YSs3BQcyrkdjb4eTt19+gbZt4dVX4Y47YP16K+JnTBGTW4tin6r+u8AiMfy27RBPfLqGyxtX58XBbXy/ZHhCAlx/PVSuDD/84Nz2aowpcnJLFD7+LVW0bDkQz9gPV9KwRnneucXHS4avWAFduzo1mb75xllUqHx5b0dljPGQ3L6NehVYFMXcwfhkRs+KoExJP2aN7uS7JcMPHYJbboErrjhdxK9TJ0sSxhRxObYoVPVIQQZSXCWlpHHnnEiOJKbw8V1dqOuLJcNV4eOP4d574ehRZ+DaivgZU2xYDQUvckqGR7FuTxwzbg2mTaCPlgy//354+21nadIffoA2bfL+jDGmyLBE4UWTvtzAso0H+PegVvRu6WMlw1UhNRVKlYLBg+Hii+GBB5xSHMaYYsWHR0yLtvd/3cHs33dyx+UNGOlrJcP//ht69YJnnnG2e/SAhx+2JGFMMWWJwguWrt/PpK820K9VLZ66uoW3wzktPR2mTHG6llauhGbNvB2RMcYHWNdTAftr9zHuW7CatoGVeWNoB/x8pWT4pk1w220QHg4DB8K770LdQjAr3BjjcZYoCtDuI0ncMSeCGgGlmTkymLKlfKgrJyMD9u6F+fNh6FAr4meMOcUSRQGJO5HK6NkRpKRlsGDMpdQI8IE6SOHhThG/F190ivj9/bczeG2MMVnYGEUBSEnLYOzclew6nMh7twbTuGaAdwNKSoJHHoEuXWDOHIh1rWxrScIYkw1LFB6mqjzx2Rr+2H6Y/wxpS5dGXi4Z/tNPzmD1a6/Bv/5lRfyMMXmyricPe/OHrXy2ag8P9WnK4A6B3g0mIcFZjrRyZSdhdO/u3XiMMYWCtSg86NOVMbyxbCtDOgZyb08vlgz/+WdnsDqziN+aNZYkjDFus0ThIb//fYgnPlvDZY2q8ZK3SobHxsLw4c6EuQ8/dF4LCYFy5Qo+FmNMoWVdTx6w9UA8d81dSf1q5Xn3lo6U8i/gfKzq3OZ6330QH+8sTWpF/Iwx58kSRT6LjT/J6NmZJcNDqFTWCyXD770Xpk2DSy+F//3PufXVGGPOkyWKfHQiJZ0750RwOCGFj+66lMAqBdjFk5EBaWnOLa5DhkDjxk7CsPpMxpgL5NE+ERHpLyKbRWSbiDyRzfs3i8ga1+N3EWnnyXg8KT1DuX/BatbsieOt4R1oG1i54E6+dauzDOnTTzvb3btbpVdjTL7xWKIQET9gGnAV0BIYLiJn9oHsAK5U1bbAJGCGp+LxtBe/2sjSDQeYOKAlfQqqZHhaGkyeDG3bQlQUtPChAoPGmCLDk11PnYBtqrodQEQWAIOADZk7qOrvWfb/E/DyRIPzM/u3Hbz/2w5Gd63PqK4NCuakGzfCyJEQGQmDBsE770CdOgVzbmNMseLJrqe6wO4s2zGu13JyB/BNdm+IyBgRiRSRyNjMchM+4vsNB/j3lxvo07IWz1xTwIPGBw7ARx/B559bkjDGeIwnE0V2Ewc02x1FeuAkiseze19VZ6hqsKoG1/ChchNrYo5x3/zVtKlbiTeHtfd8yfA//4Qnn3Set2jhFPG76Sar9GqM8ShPJooYoF6W7UBg75k7iUhbYCYwSFUPezCefBVzNInbZ0dSrUIpZt4WQrlSHuzFS0yEBx+Eyy6DefNOF/Er6YVbb40xxY4nE0UE0EREGohIKWAYsDjrDiISBHwG3KqqWzwYS76KO5HK7bMjOJmWzqxRIZ4tGb5sGbRuDW+8AffcY0X8jDEFzmN/BqtqmoiMB74D/ID3VXW9iIx1vT8deBaoBrzjKnGRpqrBnoopP6SkZXD3hyvZcSiROaM70aSWB0uGJyQ4M6qrVoXly6FbN8+dyxhjcuDRCXeq+jXw9RmvTc/y/E7gTk/GkJ9Ulac+X8vvfx/mtRvbcVnj6p450Y8/wpVXOkX8vvvOmVldtqxnzmWMMXmwooDn4O0ft7FwZQwP9G7CDR09cCfvgQPO4HSvXqeL+HXsaEnCGONVlijc9PnqGKZ8v4XrL6nL/b2a5O/BVWHuXKflkLk06YgR+XsOY4w5T1bryQ1/bj/MYwvX0KVhNV6+vm3+lwwfNw7efddZmvR//7MZ1sYYn2KJIg/bDsYz5oNILq5Wnun5WTI8IwNSU6F0aRg61EkO99xj9ZmMMT7Hup5ycSjBKRleyr8Es0aFUKlcPs1b2LzZGazOLOJ35ZVW6dUY47MsUeTAKRkeSWz8SWbeFkK9qvlQMjw1FV5+Gdq1g3XroE2bCz+mMcZ4mHU9ZSM9Q3ngo9X8FXOM6bd0pH29yhd+0PXr4dZbYfVquP56Z2Gh2rUv/LjGGONhliiy8X9fb+S79Qd4dkBL+rXKpy9zPz84cgQWLoQbbsifYxpjTAGwrqczfPDHTmb+uoNRl9Xn9ssvsGT477/D4646h82bw7ZtliSMMYWOJYosfth4gOcWr6d3i5pMGHABJcMTEuC+++Dyy50y4IcOOa/7WwPOGFP4WKJwWRsTx/jQ1bSqU4m3hnc4/5LhS5c6RfymToXx451B6+oeKvVhjDEFwP7EBfYcO8HtcyKoWr4U/xsVfP4lwxMS4OaboVo1WLECunbN30CNMcYLin2L4nhyKrfPiiA5NZ1Zo0OoGVDm3A/y/feQnu4U8Vu61Fm/2pKEMaaIKNaJIjU9g3s+XMXfsQlMv6UjTc+1ZPi+fc7gdN++zoJCAB06QJnzSDbGGOOjim2iUFWe/nwtv247xP9d34au51IyXBVmz3aK+H31lTOJzor4GWOKqGI7RjHtp218HBnDfT0bc2Nwvbw/kNXdd8N77zl3Nc2cCc2aeSZIU6ilpqYSExNDcnKyt0MxxUiZMmUIDAykZD4ulVwsE8WiqD1MXrqFwR3q8mCfpu59KGsRvxEjoG1bGDsWShTbRpnJQ0xMDAEBAdSvXz//Kw4bkw1V5fDhw8TExNCgwQXOA8ui2H3LhW0/zKOfrKFzg6q8fEMb9/4Bb9zoLEP61FPO9hVXOJVeLUmYXCQnJ1OtWjVLEqbAiAjVqlXL91Zssfqm+zs2gTFzV1Kvallm3BpMaf88qrWmpsJLL0H79rBpkzNQbcw5sCRhCponfueKTdfT4YSTjJ4VgX8JYdaoTnmXDF+/Hm65xbnV9cYb4e23oVatAonVGGN8SbFoUSSnpnPnB5EcOJ7MzNuCCarmRslwf3+Ii4PPPoOPP7YkYQolPz8/2rdvT+vWrRk4cCDHjh079d769evp2bMnTZs2pUmTJkyaNAlVPfX+N998Q3BwMC1atKB58+Y88sgjXvgJcrd69WruvPNOb4eRo5MnTzJ06FAaN25M586d2blzZ7b7paSkMGbMGJo2bUrz5s359NNPAZg+fTpt2rShffv2XH755WzYsAGA2NhY+vfvX1A/hjP4UZgeHTt21HORnp6hY+dGav0nvtRv1u7Nfefly1Uffvj0dmrqOZ3LmKw2bNjg7RC0fPnyp56PHDlSX3jhBVVVTUpK0oYNG+p3332nqqqJiYnav39/nTp1qqqqrl27Vhs2bKgbN25UVdXU1FSdNm1avsaWmg//voYMGaJRUVEFes5zMW3aNL3rrrtUVXX+/Pl60003Zbvfs88+q08//bSqqqanp2tsbKyqqsbFxZ3aZ9GiRdqvX79T26NGjdJff/012+Nl97sHROp5fu8W+a6nl7/dxDfr9vPMNS3o3/qi7HeKj4cnnoB33oEGDZzn1atbET+Tb55fsp4Ne4/n6zFb1qnIxIGt3N6/S5curFmzBoDQ0FC6du1K3759AShXrhxTp06le/fujBs3jv/85z88/fTTNG/eHAB/f3/uueees46ZkJDAvffeS2RkJCLCxIkTueGGG6hQoQIJCQkALFy4kC+//JLZs2czatQoqlatyurVq2nfvj2ff/45UVFRVK5cGYDGjRvz22+/UaJECcaOHUt0dDQAb7zxBl3PqHYQHx/PmjVraNeuHQDh4eE88MADnDhxgrJlyzJr1iyaNWvG7Nmz+eqrr0hOTiYxMZElS5Zw7733snbtWtLS0njuuecYNGgQO3fu5NZbbyUxMRGAqVOnctlll7l9fbOzaNEinnvuOQCGDBnC+PHjUdWzxhHef/99Nm3aBECJEiWo7qoPV7FixVP7JCYm/uNz1113HfPmzTvrunhCkf4mnPvnLmYs387ILhdzR04lw7/5Bu66C2Ji4IEH4IUXoHz5Ao3TGE9LT0/nhx9+4I477gCcbqeOHTv+Y59GjRqRkJDA8ePHWbduHQ8//HCex500aRKVKlVi7dq1ABw9ejTPz2zZsoVly5bh5+dHRkYGn3/+OaNHjyYsLIz69etTq1YtRowYwYMPPsjll19OdHQ0/fr1Y+PGjf84TmRkJK1btz613bx5c5YvX46/vz/Lli3jqaeeOtWF88cff7BmzRqqVq3KU089Rc+ePXn//fc5duwYnTp1onfv3tSsWZPvv/+eMmXKsHXrVoYPH05kZORZ8Xfr1o34+PizXp88eTK9e/f+x2t79uyhXj1nnpa/vz+VKlXi8OHDpxIBcKo7cMKECfz88880atSIqVOnUsvV3T1t2jSmTJlCSkoKP/7446nPBQcH88wzz+R5vfNDkU0UP206yMRF6+jVvCbPDmiZ/Z0A8fEwciTUrOmsHXHppQUfqCkWzuUv//x04sQJ2rdvz86dO+nYsSN9+vQByPav2kznctfMsmXLWLBgwantKlWq5PmZG2+8ET/X+vBDhw7l3//+N6NHj2bBggUMHTr01HEz++MBjh8/Tnx8PAEBp8vs7Nu3jxo1apzajouL47bbbmPr1q2ICKmpqafe69OnD1WrVgVg6dKlLF68mMmTJwPObczR0dHUqVOH8ePHExUVhZ+fH1u2bMk2/hUrVuT5M2bSLGM+mc68vmlpacTExNC1a1emTJnClClTeOSRR5g7dy4A48aNY9y4cYSGhvLCCy8wZ84cAGrWrMnevXvdjuVCFMnB7HV74hgXuoqWdSry1vAO+Ptl+TFV4dtvnSJ+AQGwbBmsWmVJwhRJZcuWJSoqil27dpGSksK0adMAaNWq1Vl/LW/fvp0KFSoQEBBAq1atWLlyZZ7HzynhZH3tzHv6y2dpsXfp0oVt27YRGxvLF198wfXXXw9ARkYGf/zxB1FRUURFRbFnz55/JInMny3rsSdMmECPHj1Yt24dS5Ys+cd7Wc+pqnz66aenjh0dHU2LFi14/fXXqVWrFn/99ReRkZGkpKRk+zN369aN9u3bn/VYtmzZWfsGBgaye/duwEkIcXFxpxJWpmrVqlGuXDkGDx4MOIl01apVZx1r2LBhfPHFF/+4rmXLls02xvxW5BLF3mMnuH12BJXLluT920IoXzpLo2nfPme96quuOl3Er107Z7a1MUVYpUqVeOutt5g8eTKpqancfPPN/Prrr6e+3E6cOMF9993HY489BsCjjz7KSy+9dOqv6oyMDKZMmXLWcfv27cvUqVNPbWd2PdWqVYuNGzee6lrKiYgwePBgHnroIVq0aEG1atWyPW5UVNRZn23RogXbtm07tR0XF0fdunUBmD17do7n7NevH2+//fapv/ZXr1596vMXXXQRJUqUYO7cuaSnp2f7+RUrVpxKMlkfZ3Y7AVx77bWnWgALFy6kZ8+eZyVWEWHgwIH8/PPPAPzwww+0bOksnLZ169ZT+3311Vc0adLk1PaWLVv+0fXmSUUqUcQnp3L77AhOpKTz/ugQalZ0VXFVhfffhxYtnNbEf/5jRfxMsdOhQwfatWvHggULKFu2LIsWLeKFF16gWbNmtGnThpCQEMaPHw9A27ZteeONNxg+fDgtWrSgdevW7Nu376xjPvPMMxw9epTWrVvTrl07fvrpJwBefvllBgwYQM+ePbnoohxuInEZOnQoH3744aluJ4C33nqLyMhI2rZtS8uWLZk+ffpZn2vevDlxcXGnxgsee+wxnnzySbp27Zrjlzw4LY/U1FTatm1L69atmTBhAgD33HMPc+bM4dJLL2XLli3/aIWcrzvuuIPDhw/TuHFjpkyZwssvv3zqvfbt2596/sorr/Dcc8/Rtm1b5s6dy2uvvQY4A+qtWrWiffv2TJky5VTSAfjpp5+45pprLjhGd0h2fWi+LDg4WLMbYEpNz+D22RH88fdhZo/uxOVNslSDvesumDHDKb0xcyZkycrGeMrGjRtp0aKFt8Mo0l5//XUCAgJ8ei6Fp1xxxRUsWrQo23Gh7H73RGSlqgafz7mKRItCVZnwxTpWbD3ES4PbOEkiPR0y+yhvuQXefRd++smShDFFyN13303pYth1HBsby0MPPeTWzQP5oUgkind+/psFEbsZ36MxN4XUc8pvdO16uohft25W6dWYIqhMmTLceuut3g6jwNWoUYPrrruuwM5X6L85F/+1l1e/28yg9nV4uHt9mDTJKd63bRuEhHg7PFPMFbauXVP4eeJ3rlDPo4jYeYRHPv6LTvWr8mozQUJCYO1aGDYM3noLstxjbUxBK1OmDIcPH7ZS46bAqGs9ijL5vBxzoU0U22MT+NcHkQRWLcuMkR0ptXsHJCXBokVw7bXeDs8YAgMDiYmJITY21tuhmGIkc4W7/FQoE8XhhJOMnh1B8M61TCmzi4rlujvLkW7eDH55rDFhTAEpWbJkvq4yZoy3eHSMQkT6i8hmEdkmIk9k876IyFuu99eIyCV5HVMV7nvvF8YumMzMWY9Q8buv4NAh501LEsYYk+88No9CRPyALUAfIAaIAIar6oYs+1wN3AtcDXQG3lTVzrkd9+LaQfpH0gkuSjyCPPCAM3hdzo31JYwxphi7kHkUnux66gRsU9XtACKyABgEbMiyzyDgA1et9D9FpLKIXKSqZ08BdalycA9l6jdCvv8SOueaU4wxxuQDTyaKusDuLNsxOK2GvPapC/wjUYjIGGCMa/NktR1b11kRPwCqA4e8HYSPsGtxml2L0+xanNbsfD/oyUSR3f2AZ/ZzubMPqjoDmAEgIpHn23wqauxanGbX4jS7FqfZtThNRM6ufeQmTw5mxwD1smwHAmcWT3dnH2OMMV7kyUQRATQRkQYiUgoYBiw+Y5/FwEjX3U+XAnG5jU8YY4wpeB7relLVNBEZD3wH+AHvq+p6ERnren868DXOHU/bgCRgtBuHnuGhkAsjuxan2bU4za7FaXYtTjvva1HoyowbY4wpWIW+KKAxxhjPskRhjDEmVz6bKDxR/qOwcuNa3Oy6BmtE5HcRaeeNOAtCXtciy34hIpIuIkMKMr6C5M61EJHuIhIlIutF5JeCjrGguPFvpJKILBGRv1zXwp3x0EJHRN4XkYMisi6H98/ve1NVfe6BM/j9N9AQKAX8BbQ8Y5+rgW9w5mJcCoR5O24vXovLgCqu51cV52uRZb8fcW6WGOLtuL34e1EZpxJCkGu7prfj9uK1eAp4xfW8BnAEKOXt2D1wLa4ALgHW5fD+eX1v+mqL4lT5D1VNATLLf2R1qvyHqv4JVBaR3FdxL5zyvBaq+ruqHnVt/okzH6Uocuf3Apz6YZ8CBwsyuALmzrUYAXymqtEAqlpUr4c710KBAHEWBqmAkyjSCjZMz1PV5Tg/W07O63vTVxNFTqU9znWfouBcf847cP5iKIryvBYiUhcYDEwvwLi8wZ3fi6ZAFRH5WURWisjIAouuYLlzLaYCLXAm9K4F7lfVjIIJz6ec1/emr65HkW/lP4oAt39OEemBkygu92hE3uPOtXgDeFxV04v4qnLuXAt/oCPQCygL/CEif6rqFk8HV8DcuRb9gCigJ9AI+F5EVqjqcQ/H5mvO63vTVxOFlf84za2fU0TaAjOBq1T1cAHFVtDcuRbBwAJXkqgOXC0iaar6RYFEWHDc/TdySFUTgUQRWQ60wyn/X5S4cy1GAy+r01G/TUR2AM2B8IIJ0Wec1/emr3Y9WfmP0/K8FiISBHwG3FoE/1rMKs9roaoNVLW+qtYHFgL3FMEkAe79G1kEdBMRfxEph1O9eWMBx1kQ3LkW0TgtK0SkFk4l1e0FGqVvOK/vTZ9sUajnyn8UOm5ei2eBasA7rr+k07QIVsx081oUC+5cC1XdKCLfAmuADGCmqmZ722Rh5ubvxSRgtoisxel+eVxVi1z5cRGZD3QHqotIDDARKAkX9r1pJTyMMcbkyle7nowxxvgISxTGGGNyZYnCGGNMrixRGGOMyZUlCmOMMbmyRGF8kqvya1SWR/1c9k3Ih/PNFpEdrnOtEpEu53GMmSLS0vX8qTPe+/1CY3QdJ/O6rHNVQ62cx/7tReTq/Di3Kb7s9ljjk0QkQVUr5Pe+uRxjNvClqi4Ukb7AZFVtewHHu+CY8jquiMwBtqjqi7nsPwoIVtXx+R2LKT6sRWEKBRGpICI/uP7aXysiZ1WNFZGLRGR5lr+4u7le7ysif7g++4mI5PUFvhxo7PrsQ65jrRORB1yvlReRr1xrG6wTkaGu138WkWAReRko64pjnuu9BNd/P8r6F76rJXODiPiJyKsiEiHOOgF3uXFZ/sBV0E1EOomzFslq13+buWYp/xsY6oplqCv2913nWZ3ddTTmLN6un24Pe2T3ANJxirhFAZ/jVBGo6HqvOs7M0swWcYLrvw8DT7ue+wEBrn2XA+Vdrz8OPJvN+WbjWrsCuBEIwymotxYoj1Oaej3QAbgB+G+Wz1Zy/fdnnL/eT8WUZZ/MGAcDc1zPS+FU8iwLjAGecb1eGogEGmQTZ0KWn+8ToL9ruyLg73reG/jU9XwUMDXL518CbnE9r4xT96m8t/9/28O3Hz5ZwsMY4ISqts/cEJGSwEsicgVOOYq6QC1gf5bPRADvu/b9QlWjRORKoCXwm6u8SSmcv8Sz86qIPAPE4lTh7QV8rk5RPUTkM6Ab8C0wWURewemuWnEOP9c3wFsiUhroDyxX1ROu7q62cnpFvkpAE2DHGZ8vKyJRQH1gJfB9lv3niEgTnGqgJXM4f1/gWhF5xLVdBgiiaNaAMvnEEoUpLG7GWZmso6qmishOnC+5U1R1uSuRXAPMFZFXgaPA96o63I1zPKqqCzM3RKR3djup6hYR6YhTM+f/RGSpqv7bnR9CVZNF5GecstdDgfmZpwPuVdXv8jjECVVtLyKVgC+BccBbOLWMflLVwa6B/59z+LwAN6jqZnfiNQZsjMIUHpWAg64k0QO4+MwdRORi1z7/Bf6HsyTkn0BXEckccygnIk3dPOdy4DrXZ8rjdButEJE6QJKqfghMdp3nTKmulk12FuAUY+uGU8gO13/vzvyMiDR1nTNbqhoH3Ac84vpMJWCP6+1RWXaNx+mCy/QdcK+4mlci0iGncxiTyRKFKSzmAcEiEonTutiUzT7dgSgRWY0zjvCmqsbifHHOF5E1OImjuTsnVNVVOGMX4ThjFjNVdTXQBgh3dQE9DbyQzcdnAGsyB7PPsBRnbeNl6izdCc5aIhuAVSKyDniPPFr8rlj+wimr/R+c1s1vOOMXmX4CWmYOZuO0PEq6Ylvn2jYmV3Z7rDHGmFxZi8IYY0yuLFEYY4zJlSUKY4wxubJEYYwxJleWKIwxxuTKEoUxxphcWaIwxhiTq/8HM4yKLqFg5c4AAAAASUVORK5CYII=\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "from sklearn.metrics import roc_curve, roc_auc_score\n",
    "\n",
    "# Calculate the ROC curve and ROC AUC score\n",
    "fpr, tpr, thresholds = roc_curve(y_test, y_pred_lr)\n",
    "roc_auc = roc_auc_score(y_test, y_pred_lr)\n",
    "\n",
    "# Plot the ROC curve\n",
    "plt.plot(fpr, tpr, label='ROC curve (area = %0.2f)' % roc_auc)\n",
    "plt.plot([0, 1], [0, 1], 'r--')\n",
    "plt.xlim([0, 1])\n",
    "plt.ylim([0, 1])\n",
    "plt.xlabel('False Positive Rate')\n",
    "plt.ylabel('True Positive Rate')\n",
    "plt.title('ROC Curve')\n",
    "plt.legend(loc='lower right')\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "id": "75bce015",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.ensemble import RandomForestClassifier"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 78,
   "id": "2116e95c",
   "metadata": {},
   "outputs": [],
   "source": [
    "rfc=RandomForestClassifier(class_weight='balanced')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "id": "15c715f8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<style>#sk-container-id-2 {color: black;background-color: white;}#sk-container-id-2 pre{padding: 0;}#sk-container-id-2 div.sk-toggleable {background-color: white;}#sk-container-id-2 label.sk-toggleable__label {cursor: pointer;display: block;width: 100%;margin-bottom: 0;padding: 0.3em;box-sizing: border-box;text-align: center;}#sk-container-id-2 label.sk-toggleable__label-arrow:before {content: \"▸\";float: left;margin-right: 0.25em;color: #696969;}#sk-container-id-2 label.sk-toggleable__label-arrow:hover:before {color: black;}#sk-container-id-2 div.sk-estimator:hover label.sk-toggleable__label-arrow:before {color: black;}#sk-container-id-2 div.sk-toggleable__content {max-height: 0;max-width: 0;overflow: hidden;text-align: left;background-color: #f0f8ff;}#sk-container-id-2 div.sk-toggleable__content pre {margin: 0.2em;color: black;border-radius: 0.25em;background-color: #f0f8ff;}#sk-container-id-2 input.sk-toggleable__control:checked~div.sk-toggleable__content {max-height: 200px;max-width: 100%;overflow: auto;}#sk-container-id-2 input.sk-toggleable__control:checked~label.sk-toggleable__label-arrow:before {content: \"▾\";}#sk-container-id-2 div.sk-estimator input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-2 div.sk-label input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-2 input.sk-hidden--visually {border: 0;clip: rect(1px 1px 1px 1px);clip: rect(1px, 1px, 1px, 1px);height: 1px;margin: -1px;overflow: hidden;padding: 0;position: absolute;width: 1px;}#sk-container-id-2 div.sk-estimator {font-family: monospace;background-color: #f0f8ff;border: 1px dotted black;border-radius: 0.25em;box-sizing: border-box;margin-bottom: 0.5em;}#sk-container-id-2 div.sk-estimator:hover {background-color: #d4ebff;}#sk-container-id-2 div.sk-parallel-item::after {content: \"\";width: 100%;border-bottom: 1px solid gray;flex-grow: 1;}#sk-container-id-2 div.sk-label:hover label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-2 div.sk-serial::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: 0;}#sk-container-id-2 div.sk-serial {display: flex;flex-direction: column;align-items: center;background-color: white;padding-right: 0.2em;padding-left: 0.2em;position: relative;}#sk-container-id-2 div.sk-item {position: relative;z-index: 1;}#sk-container-id-2 div.sk-parallel {display: flex;align-items: stretch;justify-content: center;background-color: white;position: relative;}#sk-container-id-2 div.sk-item::before, #sk-container-id-2 div.sk-parallel-item::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: -1;}#sk-container-id-2 div.sk-parallel-item {display: flex;flex-direction: column;z-index: 1;position: relative;background-color: white;}#sk-container-id-2 div.sk-parallel-item:first-child::after {align-self: flex-end;width: 50%;}#sk-container-id-2 div.sk-parallel-item:last-child::after {align-self: flex-start;width: 50%;}#sk-container-id-2 div.sk-parallel-item:only-child::after {width: 0;}#sk-container-id-2 div.sk-dashed-wrapped {border: 1px dashed gray;margin: 0 0.4em 0.5em 0.4em;box-sizing: border-box;padding-bottom: 0.4em;background-color: white;}#sk-container-id-2 div.sk-label label {font-family: monospace;font-weight: bold;display: inline-block;line-height: 1.2em;}#sk-container-id-2 div.sk-label-container {text-align: center;}#sk-container-id-2 div.sk-container {/* jupyter's `normalize.less` sets `[hidden] { display: none; }` but bootstrap.min.css set `[hidden] { display: none !important; }` so we also need the `!important` here to be able to override the default hidden behavior on the sphinx rendered scikit-learn.org. See: https://github.com/scikit-learn/scikit-learn/issues/21755 */display: inline-block !important;position: relative;}#sk-container-id-2 div.sk-text-repr-fallback {display: none;}</style><div id=\"sk-container-id-2\" class=\"sk-top-container\"><div class=\"sk-text-repr-fallback\"><pre>RandomForestClassifier(class_weight=&#x27;balanced&#x27;)</pre><b>In a Jupyter environment, please rerun this cell to show the HTML representation or trust the notebook. <br />On GitHub, the HTML representation is unable to render, please try loading this page with nbviewer.org.</b></div><div class=\"sk-container\" hidden><div class=\"sk-item\"><div class=\"sk-estimator sk-toggleable\"><input class=\"sk-toggleable__control sk-hidden--visually\" id=\"sk-estimator-id-2\" type=\"checkbox\" checked><label for=\"sk-estimator-id-2\" class=\"sk-toggleable__label sk-toggleable__label-arrow\">RandomForestClassifier</label><div class=\"sk-toggleable__content\"><pre>RandomForestClassifier(class_weight=&#x27;balanced&#x27;)</pre></div></div></div></div></div>"
      ],
      "text/plain": [
       "RandomForestClassifier(class_weight='balanced')"
      ]
     },
     "execution_count": 79,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "rfc.fit(x_train,y_train)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 80,
   "id": "0221a79e",
   "metadata": {},
   "outputs": [],
   "source": [
    "y_pred_rfc=rfc.predict(x_test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "id": "1cf05bfa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([1, 0, 0, ..., 0, 0, 1])"
      ]
     },
     "execution_count": 81,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "y_pred_rfc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 82,
   "id": "f7767f9c",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.871"
      ]
     },
     "execution_count": 82,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "recall_score(y_test,y_pred_rfc,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "id": "df04d2ee",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.8652246030599158"
      ]
     },
     "execution_count": 83,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "precision_score(y_test,y_pred_rfc,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 84,
   "id": "3c8d6963",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.8678966553171217"
      ]
     },
     "execution_count": 84,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "f1_score(y_test,y_pred_rfc,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "id": "629a6096",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.6798455748088652"
      ]
     },
     "execution_count": 85,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "balanced_acc = balanced_accuracy_score(y_test, y_pred_rfc)\n",
    "balanced_acc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 86,
   "id": "eb8774e5",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "from sklearn.metrics import roc_curve, roc_auc_score\n",
    "\n",
    "# Calculate the ROC curve and ROC AUC score\n",
    "fpr, tpr, thresholds = roc_curve(y_test, y_pred_rfc)\n",
    "roc_auc = roc_auc_score(y_test, y_pred_rfc)\n",
    "\n",
    "# Plot the ROC curve\n",
    "plt.plot(fpr, tpr, label='ROC curve (area = %0.2f)' % roc_auc)\n",
    "plt.plot([0, 1], [0, 1], 'r--')\n",
    "plt.xlim([0, 1])\n",
    "plt.ylim([0, 1])\n",
    "plt.xlabel('False Positive Rate')\n",
    "plt.ylabel('True Positive Rate')\n",
    "plt.title('ROC Curve')\n",
    "plt.legend(loc='lower right')\n",
    "plt.show()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 87,
   "id": "cd7e4c51",
   "metadata": {},
   "outputs": [],
   "source": [
    "import xgboost as xgb"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 88,
   "id": "7774f958",
   "metadata": {},
   "outputs": [],
   "source": [
    "smallest_class_count = y_train.sum()\n",
    "largest_class_count = len(y_train) - smallest_class_count\n",
    "spw = largest_class_count / smallest_class_count"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "id": "0ca6f8ca",
   "metadata": {},
   "outputs": [],
   "source": [
    "xg=xgb.XGBClassifier(scale_pos_weight=spw)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "id": "32dad1a2",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\xgboost\\sklearn.py:1224: UserWarning: The use of label encoder in XGBClassifier is deprecated and will be removed in a future release. To remove this warning, do the following: 1) Pass option use_label_encoder=False when constructing XGBClassifier object; and 2) Encode your labels (y) as integers starting with 0, i.e. 0, 1, 2, ..., [num_class - 1].\n",
      "  warnings.warn(label_encoder_deprecation_msg, UserWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[12:16:41] WARNING: ..\\src\\learner.cc:1115: Starting in XGBoost 1.3.0, the default evaluation metric used with the objective 'binary:logistic' was changed from 'error' to 'logloss'. Explicitly set eval_metric if you'd like to restore the old behavior.\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<style>#sk-container-id-3 {color: black;background-color: white;}#sk-container-id-3 pre{padding: 0;}#sk-container-id-3 div.sk-toggleable {background-color: white;}#sk-container-id-3 label.sk-toggleable__label {cursor: pointer;display: block;width: 100%;margin-bottom: 0;padding: 0.3em;box-sizing: border-box;text-align: center;}#sk-container-id-3 label.sk-toggleable__label-arrow:before {content: \"▸\";float: left;margin-right: 0.25em;color: #696969;}#sk-container-id-3 label.sk-toggleable__label-arrow:hover:before {color: black;}#sk-container-id-3 div.sk-estimator:hover label.sk-toggleable__label-arrow:before {color: black;}#sk-container-id-3 div.sk-toggleable__content {max-height: 0;max-width: 0;overflow: hidden;text-align: left;background-color: #f0f8ff;}#sk-container-id-3 div.sk-toggleable__content pre {margin: 0.2em;color: black;border-radius: 0.25em;background-color: #f0f8ff;}#sk-container-id-3 input.sk-toggleable__control:checked~div.sk-toggleable__content {max-height: 200px;max-width: 100%;overflow: auto;}#sk-container-id-3 input.sk-toggleable__control:checked~label.sk-toggleable__label-arrow:before {content: \"▾\";}#sk-container-id-3 div.sk-estimator input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-3 div.sk-label input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-3 input.sk-hidden--visually {border: 0;clip: rect(1px 1px 1px 1px);clip: rect(1px, 1px, 1px, 1px);height: 1px;margin: -1px;overflow: hidden;padding: 0;position: absolute;width: 1px;}#sk-container-id-3 div.sk-estimator {font-family: monospace;background-color: #f0f8ff;border: 1px dotted black;border-radius: 0.25em;box-sizing: border-box;margin-bottom: 0.5em;}#sk-container-id-3 div.sk-estimator:hover {background-color: #d4ebff;}#sk-container-id-3 div.sk-parallel-item::after {content: \"\";width: 100%;border-bottom: 1px solid gray;flex-grow: 1;}#sk-container-id-3 div.sk-label:hover label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-3 div.sk-serial::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: 0;}#sk-container-id-3 div.sk-serial {display: flex;flex-direction: column;align-items: center;background-color: white;padding-right: 0.2em;padding-left: 0.2em;position: relative;}#sk-container-id-3 div.sk-item {position: relative;z-index: 1;}#sk-container-id-3 div.sk-parallel {display: flex;align-items: stretch;justify-content: center;background-color: white;position: relative;}#sk-container-id-3 div.sk-item::before, #sk-container-id-3 div.sk-parallel-item::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: -1;}#sk-container-id-3 div.sk-parallel-item {display: flex;flex-direction: column;z-index: 1;position: relative;background-color: white;}#sk-container-id-3 div.sk-parallel-item:first-child::after {align-self: flex-end;width: 50%;}#sk-container-id-3 div.sk-parallel-item:last-child::after {align-self: flex-start;width: 50%;}#sk-container-id-3 div.sk-parallel-item:only-child::after {width: 0;}#sk-container-id-3 div.sk-dashed-wrapped {border: 1px dashed gray;margin: 0 0.4em 0.5em 0.4em;box-sizing: border-box;padding-bottom: 0.4em;background-color: white;}#sk-container-id-3 div.sk-label label {font-family: monospace;font-weight: bold;display: inline-block;line-height: 1.2em;}#sk-container-id-3 div.sk-label-container {text-align: center;}#sk-container-id-3 div.sk-container {/* jupyter's `normalize.less` sets `[hidden] { display: none; }` but bootstrap.min.css set `[hidden] { display: none !important; }` so we also need the `!important` here to be able to override the default hidden behavior on the sphinx rendered scikit-learn.org. See: https://github.com/scikit-learn/scikit-learn/issues/21755 */display: inline-block !important;position: relative;}#sk-container-id-3 div.sk-text-repr-fallback {display: none;}</style><div id=\"sk-container-id-3\" class=\"sk-top-container\"><div class=\"sk-text-repr-fallback\"><pre>XGBClassifier(base_score=0.5, booster=&#x27;gbtree&#x27;, colsample_bylevel=1,\n",
       "              colsample_bynode=1, colsample_bytree=1, enable_categorical=False,\n",
       "              gamma=0, gpu_id=-1, importance_type=None,\n",
       "              interaction_constraints=&#x27;&#x27;, learning_rate=0.300000012,\n",
       "              max_delta_step=0, max_depth=6, min_child_weight=1, missing=nan,\n",
       "              monotone_constraints=&#x27;()&#x27;, n_estimators=100, n_jobs=8,\n",
       "              num_parallel_tree=1, predictor=&#x27;auto&#x27;, random_state=0,\n",
       "              reg_alpha=0, reg_lambda=1, scale_pos_weight=7.484848484848484,\n",
       "              subsample=1, tree_method=&#x27;exact&#x27;, validate_parameters=1,\n",
       "              verbosity=None)</pre><b>In a Jupyter environment, please rerun this cell to show the HTML representation or trust the notebook. <br />On GitHub, the HTML representation is unable to render, please try loading this page with nbviewer.org.</b></div><div class=\"sk-container\" hidden><div class=\"sk-item\"><div class=\"sk-estimator sk-toggleable\"><input class=\"sk-toggleable__control sk-hidden--visually\" id=\"sk-estimator-id-3\" type=\"checkbox\" checked><label for=\"sk-estimator-id-3\" class=\"sk-toggleable__label sk-toggleable__label-arrow\">XGBClassifier</label><div class=\"sk-toggleable__content\"><pre>XGBClassifier(base_score=0.5, booster=&#x27;gbtree&#x27;, colsample_bylevel=1,\n",
       "              colsample_bynode=1, colsample_bytree=1, enable_categorical=False,\n",
       "              gamma=0, gpu_id=-1, importance_type=None,\n",
       "              interaction_constraints=&#x27;&#x27;, learning_rate=0.300000012,\n",
       "              max_delta_step=0, max_depth=6, min_child_weight=1, missing=nan,\n",
       "              monotone_constraints=&#x27;()&#x27;, n_estimators=100, n_jobs=8,\n",
       "              num_parallel_tree=1, predictor=&#x27;auto&#x27;, random_state=0,\n",
       "              reg_alpha=0, reg_lambda=1, scale_pos_weight=7.484848484848484,\n",
       "              subsample=1, tree_method=&#x27;exact&#x27;, validate_parameters=1,\n",
       "              verbosity=None)</pre></div></div></div></div></div>"
      ],
      "text/plain": [
       "XGBClassifier(base_score=0.5, booster='gbtree', colsample_bylevel=1,\n",
       "              colsample_bynode=1, colsample_bytree=1, enable_categorical=False,\n",
       "              gamma=0, gpu_id=-1, importance_type=None,\n",
       "              interaction_constraints='', learning_rate=0.300000012,\n",
       "              max_delta_step=0, max_depth=6, min_child_weight=1, missing=nan,\n",
       "              monotone_constraints='()', n_estimators=100, n_jobs=8,\n",
       "              num_parallel_tree=1, predictor='auto', random_state=0,\n",
       "              reg_alpha=0, reg_lambda=1, scale_pos_weight=7.484848484848484,\n",
       "              subsample=1, tree_method='exact', validate_parameters=1,\n",
       "              verbosity=None)"
      ]
     },
     "execution_count": 90,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "xg.fit(x_train,y_train)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "id": "5acbfbaa",
   "metadata": {},
   "outputs": [],
   "source": [
    "y_pred_xg=xg.predict(x_test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 92,
   "id": "8b9dc64b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.838"
      ]
     },
     "execution_count": 92,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "recall_score(y_test,y_pred_xg,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 93,
   "id": "bd8cacb8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.8741219041081963"
      ]
     },
     "execution_count": 93,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "precision_score(y_test,y_pred_xg,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 94,
   "id": "49adf574",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.8519946052542103"
      ]
     },
     "execution_count": 94,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "f1_score(y_test,y_pred_xg,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 95,
   "id": "6c03e1df",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.7420436987816794"
      ]
     },
     "execution_count": 95,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "balanced_acc = balanced_accuracy_score(y_test, y_pred_xg)\n",
    "balanced_acc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 96,
   "id": "cacd91c3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "from sklearn.metrics import roc_curve, roc_auc_score\n",
    "\n",
    "# Calculate the ROC curve and ROC AUC score\n",
    "fpr, tpr, thresholds = roc_curve(y_test, y_pred_xg)\n",
    "roc_auc = roc_auc_score(y_test, y_pred_xg)\n",
    "\n",
    "# Plot the ROC curve\n",
    "plt.plot(fpr, tpr, label='ROC curve (area = %0.2f)' % roc_auc)\n",
    "plt.plot([0, 1], [0, 1], 'r--')\n",
    "plt.xlim([0, 1])\n",
    "plt.ylim([0, 1])\n",
    "plt.xlabel('False Positive Rate')\n",
    "plt.ylabel('True Positive Rate')\n",
    "plt.title('ROC Curve')\n",
    "plt.legend(loc='lower right')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "id": "8f04d088",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn import model_selection\n",
    "class Benchmark:\n",
    "    def plot_cv_results(self):\n",
    "        plt.figure(figsize=(15,5))\n",
    "        x = np.arange(len(self.results))\n",
    "        plt.bar(x, list(self.results.values()), align='center', color ='g')\n",
    "        plt.xticks(x, list(self.results.keys()))\n",
    "        plt.ylim([0, 1])\n",
    "        plt.ylabel('Cross-Validation Score')\n",
    "        plt.xlabel('Models')\n",
    "        plt.title('Model Comparison')\n",
    "        for index, value in enumerate(self.results.values()):\n",
    "            plt.text(index, value, str(round(value,2)))\n",
    "        plt.show()\n",
    "\n",
    "\n",
    "    def __init__(self, models):\n",
    "        self.models = models\n",
    "\n",
    "    def test_models(self, X=x, y=y, cv=5):\n",
    "        self.results = {}\n",
    "        for name, model in self.models.items():\n",
    "            scores = model_selection.cross_val_score(model, X, y, cv=cv)\n",
    "            self.results[name] = scores.mean()\n",
    "        self.best_model = max(self.results, key=self.results.get)\n",
    "        return f\"The best model is: {self.best_model} with a score of {self.results[self.best_model]:.3f}\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 98,
   "id": "7e23e58b",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\sklearn\\linear_model\\_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\n",
      "STOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n",
      "\n",
      "Increase the number of iterations (max_iter) or scale the data as shown in:\n",
      "    https://scikit-learn.org/stable/modules/preprocessing.html\n",
      "Please also refer to the documentation for alternative solver options:\n",
      "    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n",
      "  n_iter_i = _check_optimize_result(\n",
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\sklearn\\linear_model\\_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\n",
      "STOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n",
      "\n",
      "Increase the number of iterations (max_iter) or scale the data as shown in:\n",
      "    https://scikit-learn.org/stable/modules/preprocessing.html\n",
      "Please also refer to the documentation for alternative solver options:\n",
      "    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n",
      "  n_iter_i = _check_optimize_result(\n",
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\sklearn\\linear_model\\_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\n",
      "STOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n",
      "\n",
      "Increase the number of iterations (max_iter) or scale the data as shown in:\n",
      "    https://scikit-learn.org/stable/modules/preprocessing.html\n",
      "Please also refer to the documentation for alternative solver options:\n",
      "    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n",
      "  n_iter_i = _check_optimize_result(\n",
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\sklearn\\linear_model\\_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\n",
      "STOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n",
      "\n",
      "Increase the number of iterations (max_iter) or scale the data as shown in:\n",
      "    https://scikit-learn.org/stable/modules/preprocessing.html\n",
      "Please also refer to the documentation for alternative solver options:\n",
      "    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n",
      "  n_iter_i = _check_optimize_result(\n",
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\sklearn\\linear_model\\_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\n",
      "STOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n",
      "\n",
      "Increase the number of iterations (max_iter) or scale the data as shown in:\n",
      "    https://scikit-learn.org/stable/modules/preprocessing.html\n",
      "Please also refer to the documentation for alternative solver options:\n",
      "    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n",
      "  n_iter_i = _check_optimize_result(\n",
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\xgboost\\sklearn.py:1224: UserWarning: The use of label encoder in XGBClassifier is deprecated and will be removed in a future release. To remove this warning, do the following: 1) Pass option use_label_encoder=False when constructing XGBClassifier object; and 2) Encode your labels (y) as integers starting with 0, i.e. 0, 1, 2, ..., [num_class - 1].\n",
      "  warnings.warn(label_encoder_deprecation_msg, UserWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[12:16:48] WARNING: ..\\src\\learner.cc:1115: Starting in XGBoost 1.3.0, the default evaluation metric used with the objective 'binary:logistic' was changed from 'error' to 'logloss'. Explicitly set eval_metric if you'd like to restore the old behavior.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\xgboost\\sklearn.py:1224: UserWarning: The use of label encoder in XGBClassifier is deprecated and will be removed in a future release. To remove this warning, do the following: 1) Pass option use_label_encoder=False when constructing XGBClassifier object; and 2) Encode your labels (y) as integers starting with 0, i.e. 0, 1, 2, ..., [num_class - 1].\n",
      "  warnings.warn(label_encoder_deprecation_msg, UserWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[12:16:48] WARNING: ..\\src\\learner.cc:1115: Starting in XGBoost 1.3.0, the default evaluation metric used with the objective 'binary:logistic' was changed from 'error' to 'logloss'. Explicitly set eval_metric if you'd like to restore the old behavior.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\xgboost\\sklearn.py:1224: UserWarning: The use of label encoder in XGBClassifier is deprecated and will be removed in a future release. To remove this warning, do the following: 1) Pass option use_label_encoder=False when constructing XGBClassifier object; and 2) Encode your labels (y) as integers starting with 0, i.e. 0, 1, 2, ..., [num_class - 1].\n",
      "  warnings.warn(label_encoder_deprecation_msg, UserWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[12:16:49] WARNING: ..\\src\\learner.cc:1115: Starting in XGBoost 1.3.0, the default evaluation metric used with the objective 'binary:logistic' was changed from 'error' to 'logloss'. Explicitly set eval_metric if you'd like to restore the old behavior.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\xgboost\\sklearn.py:1224: UserWarning: The use of label encoder in XGBClassifier is deprecated and will be removed in a future release. To remove this warning, do the following: 1) Pass option use_label_encoder=False when constructing XGBClassifier object; and 2) Encode your labels (y) as integers starting with 0, i.e. 0, 1, 2, ..., [num_class - 1].\n",
      "  warnings.warn(label_encoder_deprecation_msg, UserWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[12:16:49] WARNING: ..\\src\\learner.cc:1115: Starting in XGBoost 1.3.0, the default evaluation metric used with the objective 'binary:logistic' was changed from 'error' to 'logloss'. Explicitly set eval_metric if you'd like to restore the old behavior.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\xgboost\\sklearn.py:1224: UserWarning: The use of label encoder in XGBClassifier is deprecated and will be removed in a future release. To remove this warning, do the following: 1) Pass option use_label_encoder=False when constructing XGBClassifier object; and 2) Encode your labels (y) as integers starting with 0, i.e. 0, 1, 2, ..., [num_class - 1].\n",
      "  warnings.warn(label_encoder_deprecation_msg, UserWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[12:16:49] WARNING: ..\\src\\learner.cc:1115: Starting in XGBoost 1.3.0, the default evaluation metric used with the objective 'binary:logistic' was changed from 'error' to 'logloss'. Explicitly set eval_metric if you'd like to restore the old behavior.\n",
      "The best model is: Random Forest with a score of 0.880\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x360 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "models = {\n",
    "    'logistic': lr,\n",
    "    'Random Forest': rfc ,\n",
    "    'XGBoost': xg\n",
    "\n",
    "}\n",
    "\n",
    "benchmark = Benchmark(models)\n",
    "print(benchmark.test_models())\n",
    "benchmark.plot_cv_results()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 99,
   "id": "ba92b8e8",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.tree import DecisionTreeClassifier"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 100,
   "id": "f248e2ab",
   "metadata": {},
   "outputs": [],
   "source": [
    "dt= DecisionTreeClassifier(class_weight='balanced')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 101,
   "id": "59dfc789",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<style>#sk-container-id-4 {color: black;background-color: white;}#sk-container-id-4 pre{padding: 0;}#sk-container-id-4 div.sk-toggleable {background-color: white;}#sk-container-id-4 label.sk-toggleable__label {cursor: pointer;display: block;width: 100%;margin-bottom: 0;padding: 0.3em;box-sizing: border-box;text-align: center;}#sk-container-id-4 label.sk-toggleable__label-arrow:before {content: \"▸\";float: left;margin-right: 0.25em;color: #696969;}#sk-container-id-4 label.sk-toggleable__label-arrow:hover:before {color: black;}#sk-container-id-4 div.sk-estimator:hover label.sk-toggleable__label-arrow:before {color: black;}#sk-container-id-4 div.sk-toggleable__content {max-height: 0;max-width: 0;overflow: hidden;text-align: left;background-color: #f0f8ff;}#sk-container-id-4 div.sk-toggleable__content pre {margin: 0.2em;color: black;border-radius: 0.25em;background-color: #f0f8ff;}#sk-container-id-4 input.sk-toggleable__control:checked~div.sk-toggleable__content {max-height: 200px;max-width: 100%;overflow: auto;}#sk-container-id-4 input.sk-toggleable__control:checked~label.sk-toggleable__label-arrow:before {content: \"▾\";}#sk-container-id-4 div.sk-estimator input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-4 div.sk-label input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-4 input.sk-hidden--visually {border: 0;clip: rect(1px 1px 1px 1px);clip: rect(1px, 1px, 1px, 1px);height: 1px;margin: -1px;overflow: hidden;padding: 0;position: absolute;width: 1px;}#sk-container-id-4 div.sk-estimator {font-family: monospace;background-color: #f0f8ff;border: 1px dotted black;border-radius: 0.25em;box-sizing: border-box;margin-bottom: 0.5em;}#sk-container-id-4 div.sk-estimator:hover {background-color: #d4ebff;}#sk-container-id-4 div.sk-parallel-item::after {content: \"\";width: 100%;border-bottom: 1px solid gray;flex-grow: 1;}#sk-container-id-4 div.sk-label:hover label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-4 div.sk-serial::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: 0;}#sk-container-id-4 div.sk-serial {display: flex;flex-direction: column;align-items: center;background-color: white;padding-right: 0.2em;padding-left: 0.2em;position: relative;}#sk-container-id-4 div.sk-item {position: relative;z-index: 1;}#sk-container-id-4 div.sk-parallel {display: flex;align-items: stretch;justify-content: center;background-color: white;position: relative;}#sk-container-id-4 div.sk-item::before, #sk-container-id-4 div.sk-parallel-item::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: -1;}#sk-container-id-4 div.sk-parallel-item {display: flex;flex-direction: column;z-index: 1;position: relative;background-color: white;}#sk-container-id-4 div.sk-parallel-item:first-child::after {align-self: flex-end;width: 50%;}#sk-container-id-4 div.sk-parallel-item:last-child::after {align-self: flex-start;width: 50%;}#sk-container-id-4 div.sk-parallel-item:only-child::after {width: 0;}#sk-container-id-4 div.sk-dashed-wrapped {border: 1px dashed gray;margin: 0 0.4em 0.5em 0.4em;box-sizing: border-box;padding-bottom: 0.4em;background-color: white;}#sk-container-id-4 div.sk-label label {font-family: monospace;font-weight: bold;display: inline-block;line-height: 1.2em;}#sk-container-id-4 div.sk-label-container {text-align: center;}#sk-container-id-4 div.sk-container {/* jupyter's `normalize.less` sets `[hidden] { display: none; }` but bootstrap.min.css set `[hidden] { display: none !important; }` so we also need the `!important` here to be able to override the default hidden behavior on the sphinx rendered scikit-learn.org. See: https://github.com/scikit-learn/scikit-learn/issues/21755 */display: inline-block !important;position: relative;}#sk-container-id-4 div.sk-text-repr-fallback {display: none;}</style><div id=\"sk-container-id-4\" class=\"sk-top-container\"><div class=\"sk-text-repr-fallback\"><pre>DecisionTreeClassifier(class_weight=&#x27;balanced&#x27;)</pre><b>In a Jupyter environment, please rerun this cell to show the HTML representation or trust the notebook. <br />On GitHub, the HTML representation is unable to render, please try loading this page with nbviewer.org.</b></div><div class=\"sk-container\" hidden><div class=\"sk-item\"><div class=\"sk-estimator sk-toggleable\"><input class=\"sk-toggleable__control sk-hidden--visually\" id=\"sk-estimator-id-4\" type=\"checkbox\" checked><label for=\"sk-estimator-id-4\" class=\"sk-toggleable__label sk-toggleable__label-arrow\">DecisionTreeClassifier</label><div class=\"sk-toggleable__content\"><pre>DecisionTreeClassifier(class_weight=&#x27;balanced&#x27;)</pre></div></div></div></div></div>"
      ],
      "text/plain": [
       "DecisionTreeClassifier(class_weight='balanced')"
      ]
     },
     "execution_count": 101,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "dt.fit(x_train,y_train)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 102,
   "id": "42b79c26",
   "metadata": {},
   "outputs": [],
   "source": [
    "y_pred_dt=dt.predict(x_test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "id": "da97e8b3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.8243333333333334"
      ]
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "recall_score(y_test,y_pred_dt,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "id": "2e239bc3",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.8476296890600485"
      ]
     },
     "execution_count": 104,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "precision_score(y_test,y_pred_dt,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 105,
   "id": "05ab6ec4",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.834579440442723"
      ]
     },
     "execution_count": 105,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "f1_score(y_test,y_pred_dt,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 106,
   "id": "2fd40998",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.664794706359402"
      ]
     },
     "execution_count": 106,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "balanced_acc = balanced_accuracy_score(y_test, y_pred_dt)\n",
    "balanced_acc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 107,
   "id": "7d1510c8",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "from sklearn.metrics import roc_curve, roc_auc_score\n",
    "\n",
    "# Calculate the ROC curve and ROC AUC score\n",
    "fpr, tpr, thresholds = roc_curve(y_test, y_pred_dt)\n",
    "roc_auc = roc_auc_score(y_test, y_pred_dt)\n",
    "\n",
    "# Plot the ROC curve\n",
    "plt.plot(fpr, tpr, label='ROC curve (area = %0.2f)' % roc_auc)\n",
    "plt.plot([0, 1], [0, 1], 'r--')\n",
    "plt.xlim([0, 1])\n",
    "plt.ylim([0, 1])\n",
    "plt.xlabel('False Positive Rate')\n",
    "plt.ylabel('True Positive Rate')\n",
    "plt.title('ROC Curve')\n",
    "plt.legend(loc='lower right')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 108,
   "id": "c44b589d",
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.svm import SVC"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "id": "19926b9e",
   "metadata": {},
   "outputs": [],
   "source": [
    "sv=SVC(class_weight='balanced')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 110,
   "id": "336c37c9",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<style>#sk-container-id-5 {color: black;background-color: white;}#sk-container-id-5 pre{padding: 0;}#sk-container-id-5 div.sk-toggleable {background-color: white;}#sk-container-id-5 label.sk-toggleable__label {cursor: pointer;display: block;width: 100%;margin-bottom: 0;padding: 0.3em;box-sizing: border-box;text-align: center;}#sk-container-id-5 label.sk-toggleable__label-arrow:before {content: \"▸\";float: left;margin-right: 0.25em;color: #696969;}#sk-container-id-5 label.sk-toggleable__label-arrow:hover:before {color: black;}#sk-container-id-5 div.sk-estimator:hover label.sk-toggleable__label-arrow:before {color: black;}#sk-container-id-5 div.sk-toggleable__content {max-height: 0;max-width: 0;overflow: hidden;text-align: left;background-color: #f0f8ff;}#sk-container-id-5 div.sk-toggleable__content pre {margin: 0.2em;color: black;border-radius: 0.25em;background-color: #f0f8ff;}#sk-container-id-5 input.sk-toggleable__control:checked~div.sk-toggleable__content {max-height: 200px;max-width: 100%;overflow: auto;}#sk-container-id-5 input.sk-toggleable__control:checked~label.sk-toggleable__label-arrow:before {content: \"▾\";}#sk-container-id-5 div.sk-estimator input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-5 div.sk-label input.sk-toggleable__control:checked~label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-5 input.sk-hidden--visually {border: 0;clip: rect(1px 1px 1px 1px);clip: rect(1px, 1px, 1px, 1px);height: 1px;margin: -1px;overflow: hidden;padding: 0;position: absolute;width: 1px;}#sk-container-id-5 div.sk-estimator {font-family: monospace;background-color: #f0f8ff;border: 1px dotted black;border-radius: 0.25em;box-sizing: border-box;margin-bottom: 0.5em;}#sk-container-id-5 div.sk-estimator:hover {background-color: #d4ebff;}#sk-container-id-5 div.sk-parallel-item::after {content: \"\";width: 100%;border-bottom: 1px solid gray;flex-grow: 1;}#sk-container-id-5 div.sk-label:hover label.sk-toggleable__label {background-color: #d4ebff;}#sk-container-id-5 div.sk-serial::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: 0;}#sk-container-id-5 div.sk-serial {display: flex;flex-direction: column;align-items: center;background-color: white;padding-right: 0.2em;padding-left: 0.2em;position: relative;}#sk-container-id-5 div.sk-item {position: relative;z-index: 1;}#sk-container-id-5 div.sk-parallel {display: flex;align-items: stretch;justify-content: center;background-color: white;position: relative;}#sk-container-id-5 div.sk-item::before, #sk-container-id-5 div.sk-parallel-item::before {content: \"\";position: absolute;border-left: 1px solid gray;box-sizing: border-box;top: 0;bottom: 0;left: 50%;z-index: -1;}#sk-container-id-5 div.sk-parallel-item {display: flex;flex-direction: column;z-index: 1;position: relative;background-color: white;}#sk-container-id-5 div.sk-parallel-item:first-child::after {align-self: flex-end;width: 50%;}#sk-container-id-5 div.sk-parallel-item:last-child::after {align-self: flex-start;width: 50%;}#sk-container-id-5 div.sk-parallel-item:only-child::after {width: 0;}#sk-container-id-5 div.sk-dashed-wrapped {border: 1px dashed gray;margin: 0 0.4em 0.5em 0.4em;box-sizing: border-box;padding-bottom: 0.4em;background-color: white;}#sk-container-id-5 div.sk-label label {font-family: monospace;font-weight: bold;display: inline-block;line-height: 1.2em;}#sk-container-id-5 div.sk-label-container {text-align: center;}#sk-container-id-5 div.sk-container {/* jupyter's `normalize.less` sets `[hidden] { display: none; }` but bootstrap.min.css set `[hidden] { display: none !important; }` so we also need the `!important` here to be able to override the default hidden behavior on the sphinx rendered scikit-learn.org. See: https://github.com/scikit-learn/scikit-learn/issues/21755 */display: inline-block !important;position: relative;}#sk-container-id-5 div.sk-text-repr-fallback {display: none;}</style><div id=\"sk-container-id-5\" class=\"sk-top-container\"><div class=\"sk-text-repr-fallback\"><pre>SVC(class_weight=&#x27;balanced&#x27;)</pre><b>In a Jupyter environment, please rerun this cell to show the HTML representation or trust the notebook. <br />On GitHub, the HTML representation is unable to render, please try loading this page with nbviewer.org.</b></div><div class=\"sk-container\" hidden><div class=\"sk-item\"><div class=\"sk-estimator sk-toggleable\"><input class=\"sk-toggleable__control sk-hidden--visually\" id=\"sk-estimator-id-5\" type=\"checkbox\" checked><label for=\"sk-estimator-id-5\" class=\"sk-toggleable__label sk-toggleable__label-arrow\">SVC</label><div class=\"sk-toggleable__content\"><pre>SVC(class_weight=&#x27;balanced&#x27;)</pre></div></div></div></div></div>"
      ],
      "text/plain": [
       "SVC(class_weight='balanced')"
      ]
     },
     "execution_count": 110,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sv.fit(x_train,y_train)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "id": "e4f71705",
   "metadata": {},
   "outputs": [],
   "source": [
    "y_pred_sv=sv.predict(x_test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "id": "b75e646f",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.13633333333333333"
      ]
     },
     "execution_count": 112,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "recall_score(y_test,y_pred_sv,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 113,
   "id": "2b0d40e2",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.8918229799684897"
      ]
     },
     "execution_count": 113,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "precision_score(y_test,y_pred_sv,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 114,
   "id": "1a0e187b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.05250333154800294"
      ]
     },
     "execution_count": 114,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "f1_score(y_test,y_pred_sv,average='weighted')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "id": "909aba71",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0.5072270825408901"
      ]
     },
     "execution_count": 115,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "balanced_acc = balanced_accuracy_score(y_test, y_pred_sv)\n",
    "balanced_acc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 116,
   "id": "00d97efc",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "from sklearn.metrics import roc_curve, roc_auc_score\n",
    "\n",
    "# Calculate the ROC curve and ROC AUC score\n",
    "fpr, tpr, thresholds = roc_curve(y_test, y_pred_sv)\n",
    "roc_auc = roc_auc_score(y_test, y_pred_sv)\n",
    "\n",
    "# Plot the ROC curve\n",
    "plt.plot(fpr, tpr, label='ROC curve (area = %0.2f)' % roc_auc)\n",
    "plt.plot([0, 1], [0, 1], 'r--')\n",
    "plt.xlim([0, 1])\n",
    "plt.ylim([0, 1])\n",
    "plt.xlabel('False Positive Rate')\n",
    "plt.ylabel('True Positive Rate')\n",
    "plt.title('ROC Curve')\n",
    "plt.legend(loc='lower right')\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 117,
   "id": "fd9f4c82",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\sklearn\\linear_model\\_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\n",
      "STOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n",
      "\n",
      "Increase the number of iterations (max_iter) or scale the data as shown in:\n",
      "    https://scikit-learn.org/stable/modules/preprocessing.html\n",
      "Please also refer to the documentation for alternative solver options:\n",
      "    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n",
      "  n_iter_i = _check_optimize_result(\n",
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\sklearn\\linear_model\\_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\n",
      "STOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n",
      "\n",
      "Increase the number of iterations (max_iter) or scale the data as shown in:\n",
      "    https://scikit-learn.org/stable/modules/preprocessing.html\n",
      "Please also refer to the documentation for alternative solver options:\n",
      "    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n",
      "  n_iter_i = _check_optimize_result(\n",
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\sklearn\\linear_model\\_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\n",
      "STOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n",
      "\n",
      "Increase the number of iterations (max_iter) or scale the data as shown in:\n",
      "    https://scikit-learn.org/stable/modules/preprocessing.html\n",
      "Please also refer to the documentation for alternative solver options:\n",
      "    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n",
      "  n_iter_i = _check_optimize_result(\n",
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\sklearn\\linear_model\\_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\n",
      "STOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n",
      "\n",
      "Increase the number of iterations (max_iter) or scale the data as shown in:\n",
      "    https://scikit-learn.org/stable/modules/preprocessing.html\n",
      "Please also refer to the documentation for alternative solver options:\n",
      "    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n",
      "  n_iter_i = _check_optimize_result(\n",
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\sklearn\\linear_model\\_logistic.py:458: ConvergenceWarning: lbfgs failed to converge (status=1):\n",
      "STOP: TOTAL NO. of ITERATIONS REACHED LIMIT.\n",
      "\n",
      "Increase the number of iterations (max_iter) or scale the data as shown in:\n",
      "    https://scikit-learn.org/stable/modules/preprocessing.html\n",
      "Please also refer to the documentation for alternative solver options:\n",
      "    https://scikit-learn.org/stable/modules/linear_model.html#logistic-regression\n",
      "  n_iter_i = _check_optimize_result(\n",
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\xgboost\\sklearn.py:1224: UserWarning: The use of label encoder in XGBClassifier is deprecated and will be removed in a future release. To remove this warning, do the following: 1) Pass option use_label_encoder=False when constructing XGBClassifier object; and 2) Encode your labels (y) as integers starting with 0, i.e. 0, 1, 2, ..., [num_class - 1].\n",
      "  warnings.warn(label_encoder_deprecation_msg, UserWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[12:17:04] WARNING: ..\\src\\learner.cc:1115: Starting in XGBoost 1.3.0, the default evaluation metric used with the objective 'binary:logistic' was changed from 'error' to 'logloss'. Explicitly set eval_metric if you'd like to restore the old behavior.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\xgboost\\sklearn.py:1224: UserWarning: The use of label encoder in XGBClassifier is deprecated and will be removed in a future release. To remove this warning, do the following: 1) Pass option use_label_encoder=False when constructing XGBClassifier object; and 2) Encode your labels (y) as integers starting with 0, i.e. 0, 1, 2, ..., [num_class - 1].\n",
      "  warnings.warn(label_encoder_deprecation_msg, UserWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[12:17:04] WARNING: ..\\src\\learner.cc:1115: Starting in XGBoost 1.3.0, the default evaluation metric used with the objective 'binary:logistic' was changed from 'error' to 'logloss'. Explicitly set eval_metric if you'd like to restore the old behavior.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\xgboost\\sklearn.py:1224: UserWarning: The use of label encoder in XGBClassifier is deprecated and will be removed in a future release. To remove this warning, do the following: 1) Pass option use_label_encoder=False when constructing XGBClassifier object; and 2) Encode your labels (y) as integers starting with 0, i.e. 0, 1, 2, ..., [num_class - 1].\n",
      "  warnings.warn(label_encoder_deprecation_msg, UserWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[12:17:04] WARNING: ..\\src\\learner.cc:1115: Starting in XGBoost 1.3.0, the default evaluation metric used with the objective 'binary:logistic' was changed from 'error' to 'logloss'. Explicitly set eval_metric if you'd like to restore the old behavior.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\xgboost\\sklearn.py:1224: UserWarning: The use of label encoder in XGBClassifier is deprecated and will be removed in a future release. To remove this warning, do the following: 1) Pass option use_label_encoder=False when constructing XGBClassifier object; and 2) Encode your labels (y) as integers starting with 0, i.e. 0, 1, 2, ..., [num_class - 1].\n",
      "  warnings.warn(label_encoder_deprecation_msg, UserWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[12:17:05] WARNING: ..\\src\\learner.cc:1115: Starting in XGBoost 1.3.0, the default evaluation metric used with the objective 'binary:logistic' was changed from 'error' to 'logloss'. Explicitly set eval_metric if you'd like to restore the old behavior.\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\xgboost\\sklearn.py:1224: UserWarning: The use of label encoder in XGBClassifier is deprecated and will be removed in a future release. To remove this warning, do the following: 1) Pass option use_label_encoder=False when constructing XGBClassifier object; and 2) Encode your labels (y) as integers starting with 0, i.e. 0, 1, 2, ..., [num_class - 1].\n",
      "  warnings.warn(label_encoder_deprecation_msg, UserWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[12:17:06] WARNING: ..\\src\\learner.cc:1115: Starting in XGBoost 1.3.0, the default evaluation metric used with the objective 'binary:logistic' was changed from 'error' to 'logloss'. Explicitly set eval_metric if you'd like to restore the old behavior.\n",
      "The best model is: Random Forest with a score of 0.882\n"
     ]
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1080x360 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "models = {\n",
    "    'logistic': lr,\n",
    "    'Random Forest': rfc ,\n",
    "    'XGBoost': xg,\n",
    "    'SVM' : sv,\n",
    "    'Decision Tree': dt\n",
    "\n",
    "}\n",
    "\n",
    "benchmark = Benchmark(models)\n",
    "print(benchmark.test_models())\n",
    "benchmark.plot_cv_results()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 118,
   "id": "04ed6114",
   "metadata": {},
   "outputs": [],
   "source": [
    "cds1.to_csv(r'C:/Users/rabhi/OneDrive/Documents/Data_Clinical_Test1.csv', index = False, header = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "id": "b239014f",
   "metadata": {},
   "outputs": [],
   "source": [
    "cd.to_csv(r'C:/Users/rabhi/OneDrive/Documents/Data_Clinical_Samples.csv', index = False, header = True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "id": "95db0409",
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\rabhi\\anaconda3\\lib\\site-packages\\seaborn\\_decorators.py:36: FutureWarning: Pass the following variable as a keyword arg: x. From version 0.12, the only valid positional argument will be `data`, and passing other arguments without an explicit keyword will result in an error or misinterpretation.\n",
      "  warnings.warn(\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<AxesSubplot:xlabel='Status', ylabel='count'>"
      ]
     },
     "execution_count": 120,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "sns.countplot(cds1['Status'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "3c8576e3",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
